Sentence,class,file
Infinium Methylation Assay Microarrays  The transverse colonic mucosal DNA sample quality  was examined with PicoGreen (http://probes.invitrogen.com/media/pis/mp07581.pdf) before processing toward the microarrays.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
"After removal of probes containing SNPs (http://www.rforge.net/IMA/snpsites.txt), 390,433 CpG probes on the array were used for subsequent analysis.",OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
The raw data of the microarrays  was uploaded to Gene Expression Omnibus (GEO; Series GSE32146) and is accessible at: Discovery cohort: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=frutfkgmamamkvi&acc= GSE32146.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Validation cohort: http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?token=pvojjiqcqiuqori&acc=GSE42921.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
The CEL files and RMA normalized expression values can be downloaded from http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=pzyffweqggmsgnk&acc=GSE42911.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
DAVID (http://david.abcc.ncifcrf.gov/) was utilized to examine gene ontology enrichment in the select gene lists; significance was declared at P values adjusted for multiple testing P < 0.05.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Data Access DNA methylation: Gene Expression Omnibus (GEO; Series  GSE32146) and is accessible at: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=frutfkgmamamkvi&acc=GSE32146.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=pvojj iqcqiuqori&acc=GSE42921 Gene expression: The CEL files and RMA normalized  expression values can be downloaded from http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=pzyffweqggmsgnk&acc=GSE42911.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
"Gastroenterology  2012; 142:46-54, e42, quiz e30; PMID:22001864 ;  http://dx.doi.org/10.1053/j.gastro.2011.10.001 2.",Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Inflamm Bowel Dis  2011 ; 17:1603 -9; PMID:21053357 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Gut 2009 ; 58:1490 - 7; PMID:19651626 ; http://dx.doi.org/10.1136/ gut.2009.188383 4.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
"J Pediatr  2010 ; 157:233,  e1; PMID:20400099 ; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Inflamm Bowel Dis  2010 ; 16:638-44; PMID:19760783 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
J Pediatr Gastroenterol Nutr 2011 ; 53:141- 4; PMID:21788753 ; http://dx.doi.org/10.1097/ MPG.0b013e318218be35,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Best Pract Res Clin  Gastroenterol  2004 ; 18:509-23; PMID :15157824 ;  http://dx.doi.org/10.1016/j.bpg.2004.01.002 8.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Dig Dis Sci 2013 ; 58:519-25;  PMID:22926499 ; http://dx.doi.org/10.1007/ s10620-012-2371-5 9.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Gastroenterology   2008 ; 135:1114 -22; PMID:18725221 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Mutat Res   2010 ; 690:71-80; PMID:20188748 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Am J Gastroenterol  2011 ; 106:563-73; PMID:21468064 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
PLoS One  2013 ; 8:e73162 ; PMID:23977377 ;  http://dx.doi.org/10.1371/journal.pone.0073162 16.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
J Immunol   2011 ; 186:6505 -14; PMID :21515785 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Genome Res 2012 ; 22:2130 - 7; PMID:22826509 ; http://dx.doi.org/10.1101/ gr.138347.11219.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Gastroenterology   2007 ; 133:423-32; PMID:17681163 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Int J Epidemiol 2012 ; 41:200- 9; PMID:22422453 ; http://dx.doi.org/10.1093/ije/ dyr238 21.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Epigenetics  2011 ; 6:692- 702; PMID:21593595 ; http://dx.doi.org/10.4161/ epi.6.6.16196 23.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Inflamm Bowel Dis 2012 ; 18:2334 - 41; PMID:22467598 ; http://dx.doi.org/10.1002/ ibd.22956 25.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Dig Dis Sci 2012 ; 57:3145 - 53; PMID:22821069 ; http://dx.doi.org/10.1007/ s10620-012-2288-z 26.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Inflamm Bowel Dis 2013 ; 19:E66-7;  PMID:23314245 ; http://dx.doi.org/10.1097/ MIB.0b013e318280eca4 27.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
PLoS One  2013 ; 8:e55636 ;  PMID:23409010 ; http://dx.doi.org/10.1371/ journal.pone.0055636 28.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Hum Mol Genet 2001 ; 10:445-56; PMID:11181568 ;  http://dx.doi.org/10.1093/hmg/10.5.445 29.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
J  Leukoc Biol  2007 ; 81:907-15; PMID:17200145 ;  http://dx.doi.org/10.1189/jlb.090658131.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Inflamm Bowel Dis  2008 ; 14:446-57; PMID:18069684 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Exp  Mol Pathol  2014 ; 96:346-53; PMID:24613686 ;  http://dx.doi.org/10.1016/j.yexmp.2014.02.013 33.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Aliment Pharmacol Ther   2005 ; 21:1091 -7; PMID :15854170 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Inflamm Bowel Dis 2013 ; 19:221- 9; PMID:22605655 ; http://dx.doi.org/10.1002/ ibd.23020 35.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Clin Biochem  2008 ;  41:1440 -8; PMID:18835263 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
PLoS One  2010 ; 5:e13607 ; PMID:21042588 ;  http://dx.doi.org/10.1371/journal.pone.0013607 37.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Gastroenterology   2011 ; 141:227-36; PMID:21621540 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Mol Cell Biol  2003 ; 23:5293 - 300; PMID :12861015 ; http://dx.doi.org/10.1128/ MCB.23.15.5293-5300.2003 39.,Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Bioinformatics  2014 ; 30:1363 -9;  PMID:24478339 ; http://dx.doi.org/10.1093/ bioinformatics/btu049 40.,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
Bioinformatics  2004 ; 20:307- 15; PMID:14960456 ; http://dx.doi.org/10.1093/ bioinformatics/btg405,OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
"*Correspondence to: Charles De Smet; Email: charles.desmet@uclouvain.be Submitted: 05/12/2014; Revised: 06/13/2014; Accepted: 06/17/2014; Published Online: 07/08/2014http://dx.doi.org/10.4161/epi.29628A novel cancer-germline transcript carrying   pro-metastatic miR-105 and TET -targeting miR-767  induced by DNA hypomethylation in tumors Axelle Loriot1,‡, Aurélie Van t ongelen1,‡, Jordi Blanco1,†, simon Klaessens1, Julie c annuyer1, Nicolas van Baren2,   Anabelle Decottignies1, and c harles De s met1,* 1Group of Genetics and e pigenetics; de Duve i nstitute; Université c atholique de Louvain; Brussels, Belgium; 2Ludwig i nstitute for c ancer r esearch Ltd;   centre du c ancer des c liniques Universitaires s aint-Luc; Brussels, Belgium †current affiliation: p hysiology Unit; s chool of Medicine; Universitat r ovira i Virgili; r eus, s pain ‡these authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Genes Dev 2002; 16:6-21;  PMID:11782440 ; http://dx.doi.org/10.1101/ gad.947102 2.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Adv  Exp Med Biol 2013; 754:149-66; PMID:22956500 ;  http://dx.doi.org/10.1007/978-1-4419-9967-2_7 4.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Nat Rev Cancer 2005; 5:615-25;   PMID:16034368 ; http://dx.doi.org/10.1038/ nrc1669 5.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
PLoS One  2013; 8:e58743;  PMID:23472218 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Nat Rev Genet 2009; 10:704- 14; PMID :19763153 ; http://dx.doi.org/10.1038/ nrg2634 8.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
FEBS Lett 2011; 585:2087- 99; PMID:20708002 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
World J Gastroenterol 2008; 14:7175- 82; PMID:19084931 ; http://dx.doi.org/10.3748/ wjg.14.7175 11.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
PLoS Med 2006;  3:e467;  PMID:17194181 ; http://dx.doi.org/10.1371/ journal.pmed.0030467 12.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Epigenetics Chromatin 2013; 6:10; PMID:23634848 ;  http://dx.doi.org/10.1186/1756-8935-6-1015.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Nature 2010; 466:1129- 33; PMID:20639862 ; http://dx.doi.org/10.1038/ nature09303 16.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Science 2009; 324:930- 5; PMID:19372391 ; http://dx.doi.org/10.1126/ science.1170116 17.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cell 2012; 150:1135-46; PMID:22980977 ;  http://dx.doi.org/10.1016/j.cell.2012.07.033 19.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Oncogene  2013; 32:663-9;  PMID :22391558 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cancer Cell 2010; 18:553-67;  PMID:21130701 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cell Rep  2012; 2:568-79;  PMID:22999938 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cell Stem Cell 2013; 13:87- 101; PMID:23827711 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cell 2013; 154:311-24;  PMID:23830207 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cancer Cell  2011; 20:11-24;  PMID:21723200 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cancer Cell 2011; 20:25- 38; PMID:21723201 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
PLoS One 2014; 9:e87665;  PMID:24498348 ; http://dx.doi.org/10.1371/jour - nal.pone.0087665 28.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
EMBO Rep 2012; 13:28-35; PMID:22157888 ;  http://dx.doi.org/10.1038/embor.2011.233 29.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Science 2013; 339:448-52; PMID:23223451 ; http://dx.doi.org/10.1126/ science.1229277 30.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Nature  2013; 504:460-4;  PMID:24291790 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Hum Reprod 2007; 22:953-60; PMID:17208940 ;  http://dx.doi.org/10.1093/humrep/del494 32.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Cancer Res 2004; 64:5988-93;  PMID :15342378 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1187 33.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Development 2006; 133:3411- 8; PMID:16887828 ; http://dx.doi.org/10.1242/ dev.02500 34.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Nucleic Acids Res 2011; 39:5015-24;  PMID:21378125 ; http://dx.doi.org/10.1093/nar/ gkr120 35.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Neuron 2013; 79:1086- 93; PMID:24050399 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Neuron 2013; 79:1109- 22; PMID:24050401 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Biochem Biophys Res Commun 2012; 417:187-91;  PMID :22155245 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Mol Cell Biol 2004; 24:4781-90;  PMID:15143172 ; http://dx.doi.org/10.1128/ MCB.24.11.4781-4790.200440.,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Proc Natl Acad Sci U S A  1996; 93:7149-53;  PMID:8692960 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
Nature 2012; 489:519- 25; PMID:22960745 ; http://dx.doi.org/10.1038/ nature11404,Non-OADS,/arxiv_data1/oa_pdf/95/aa/epi-9-1163.PMC4164501.pdf
The Venn diagram was generated at http://bioinformatics.psb.ugent.be/webtools/Venn/.NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5611 ARTICLE NATURE COMMUNICATIONS | 5:4611 | DOI: 10.1038/ncomms5611 | www.nature.com/naturecommunications 5 &2014 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/42/25/ncomms5611.PMC4164542.pdf
"gambiae (RepBase version 17.08 09-01-2012, http://www.fruitﬂy.org/data/ p_disrupt/datasets/ASHBURNER/D_mel_transposon_sequence_set.fasta version 9.41) 51.",Non-OADS,/arxiv_data1/oa_pdf/42/25/ncomms5611.PMC4164542.pdf
http://picard.sourceforge.net (2013).46.,Non-OADS,/arxiv_data1/oa_pdf/42/25/ncomms5611.PMC4164542.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/25/ncomms5611.PMC4164542.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kelley, J. L. et al.",Non-OADS,/arxiv_data1/oa_pdf/42/25/ncomms5611.PMC4164542.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5611 8 NATURE COMMUNICATIONS | 5:4611 | DOI: 10.1038/ncomms5611 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/42/25/ncomms5611.PMC4164542.pdf
"Thomas D. Brothers, BA1, Olga Theou, PhD1, Kenneth Rockwood, MD, FRCPC, FRCP1,2   1Geriatric Medicine Research, Department of Medicine, Dalhousie University, Halifax, NS;   2Centre for Health Care of the Elderly, Capital District Health Authority, Halifax, NS DOI:http://dx.doi.org/10.5770/cgj.17.114ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/9c/ff/cgj-17-103.PMC4164677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/ff/cgj-17-103.PMC4164677.pdf
Available at: http://unstats.un.org/unsd/methods/m49/ m49regin.htm .,Non-OADS,/arxiv_data1/oa_pdf/9c/ff/cgj-17-103.PMC4164677.pdf
"(4) These The Perceived Needs and Availability of   Eye Care Services for Older Adults  in Long-term Care Facilities Hélène Kergoat, OD, PhD1,2, Hélène Boisjoly, MD, MPH, FRCPC3,4, Ellen E. Freeman, PhD3,4,   Johanne Monette, MD, MSc, FRCPC5,6, Sylvie Roy, BSc2, Marie-Jeanne Kergoat, MD, FRCPC2,3  1School of Optometry, Université de Montréal, Montréal; 2Institut universitaire de gériatrie de Montréal, Montréal;   3Faculty of Medicine, Université de Montréal, Montréal; 4Ophthalmology, Hôpital Maisonneuve-Rosemont, Montréal;  5Jewish General Hospital, Montréal; 6McGill University, Montréal, QC DOI:http://dx.doi.org/10.5770/cgj.17.116ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/dd/1d/cgj-17-108.PMC4164678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/1d/cgj-17-108.PMC4164678.pdf
Available from: http://www.informa.msss.gouv.qc.ca/ Details.aspx?Id=zsmAukXA15g=&Source=jgS/Os4ab2w =.,OADS,/arxiv_data1/oa_pdf/dd/1d/cgj-17-108.PMC4164678.pdf
Available  from: http://msssa4.msss.,Non-OADS,/arxiv_data1/oa_pdf/dd/1d/cgj-17-108.PMC4164678.pdf
Available from: http://www.nei.nih.gov/nehep/ research/Manuscript.pdf.,Non-OADS,/arxiv_data1/oa_pdf/dd/1d/cgj-17-108.PMC4164678.pdf
Available from: https://www.ooq.org/optometristes/ guide-d-exercice-loi-reglementation-normes-cliniques-etc .,Non-OADS,/arxiv_data1/oa_pdf/dd/1d/cgj-17-108.PMC4164678.pdf
Dr. Kenneth M. Madden Editor-in-Chief Canadian Geriatrics JournalHead and Neck Issues in Older Adults DOI:http://dx.doi.org/10.5770/cgj.17.149EDITORIAL © 2014 Author(s).,Non-OADS,/arxiv_data1/oa_pdf/a0/5d/cgj-17-82.PMC4164679.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/5d/cgj-17-82.PMC4164679.pdf
"Ambedkar Institute Rotary Cancer Hospital, All India Institute   of Medical Sciences (AIIMS), New Delhi, India DOI:http://dx.doi.org/10.5770/cgj.17.101ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/d0/7a/cgj-17-83.PMC4164680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/7a/cgj-17-83.PMC4164680.pdf
"Rose McCloskey, RN, PhD1, Pamela Jarrett, MD, FRCPC2, Connie Stewart  PhD3,   Patricia Nicholson, RN, MN2  1Department of Nursing & Health Sciences, University of New Brunswick, Saint John, NB; 2Health & Aging Program,   Horizon Health Network NB; 3Department of Computer Science & Applied Statistics, University of New Brunswick,   Saint John, NB DOI:http://dx.doi.org/10.5770/cgj.17.106ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
Retrieved 2008 July 8 from https://secure.cihi.ca/free_products/ALC_AIB_EN.pdf  2.,OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
Available from http://www12.statcan.gc.ca/ census-recensement/2011/dp-pd/prof/index.cfm?Lang=E  11.,OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
Available from: https://www.oanhss.org/oanhssdocs/Issue_Positions/External_Resources/ walker_2011.pdf  23.,Non-OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
"Frederickton, NB: [n.d.] Avail - able from http://www2.gnb.ca/content/gnb/en/departments/ social_development/promos/nursing_homes_.html  24.",Non-OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
Retrieved from http://www.cbc.ca/thecurrent/episode/2013/01/10/canadas-hospitals-strained-caring-for-elderly-patients-with-no-where-to-go/  26.,Non-OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
"Re-trieved from http://globalnews.ca/news/514767/28-per-cent-of-hospital-occupied-by-seniors-waiting-for-nursing-home-bed/ Correspondence to: Rose McCloskey, rn, phd, Department  of Nursing & Health Sciences, University of New Brunswick  Saint John, PO Box 5050, Saint John, NB E2L 4L5, CanadaE-mail: rmcclosk@unbsj.ca",Non-OADS,/arxiv_data1/oa_pdf/b0/96/cgj-17-88.PMC4164681.pdf
"(4) While physicians’ roles  are alluded to in two Canadian practice guidelines,(5,6) com - pliance is often poor,(7) and there is little research examining Role Expectations in Dementia Care   Among Family Physicians and Specialists Susan Hum, MSc1, Carole Cohen, MD, FRCPC2, Malini Persaud, RN, PhD3, Joyce Lee, MD, CCFP4,   Neil Drummond, BA(Hons), PhD, HonMFPHM (UK)5, William Dalziel, MD, FRCPC6, Nicholas Pimlott, MD, CCFP1 1Department of Family & Community Medicine, University of Toronto, Women's College  Hospital, Toronto, ON;   2Department of Psychiatry, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON; 3Department of  Health, Nursing & Environmental Studies, York University, Toronto, ON; 4Department of Family & Community Medicine,  University of Toronto, North York General Hospital, Toronto, ON; 5Department of Family Medicine, University of Alberta,  Edmonton, AB; 6Department of Medicine, University of Ottawa, Ottawa, ON DOI:http://dx.doi.org/10.5770/cgj.17.110ORIGINAL RESEARCH © 2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ef/38/cgj-17-95.PMC4164682.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/38/cgj-17-95.PMC4164682.pdf
Available from: http://www.alz.co.uk/research/Wor ld  AlzheimerReport2011.pdf  3.,Non-OADS,/arxiv_data1/oa_pdf/ef/38/cgj-17-95.PMC4164682.pdf
https://www.candrive.ca/en/research-   projects.html .,Non-OADS,/arxiv_data1/oa_pdf/ef/38/cgj-17-95.PMC4164682.pdf
"REVIEW Korean J Intern Med 2014;29:547-557 http://dx.doi.org/10.3904/kjim.2014.29.5.547 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgRecent technological updates and clinical    applications of induced pluripotent stem cells Sebastian Diecke1,2,3,*, Seung Min Jung4,*, Jaecheol Lee1,2,3, and Ji Hyeon Ju4 1Division of Cardiology,  Department of Medicine,  2Institute for Stem Cell Biology  and Regenerative Medicine, and  3Stanford Cardiovascular Institute,  Stanford University School of  Medicine, Stanford, CA, USA;  4Division of Rheumatology,  Department of Internal Medicine,  Seoul St. Mary’s Hospital, College  of Medicine, The Catholic Uni­ versity of Korea, Seoul, Korea Received : July 21, 2014 Accepted: July 22, 2014 Correspondence to  Ji Hyeon Ju, M.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547pluripotency is similar to that of ESCs, while their uti - lization is without ethical controversy [5].",Non-OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
Recent updates of iPSC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547Conventional reprogramming techniques depend on  the stable integration of transgenes but introduce the  concurrent risk of insertional mutagenesis [16].,Non-OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547remains quite low, and the production and purification  methodology associated with this vector system is rela - tively complex and fairly time-consuming [32].",Non-OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
Recent updates of iPSC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547Defined culture conditions together with small-mol - ecule reagents and advanced stem cell transfection  protocols provided the initial foundation for the devel - opment of new editing procedures for pluripotent stem  cells.,OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547In summary, recent advances in integration-free re - programming technology and genome engineering,  combined with the enormous differentiation capacity  of pluripotent cells, renders iPSCs an ideal tool for  translational research (Fig.",OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"Recent updates of iPSC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547a spectrum, from immature cells to mature and func - tional cells.",OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547iPSCs in 2006 [6].",OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
Recent updates of iPSC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.547skin fibroblasts to induced pluripotent stem cells.,Non-OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.54736.",Non-OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
Recent updates of iPSC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.54765.,OADS,/arxiv_data1/oa_pdf/3a/26/kjim-29-547.PMC4164716.pdf
"REVIEW Korean J Intern Med 2014;29:558-570 http://dx.doi.org/10.3904/kjim.2014.29.5.558 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCrohn’s disease in Korea: past, present, and future Kang-Moon Lee and Ji Min Lee Department of Internal Medicine,  St. Vincent’s Hospital, College of  Medicine, The Catholic University  of Korea, Seoul, Korea Received : August 19, 2014 Accepted: August 24, 2014 Correspondence to  Kang-Moon Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
Crohn’s disease in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558and prognosis of Korean CD in the near future [12].,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558 showed a median time of 14 months (range, 0 to 270),  significantly shorter than the earlier cohort [27].",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"Crohn’s disease in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558Korean CD is categorized as B1, 10% to 25% as B2, and  12% to 30% as B3 at the time of diagnosis [10,19,27,44].",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558 longitudinal ulcers, aphthous ulcers, and cobblestone  appearance) were prevalent in CD.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"Crohn’s disease in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558suffer complications even with proper treatments, and  eventually, undergo surgical treatment [1,2].",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558 and fistulizing CD patients revealed that the clinical  response rate at 10 weeks after starting inf liximab  was 85%.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"Crohn’s disease in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558was evaluated or length of follow-up period, infliximab  has been shown to be effective and safe for induction  and maintenance therapy of refractory Korean CD in  real-life settings.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558 lative relapse rate was 30.7% at 1 year, 53.0% at 3 years,  and 73.4% at 5 years after remission.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
Crohn’s disease in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.5584.,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558 of Crohn’s disease and its temporal change between  1981 and 2012: a hospital-based cohort study from Ko - rea.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
http://dx.doi.org/10.1016/ j.crohns.2014.04.002 .,OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
Crohn’s disease in Korea www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558copic findings in the differential diagnosis between  intestinal tuberculosis and Crohn’s disease.,Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.558 75.",Non-OADS,/arxiv_data1/oa_pdf/fc/7b/kjim-29-558.PMC4164717.pdf
"EDITORIAL Korean J Intern Med 2014;29:571-573 http://dx.doi.org/10.3904/kjim.2014.29.5.571 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgAdverse effects of long-term amiodarone therapy  Hyoung-Seob Park and Yoon-Nyun Kim Division of Cardiology,  Department of Internal Medicine,  Keimyung University Dongsan  Medical Center, Daegu, Korea  Received : July 28, 2014 Accepted: July 31, 2014 Correspondence to  Yoon-Nyun Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/55/0d/kjim-29-571.PMC4164718.pdf
"5, September 2014 http://dx.doi.org/10.3904/kjim.2014.29.5.571 cifically, a 100 mg tablet contains 250 times the daily  iodine requirement.",Non-OADS,/arxiv_data1/oa_pdf/55/0d/kjim-29-571.PMC4164718.pdf
"A dverse effects of amiodarone http://dx.doi.org/10.3904/kjim.2014.29.5.571Taken altogether, there seems to be small risk of ei - ther minor/fatal adverse effects or death with low doses  of amiodarone (less than 200 mg per day).",Non-OADS,/arxiv_data1/oa_pdf/55/0d/kjim-29-571.PMC4164718.pdf
"EDITORIAL Korean J Intern Med 2014;29:574-576 http://dx.doi.org/10.3904/kjim.2014.29.5.574 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIs vitamin D supplementation really effective in  patients with type 2 diabetes?",Non-OADS,/arxiv_data1/oa_pdf/10/e0/kjim-29-574.PMC4164719.pdf
Effect of vitamin D in patients with type 2 diabetes http://dx.doi.org/10.3904/kjim.2014.29.5.574week) [6].,Non-OADS,/arxiv_data1/oa_pdf/10/e0/kjim-29-574.PMC4164719.pdf
"5, September 2014 http://dx.doi.org/10.3904/kjim.2014.29.5.574 insulin resistance in patients with type 2 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/10/e0/kjim-29-574.PMC4164719.pdf
"EDITORIAL Korean J Intern Med 2014;29:577-579 http://dx.doi.org/10.3904/kjim.2014.29.5.577 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCould tofacitinib, the first oral small-molecule   inhibitor proven for use in active rheumatoid    arthritis (RA) patients with insufficient response to  methotrexate, be the breakthrough drug for RA?",Non-OADS,/arxiv_data1/oa_pdf/f1/c6/kjim-29-577.PMC4164720.pdf
"5, September 2014 http://dx.doi.org/10.3904/kjim.2014.29.5.577 meta-analysis included five RCTs, including three  phase 2 and two phase 3 trials, with a total of 1,590 pa - tients.",OADS,/arxiv_data1/oa_pdf/f1/c6/kjim-29-577.PMC4164720.pdf
http://dx.doi.org/10.3904/kjim.2014.29.5.577response to methotrexate or disease-modifying anti - rheumatic drugs: a meta-analysis of randomized con - trolled trials.,Non-OADS,/arxiv_data1/oa_pdf/f1/c6/kjim-29-577.PMC4164720.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:580-587 http://dx.doi.org/10.3904/kjim.2014.29.5.580 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine  and Liver Research Institute,  Seoul National University College  of Medicine, Seoul; 2Laboratory  for Systems Biology and Bio- Inspired Engineering, Department  of Bio and Brain Engineering,  3Graduate School of Medical  Science and Engineering, Korea  Advanced Institute of Science and  Technology (KAIST), Daejeon;  Departments of 4Pathology  and 5Surgery, Seoul National  University College of Medicine,  Seoul, Korea Received : June 15, 2014 Revised : July 1, 2014 Accepted : July 2, 2014 Correspondence to  Jung-Hwan Yoon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
Protein disulfide isomerase for HCC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.580ti-cancer therapy.,Non-OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.580NY, USA), and p values < 0.05 were considered to indi - cate significance.",OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
"Protein disulfide isomerase for HCC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.580than the low-PDI-expression group ( p = 0.007 and p =  0.016, respectively).",Non-OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.580PDI low p = 0.007 PDI high 020 40 601.0 0.80.6 0.4 0.2 Months after surgeryTTP rate OS ratePDI low p = 0.016 PDI high 020 40 601.0 0.80.6 0.40.2 Months after surgery80 Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
Protein disulfide isomerase for HCC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.580DISCUSSION This study found that the expression of PDI was in - creased in HCC compared to nontumor tissue and that  increased expression was associated with the aggressive  clinicopathological features of HCC.,OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.580surveillance [21].",OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
Protein disulfide isomerase for HCC www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.5802012;8:353-362.,Non-OADS,/arxiv_data1/oa_pdf/63/ac/kjim-29-580.PMC4164721.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:588-596 http://dx.doi.org/10.3904/kjim.2014.29.5.588  Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Cardiology,  Department of Internal Medicine,  Boramae Medical Center, Seoul  National University College of  Medicine, Seoul, Korea Received : August 27, 2013 Revised : December 3, 2013 Accepted : April 7, 2014 Correspondence to  Joo-Hee Zo, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
"Adverse effects of amiodarone www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588Although recent well-controlled clinical trials and me - ta-analyses provided information regarding the adverse  effects of amiodarone [7-13], it is difficult to apply the  results from these studies to daily practice in patients  because of disparities between patient characteristics  and the way in which the treatment was applied [14].",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588Statistical analysis Continuous variables were presented as mean ± SD,  and categorical variables were expressed as percentages.",OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
Adverse effects of amiodarone www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588dose reduction.,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588Study rationale The best way to assess an adverse reaction to a drug is to  compare the rate of adverse events in patients who were  exposed to the drug with those who were exposed to the  placebo; randomized double-blinded and placebo-con - trolled trials are best suited for such comparisons.",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
Adverse effects of amiodarone www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588Electrophysiology in 2000 estimated that the incidence  of adverse effects of amiodarone was 15% during the  first year and as high as 50% with long-term therapy [16].,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588meta-analysis performed by Lewis et al.",OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
Adverse effects of amiodarone www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.588and recommended as a first-line therapy.,Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.58821.",Non-OADS,/arxiv_data1/oa_pdf/f2/b1/kjim-29-588.PMC4164722.pdf
"ORIGINAL ARTICLE  Korean J Intern Med 2014;29:597-602 http://dx.doi.org/10.3904/kjim.2014.29.5.597 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal  Medicine, 2Occupational and  Environmental Medicine, and  3Biomedical Engineering,  Keimyung University School of  Medicine, Daegu, Korea Received : February 27, 2014 Revised : March 31, 2014 Accepted : May 1, 2014 Correspondence to Chang-Wook Nam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/kjim-29-597.PMC4164723.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.597on treatment of LM bifurcation lesions are available.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/kjim-29-597.PMC4164723.pdf
"Outcome of simple LM crossover stenting www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.597angiographic characteristics, and quantitative coronary  angiographic results, are summarized in Tables 1 and 2.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/kjim-29-597.PMC4164723.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.597DISCUSSION The major findings of our current study were: 1) the  long-term outcomes of LM-to-LAD simple crossover  stenting in patients with de novo  distal LM or ostial  LAD disease (without significant ostial LCX disease)  were good; and 2) it was safe to not open a strut on the  LCX ostium after crossover stenting.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/kjim-29-597.PMC4164723.pdf
"Outcome of simple LM crossover stenting www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.597stenting, without opening of a strut on the LCX ostium.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/kjim-29-597.PMC4164723.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.5979.",Non-OADS,/arxiv_data1/oa_pdf/8b/86/kjim-29-597.PMC4164723.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:603-612 http://dx.doi.org/10.3904/kjim.2014.29.5.603 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment s of 1Internal Medicine   and 2Thoracic and Cardiovascular  Surgery , St. Vincent’s Hospital,  College of Medicine, The Catholic  University of Korea, Suwon,  Korea Received : October 14, 2013 Revised : November 18, 2013 Accepted : February 20, 2014 Correspondence to Chi Hong Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603garding primary treatment choice, there is no consen - sus regarding the optimal treatment.",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"Prognostic factors of pleural infection www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603C-reactive protein (CRP) with these managements, the  catheter was replaced with one of a larger size or an  additional catheter was placed in a different location  under US guidance.",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603= 0.001).",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"Prognostic factors of pleural infection www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603level, gross findings, and bacterial culture of pleural  fluid in both groups showed no significant difference  between the two groups.",OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.6035).",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"Prognostic factors of pleural infection www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603DISCUSSION In this study, we showed that age, duration of chief  complaint, smoking history, serum albumin level, and  pleural glucose and LDH level of the MTS and MTF  groups were significantly different.",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603Fibrin balance in the pleural space is disturbed, inhib - iting fibrin degradation, and loculations finally begin to  form.",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
Prognostic factors of pleural infection www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603Our study had several limitations.,Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.603Acknowledgments We thank Seok Hui Kang and Mi Na Oh for assistance  with data collection and processing.",Non-OADS,/arxiv_data1/oa_pdf/2d/a6/kjim-29-603.PMC4164724.pdf
"ORIGINAL ARTICLE  Korean J Intern Med 2014;29:613-619 http://dx.doi.org/10.3904/kjim.2014.29.5.613 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Chunggoo Sungsim Hospital,  Seoul; 2Department of Internal  Medicine, Hanyang University  College of Medicine, Seoul, Korea Received : January 13, 2014 Revised : March 28, 2014 Accepted : April 2, 2014 Correspondence to  Tae-Hyung Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.613COPD studies are current or ex-smokers.",Non-OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
"Secondhand smoke in never smoker COPD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.613Comparison of baseline characteristics among par - ticipants who had never smoked based on second - hand smoke exposure Of the participants that had never smoked, 32.54% had  been exposed to secondhand smoke.",OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.613prevalence of COPD in subjects exposed to secondhand  smoke was unexpected.",Non-OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
"Secondhand smoke in never smoker COPD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.613nide, and at least 50 carcinogens [12].",Non-OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.613absence of secondhand smoke exposure in those par - ticipants who had never smoked.",Non-OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
Secondhand smoke in never smoker COPD www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.61316.,Non-OADS,/arxiv_data1/oa_pdf/96/07/kjim-29-613.PMC4164725.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:620-629 http://dx.doi.org/10.3904/kjim.2014.29.5.620 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Endocrinology and  Metabolism, Department of Inter - nal Medicine, Hallym University  College of Medicine, Chuncheon ;  2Department of  Healthcare  Management, Hallym University   School of Business, Chuncheon ;  3Division of Cardiology, Depart - ment of Internal Medicine, Hallym  University College of Medicine,  Chuncheon, Korea Received : October 25, 2013 Revised : November 18, 2013 Accepted : December 30, 2013 Correspondence to  Moon-Gi Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
"The effect of vitamin D in type 2 diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620physical activity, such as winter and spring.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620daytime outdoor physical activity and arterial stiffness  of all patients at baseline and at the end of the study.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
The effect of vitamin D in type 2 diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620RESULTS Fig.,Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620Table 1.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
The effect of vitamin D in type 2 diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620–600–400–2000200Placebo (n = 21) Vitamin D (n = 24)baPWV -10 -200102030Placebo (n = 21) Vitamin D (n = 24)AIx Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620and macrophage activation [35,36].",OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
The effect of vitamin D in type 2 diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620in the serum might have caused pathological changes  by influencing calcification modulators such as pyro - phosphate and by binding to calcium-sensing recep - tors on vascular smooth muscle cells [47].,Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620son, adiposity, physical activity, and fitness.",Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
The effect of vitamin D in type 2 diabetes www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.620tamin D and regulation of the renin-angiotensin system  in humans.,Non-OADS,/arxiv_data1/oa_pdf/1b/5e/kjim-29-620.PMC4164726.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:630-636 http://dx.doi.org/10.3904/kjim.2014.29.5.630 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment of Hematology  and  Oncology, Ajou University School  of Medicine , Suwon , Korea Received : July 1, 2013 Revised : August 19, 2013 Accepted : October 4, 2013 Correspondence to  Joon Seong Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
"Etanercept for steroid- refractory acute graft-versus- host disease www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.630(IL)-2 or IL-1 antagonists [5,6].",Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.630conditioning aplastic anemia.",Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
Etanercept for steroid- refractory acute graft-versus- host disease www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.630ysis and were evaluable for response.,Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.630of acute GVHD.",Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
"Etanercept for steroid- refractory acute graft-versus- host disease www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.630and skin GVHD, and relatively fewer complications re - lated to infections.",Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.630Haematol 2001;113:217-223.",Non-OADS,/arxiv_data1/oa_pdf/42/cd/kjim-29-630.PMC4164727.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:637-646 http://dx.doi.org/10.3904/kjim.2014.29.5.637 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Konkuk University School of Medicine,  Seoul; 2Division of Infectious Diseases,  Department of Internal Medicine,  Kyung Hee University Medical Center,  Seoul; 3Division of Infectious Diseases,  Department of Internal Medicine,  Chung-Ang University Hospital, Seoul;  Departments of 4Laboratory Medicine  and 5Infectious Diseases, Asan Medical  Center, University of Ulsan College of  Medicine, Seoul, Korea Received : March 8, 2014 Revised : April 17, 2014 Accepted : May 22, 2014 Correspondence to  Seong-Ho Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637agents can be used against multidrug-resistant organ - isms producing both an ESBL and AmpC β-lactamase.",Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
ESBL-positive Enterobacter bacteremia in cancer patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637Table 2.,Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637Table 3.",Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
ESBL-positive Enterobacter bacteremia in cancer patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637between January 2005 and November 2008.,Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637compared using the chi-square or Fisher exact test, and  continuous scaled data were compared using the Stu - dent t test or Mann-Whitney U test.",OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"ESBL-positive Enterobacter bacteremia in cancer patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637DISCUSSION Based on the results of the phenotypical ESBL tests,  ESBL-producing isolates were responsible for 15.3%  of the Enterobacter  bacteremia episodes that occurred  in patients with malignancy in this study.",Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637similar to ours, antimicrobial resistance to ESCs (27.6%  vs. 48.8%) and the empirical use of broad-spectrum  antimicrobial agents such as carbapenems (23.1% vs.  54.5%) were less common in that study [25] than in ours,  respectively.",OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
ESBL-positive Enterobacter bacteremia in cancer patients www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.637Antimicrob Agents 2011;37:26-32.",Non-OADS,/arxiv_data1/oa_pdf/44/91/kjim-29-637.PMC4164728.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:647-655 http://dx.doi.org/10.3904/kjim.2014.29.5.647 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment s of 1Surgery for  Rheumatism  and 2Rheumatology,  Hanyang University Hospital for  Rheumatic Diseases,   Seoul ;  3In- stitute of Rheumatism, Hanyang  University College of Medi - cine,  Seoul ; 4Life Science R&D  Center, SK Chemicals, Seongnam ,  Korea Received : March 23, 2013 Revised : May 23, 2013 Accepted : September 25, 2013 Correspondence to  Jae-Bum Jun, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
"5, September 2014    www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647Although therapeutic strategies targeting cartilage  degradation, such as anticytokine therapy mainly focus - ing on IL-1, have been emerging, most pharmacological  treatments target the resulting pain [4].",Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
SKI306X in human OA cartilage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647modified; the IL-1 β concentration was reduced to 0.02  ng/mL and OSM (10 ng/mL) was also added.,Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
"5, September 2014    www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647RESULTS Cell viability IL-1β ± SKI306X (up to 200 µg/mL) or its components  (up to 50 µg/mL) did not affect chondrocyte viability.",Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
SKI306X in human OA cartilage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647was blocked by IL-1Ra.,Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
"5, September 2014    www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647rescently labeled substrate peptides; cleavage liberates  FRET to activate fluorescence.",OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
"SKI306X in human OA cartilage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647DISCUSSION Although clinical trials have demonstrated that SKI306X  has therapeutic efficacy comparable to that of diclofenac and celecoxib, no in vitro  studies have yet examined its  chondro-protective effects in human cartilage or chon - drocytes [10,12].",Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
"5, September 2014    www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647of SKI306X, or perhaps mixtures of only CM and PV,  would also help elucidate which components affect  degradative enzymes.",Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
SKI306X in human OA cartilage www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.647cleavage of type II collagen by collagenases in osteoar - thritic articular cartilage.,Non-OADS,/arxiv_data1/oa_pdf/b0/28/kjim-29-647.PMC4164729.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:656-663 http://dx.doi.org/10.3904/kjim.2014.29.5.656 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Rheumatology,  Department of Internal Medicine,  Korea University College of  Medicine, Seoul; 2Hospital for  Rheumatic Diseases, Hanyang  University College of Medicine,  Seoul, Korea Received : September 26, 2013 Revised : December 19, 2013 Accepted : December 23, 2013 Correspondence to  Young Ho Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
"Tofacitinib for treatment of active RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.656Intracellular pathways that include Janus kinases  (JAKs) are critical to immune cell activation, proinflam - matory cytokine production, and cytokine signaling [3].",Non-OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.656between-study variations and heterogeneity using Co - chran’s Q statistic [16].",OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
Tofacitinib for treatment of active RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.656because all data on the efficacy outcomes among the  three studies were available at 12 weeks [7-9].,Non-OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.656response rates in both the tofacitinib 5- and 10-mg  groups, when the data were analyzed at 24 weeks.",OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
Tofacitinib for treatment of active RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.65610-mg tofacitinib group.,Non-OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
"5, September 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.656In the present meta-analysis, we combined the clin - ical data of three phase-II RCTs of tofacitinib at 5 and  10 mg twice per day.",OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
"Tofacitinib for treatment of active RA www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.656Healthcare Technology R&D Project, Ministry of Health  and Welfare, Republic of Korea (A102065).",Non-OADS,/arxiv_data1/oa_pdf/6d/ee/kjim-29-656.PMC4164730.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:664-666 http://dx.doi.org/10.3904/kjim.2014.29.5.664 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Cardiology,  Department of Internal Medicine,  2Department of Diagnostic  Radiology, Kyung Hee University  School of Medicine, Seoul, KoreaUnexpected development of acute abdominal   aortic thrombosis during percutaneous coronary  intervention Sang Jin Ha1, Joo Hyeong Oh2, and Soo-Joong Kim1 Received : March 22, 2014 Revised : May 19, 2014 Accepted : June 23, 2014 Correspondence to  Soo-Joong Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/08/f7/kjim-29-664.PMC4164731.pdf
"665 http://dx.doi.org/10.3904/kjim.2014.29.5.664 Ha SJ, et al.",OADS,/arxiv_data1/oa_pdf/08/f7/kjim-29-664.PMC4164731.pdf
666 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.664 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/08/f7/kjim-29-664.PMC4164731.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:667-670 http://dx.doi.org/10.3904/kjim.2014.29.5.667 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment of Internal Medicine,  Pusan National University School  of Medicine, Busan, KoreaAdrenocorticotropic hormone-independent    macronodular adrenal hyperplasia with abnormal  cortisol secretion mediated by catecholamines Harin Rhee, Yun Kyung Jeon, Sang Soo Kim, Yang Ho Kang, Seok Man Son, Yong Ki Kim, and In Joo Kim Received : March 22, 2014 Revised : May 19, 2014 Accepted : June 23, 2014 Correspondence to  In Joo Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ba/1c/kjim-29-667.PMC4164732.pdf
668 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.667 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/1c/kjim-29-667.PMC4164732.pdf
"669 http://dx.doi.org/10.3904/kjim.2014.29.5.667 Rhee H, et al.",OADS,/arxiv_data1/oa_pdf/ba/1c/kjim-29-667.PMC4164732.pdf
670 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.667 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ba/1c/kjim-29-667.PMC4164732.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:671-674 http://dx.doi.org/10.3904/kjim.2014.29.5.671 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Seoul National University College  of Medicine, Seoul; Departments  of 2Diagnostic Medicine,  3Pathology, 4Radiology, and  5Internal Medicine, Seoul National  University Bundang Hospital,  Seongnam, KoreaImmune thrombocytopenic purpura in a patient  with renal cell carcinoma Eun Ju Cho1, Ha Jung Lee1, Kyung Un Park2, Uk-Yeon Kim3, Hak Jong Lee4, and Soo Mee Bang5 Received : August 8, 2008 Revised : August 21, 2008 Accepted : August 25, 2008 Correspondence to  Soo Mee Bang, M.D.",Non-OADS,/arxiv_data1/oa_pdf/5f/6d/kjim-29-671.PMC4164733.pdf
672 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.671 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/5f/6d/kjim-29-671.PMC4164733.pdf
"673 http://dx.doi.org/10.3904/kjim.2014.29.5.671 Cho EJ, et al.",OADS,/arxiv_data1/oa_pdf/5f/6d/kjim-29-671.PMC4164733.pdf
674 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.671 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/5f/6d/kjim-29-671.PMC4164733.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:675-678 http://dx.doi.org/10.3904/kjim.2014.29.5.675 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartment of Internal Medicine,  College of Medicine, The Catholic  University of Korea, Seoul, KoreaCytomegalovirus appendicitis with concurrent  bacteremia after chemotherapy for acute leukemia Min Jung Cho, Jongmin Lee, Joo- Yeun Hu, Jung Woo Lee, Sung-Yeon Cho, Dong-Gun Lee, and Seok Lee Received : February 15, 2013 Revised : June 21, 2013 Accepted : October 2, 2013 Correspondence to  Dong-Gun Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/26/a8/kjim-29-675.PMC4164734.pdf
676 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.675 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/26/a8/kjim-29-675.PMC4164734.pdf
"677 http://dx.doi.org/10.3904/kjim.2014.29.5.675 Cho MJ, et al.",OADS,/arxiv_data1/oa_pdf/26/a8/kjim-29-675.PMC4164734.pdf
678 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.675 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/26/a8/kjim-29-675.PMC4164734.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:679-682 http://dx.doi.org/10.3904/kjim.2014.29.5.679 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Nephrology,  Department of Internal Medicine,  St. Vincent’s Hospital, College of  Medicine, The Catholic University  of Korea, Suwon, KoreaAldosterone- and cortisol-co-producing adrenal  adenoma without clinical features of Cushing  syndrome Kyung Yoon Chang, Seongyul Ryu, Jae Young Cho, and Hyung Wook Kim Received : April 3, 2014 Revised : June 23, 2014 Accepted : July 8, 2014 Correspondence to  Hyung Wook Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/77/7c/kjim-29-679.PMC4164735.pdf
680 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.679 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/77/7c/kjim-29-679.PMC4164735.pdf
"681 http://dx.doi.org/10.3904/kjim.2014.29.5.679 Chang KY, et al.",OADS,/arxiv_data1/oa_pdf/77/7c/kjim-29-679.PMC4164735.pdf
682 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.5.679 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/77/7c/kjim-29-679.PMC4164735.pdf
"Korean J Intern Med 2014;29:683-684 http://dx.doi.org/10.3904/kjim.2014.29.5.683 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTERESTThe patient, a 38-year-old Korean wom - an, presented with a 6-month history of  arthralgia involving the hands, wrists,  feet, and shoulders.",Non-OADS,/arxiv_data1/oa_pdf/ac/6f/kjim-29-683.PMC4164736.pdf
684 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.,Non-OADS,/arxiv_data1/oa_pdf/ac/6f/kjim-29-683.PMC4164736.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/17/ncomms5877.PMC4164769.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Randel, J. C. et al.",Non-OADS,/arxiv_data1/oa_pdf/31/17/ncomms5877.PMC4164769.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5877 6 NATURE COMMUNICATIONS | 5:4877 | DOI: 10.1038/ncomms5877 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/31/17/ncomms5877.PMC4164769.pdf
Raw data can be access at http://www.ncbi.nlm.nih.gov/sra/ with the identiﬁer SRA059274.,OADS,/arxiv_data1/oa_pdf/cd/98/ncomms5723.PMC4164772.pdf
Additional information Accession codes: Raw data can be access at http://www.ncbi.nlm.nih.gov/sra/ with the identiﬁer SRA059274.Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/98/ncomms5723.PMC4164772.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lo´pez de Silanes, I. et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/ncomms5723.PMC4164772.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5723 ARTICLE NATURE COMMUNICATIONS | 5:4723 | DOI: 10.1038/ncomms5723 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/cd/98/ncomms5723.PMC4164772.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/a8/da/ncomms5485.PMC4164773.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ghienne, J.-F. et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/ncomms5485.PMC4164773.pdf
Over 80% of the rice ﬁelds in Eastern China (http://www.hzag.gov.cn/bcjb/ 200559154000.htm) and Korea were affected by this disease annually3.,Non-OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
NIP (http://www.ncbi.nlm.nih.gov) and used for gene prediction.,OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
Gene models were obtained from GRAMENE (http://www.gramene.org).,OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
"[35S]-phosphoadenosine phosphosulphate (PAPS, PerkinElmer Life and Analytical Sciences, http://www.perkinelmer.com) was used as the sul-phate donor to maximize the detection sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, Q. et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5768 8 NATURE COMMUNICATIONS | 5:4768 | DOI: 10.1038/ncomms5768 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/3b/fe/ncomms5768.PMC4164775.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/ce/ncomms5835.PMC4164776.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article : Carmi, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/ce/ncomms5835.PMC4164776.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5835 ARTICLE NATURE COMMUNICATIONS | 5:4835 | DOI: 10.1038/ncomms5835 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/4e/ce/ncomms5835.PMC4164776.pdf
"RepeatMasker-open-4-0-2 (Smit, A.F.A., Hubley, R. and Green, P. RepeatMasker athttp://repeatmasker.org) was used to estimate the distribution of TEs and other interspersed repeat elements in the genome.",OADS,/arxiv_data1/oa_pdf/86/66/ncomms5737.PMC4164777.pdf
The haploid chromosome numbers were mapped onto the tree using Mesquite (http://mesquiteproject.org).,OADS,/arxiv_data1/oa_pdf/86/66/ncomms5737.PMC4164777.pdf
"Further information, includingsuperscaffolds, linkage map and annotations are available through our website at http://www.helsinki.ﬁ/science/metapop/research/mcgenome.html.",OADS,/arxiv_data1/oa_pdf/86/66/ncomms5737.PMC4164777.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/86/66/ncomms5737.PMC4164777.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ahola, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/86/66/ncomms5737.PMC4164777.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5737 ARTICLE NATURE COMMUNICATIONS | 5:4737 | DOI: 10.1038/ncomms5737 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/86/66/ncomms5737.PMC4164777.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/77/c6/ncomms5573.PMC4164778.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhou, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/77/c6/ncomms5573.PMC4164778.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5573 ARTICLE NATURE COMMUNICATIONS | 5:4573 | DOI: 10.1038/ncomms5573 | www.nature.com/naturecommunications 15 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/77/c6/ncomms5573.PMC4164778.pdf
A summary table with the collected annotations and the code used in the analyses are publicly accessible at http://bit.ly/nPepdH.,OADS,/arxiv_data1/oa_pdf/b4/db/ncomms5830.PMC4164782.pdf
"The point mutations were performed using (Quick Change Site-Directed Mutagenesis Kit from Stratagene/ Agilent) using the following oligonucleotides: Rab32/38G19VF( 50-gttcttgtgatcggcgagttagttgttgggaagacgagcgtcatt-30), Rab32/38G19VR( 50-aatgacgctcgtcttcccaacaactaactcgccgatcacaagaac-30), Rab32/38T23NF( 50-cgagttagttgttgggaagaatagcgtcattaaaagatat-30), Rab32/38T23NR( 50-atatcttttaatgacgctattcttcccaacaactaactcg-30), shRNA-mediated RNA interference knockdown of Rab32/38 function .The coding sequence of Ci- Rab32/38 was used to identify siRNA target sites with the DSIR68and Public TRC Portal (http://www.broadinstitute.org/rnai/public/seq/ search) algorithms.",OADS,/arxiv_data1/oa_pdf/b4/db/ncomms5830.PMC4164782.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b4/db/ncomms5830.PMC4164782.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article : Racioppi, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/db/ncomms5830.PMC4164782.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/48/ncomms5750.PMC4164785.pdf
"Reprints and permission information is available online at http://www.nature.com/ reprintsandpermissions/ How to cite this article: Dong, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/02/48/ncomms5750.PMC4164785.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5750 ARTICLE NATURE COMMUNICATIONS | 5:4750 | DOI: 10.1038/ncomms5750 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/02/48/ncomms5750.PMC4164785.pdf
wrote the paperAdditional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d9/bb/ncomms5734.PMC4164786.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lindy, A. S. et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/bb/ncomms5734.PMC4164786.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5734 ARTICLE NATURE COMMUNICATIONS | 5:4734 | DOI: 10.1038/ncomms5734 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d9/bb/ncomms5734.PMC4164786.pdf
We used a validated Norwegian version (http://koos.nu).,Non-OADS,/arxiv_data1/oa_pdf/e7/db/ORT-85-463.PMC4164862.pdf
We used a validated Norwegian version (http://www.euroqol.org).,Non-OADS,/arxiv_data1/oa_pdf/e7/db/ORT-85-463.PMC4164862.pdf
Norwegian Arthroplasty Register Annual Report 2012.. http://nrlweb.ihelse.,Non-OADS,/arxiv_data1/oa_pdf/e7/db/ORT-85-463.PMC4164862.pdf
(cited 2013 Dec 27); Available from: http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/con093791.pdf  Medicines and healthcare products regulatory agency (MHRA).,Non-OADS,/arxiv_data1/oa_pdf/38/6d/ORT-85-474.PMC4164864.pdf
"(cited 2013 Dec 27); Available from: http://www.mhra.gov.uk/home/groups/dts-bs/documents/medicaldevicealert/ con155767.pdf  Pandit H, Glyn-Jones S, McLardy-Smith P, Gundle R, Whitwell D, Gibbons  C L, Ostlere S, Athanasou N, Gill H S, Murray D W. Pseudotumours asso-ciated with metal-on-metal hip resurfacings.",Non-OADS,/arxiv_data1/oa_pdf/38/6d/ORT-85-474.PMC4164864.pdf
"(updated 2013 Jan 17; cited 2013 Dec 27); Available from http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241667.htm van der Weegen W, Brakel K, Horn R J, Hoekstra H J, Sijbesma T, Pilot P,  Nelissen R G. Asymptomatic pseudotumours after metal-on-metal hip resurfacing show little change within one year.",OADS,/arxiv_data1/oa_pdf/38/6d/ORT-85-474.PMC4164864.pdf
"Its study design included the  effects of the addition of lutein (10 mg), zeaxanthin (2 mg), Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > Received 12 February 2014 | Accepted 9 September 2014 | Published 11 September 2014© 2014 Molecular Vision 1228Bioavailability of AREDS1 micronutrients from softgel capsules  and tablets: a pilot study Elizabeth J. Johnson,1 Rohini Vishwanathan,1 Helen M. Rasmussen,1 John C. Lang2 1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA.",Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
"Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1229and omega-3 fatty acids (eicosapentaenoic acid, 667 mg;  docosahexaenoic acid, 333 mg) as Tier 1 in the investigation.",Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
"Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1230curve (AUC, see below) in plasma or serum over 168 h (t = 0,  0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24, 48, and 168 h post-dose).",Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1231for each of the three phases.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1232discussed below).,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1233 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1234RESULTS The bioavailabilities of the fat- and water-soluble nutrients  in the AREDS formulations were assessed initially using the  AUCs (μmol/l*h) from the model-independent data of the 15  nutrient/dosage form responses and provided in Table 2 and  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1235AREDS1 nutrients (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1236absorption.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
"Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1237As evident from Figure 2, Figure 3, Figure 4, and Figure  5, as well as the parameters evaluated in Table 4, the model- derived kinetic constants for each nutrient changed less  significantly between dosage forms than those parameters  between nutrients.",Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1238patient-to-patient variability in absorption and bioavailability  in either of these dosage forms will contribute to irregular  and uncertain benefits across the AMD population.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1239for the bioavailability of the lipid-soluble nutrients.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  1240APPENDIX 10.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  124119.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
Molecular Vision  2014; 20:1228-1242 <http://www.molvis.org/molvis/v 20/1228 > © 2014 Molecular Vision  124245.,Non-OADS,/arxiv_data1/oa_pdf/2f/85/mv-v20-1228.PMC4164907.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1097/01.ico.0000247218.10672.7 e Anastasiadis, P.Z.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/   j.bbamcr.2006.08.04 0 Anokye-Danso, F., C.M.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/   j.stem.2011.03.00 1 Barroso-delJesus, A., G. Lucena-Aguilar, L. Sanchez, G. Ligero, I. Gutierrez- Aranda, and P. Menendez.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1096/fj.10-17222 1 Blitzer, A.L., L. Panagis, G.L.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1016/S1350-9462(02)00059- 9 Bourne, W.M., and J.W.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.exer   .2003.08.00 2 Card, D.A., P.B.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1128/MCB.00359-0 8 Chen, K.H., D. Azar, and N.C. Joyce.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1097/00003226-200110000-0001 2 Chen, H.C., Y .T.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1038/labinvest.2011.20 1 Daniel, J.M.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi   .org/10.1016/j.bbamcr.2006.08.05 2 Davis, M.A., R.C.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1083/jcb.20030711 1 Dohn, M.R., M.V .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1083/jcb.20080709 6 Drews, K., J. Jozefczuk, A. Prigione, and J. Adjaye.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1007/s00109-012-0913- 0 Engelmann, K., M. Böhnke, and P. Friedl.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1006/dbio.1996.031 8 Fischbarg, J., and D.M.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.exer.2003.09.01 0 Hatou, S., S. Yoshida, K. Higa, H. Miyashita, E. Inagaki, H. Okano, K. Tsubota,  and S. Shimmura.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1089/   scd.2012.028 6 Hatzfeld, M. 2005.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.ejcb.2004.12.01 6 Hofer-Warbinek, R., J.A.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1074/jbc.M91034619 9nonspecific staining for 30 min, they were incubated with the desired first  antibody (all at 1:50 dilution) for 16 h at 4°C.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1371/journal.pone.005800 0 Patel, S.P., and W.M.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/iovs.08-300 2 Perez-Moreno, M., C. Jamora, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/   10.1016/S0092-8674(03)00108- 9 Perez-Moreno, M., M.A.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.cell.2005.11.04 3 Perez-Moreno, M., W. Song, H.A.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/   10.1073/pnas.080730110 5 Raymond, G.M., M.M.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1083/jcb.20080511 3 Stiles, J.M., V .",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1038/nbt.186 2 Sumide, T., K. Nishida, M. Yamato, T. Ide, Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1016/j.cell.2007.11.01 9 Whikehart, D.R., C.H.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.cell.2006.09.04 6 Wong, C.E., C. Paratore, M.T.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1083/jcb.20030600 1 Xie, H.T., S.Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1002/stem.74 3 Xie, H.T., S.Y .",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"53:279– 286. http://dx.doi.org/10.1167/iovs.11-844 1 Yamagami, S., S. Yokoo, T. Mimura, T. Takato, M. Araie, and S. Amano.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.ophtha.2006   .07.04 2 Yokoo, S., S. Yamagami, Y. Yanagi, S. Uchida, T. Mimura, T. Usui, and S.  Amano.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10   .1074/jbc.274.28.1983 8 Hsiue, G.H., J.Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1097/01.tp.0000194864.13539.2 c Iglesias-García, O., B. Pelacho, and F. Prósper.",Non-OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2013.04.02 2 Ireton, R.C., M.A.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1083/jcb.20020511 5 Ishino, Y ., Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/iovs.03-001 6 Jamora, C., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.exer.2005.06.01 2 Kay, E.P ., M.S.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1076/ceyr.17.3.286.521 2 Ko, M.K., and E.P .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/iovs.05-081 8 Laing, R.A., L. Neubauer, S.S. Oak, H.L.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/S0161-6420(84)34176- 8 Lee, J.G., and E.P.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.exer.2006.04.00 7 Lee, H.T., J.G.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1074/jbc.M40520820 0 Li, W., A.L.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/iovs.11-941 4 Li, G.G., Y .T.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/iovs.12-1030 0 Liao, J.K., M. Seto, and K. Noma.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1097/FJC.0b013e318070d1b d Lin, S.L., D.C. Chang, C.H.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1093/nar/gkq85 0 Lu, M., S.C. Lin, Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi   .org/10.1016/j.molcel.2007.05.00 6 Matter, K., S. Aijaz, A. Tsapara, and M.S.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.ceb.2005.08.00 3 McGowan, S.L., H.F. Edelhauser, R.R.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/iovs.03-117 4 Miyoshi, N., H. Ishii, H. Nagano, N. Haraguchi, D.L.",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1016/j.stem.2011.05.00 1 Okumura, N., N. Koizumi, M. Ueno, Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
http://dx.doi.org/10.1016/j.ajpath   .2012.03.03 3,OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"http://dx.doi.org/10.1167/   iovs.08-169 3 Zhu, Y .T., H.C. Chen, S.Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
"125:3636– 3648. http://dx.doi.org/10.1242/jcs.10326 7 Zhu, Y .T., B. Han, F. Li, S.Y .",OADS,/arxiv_data1/oa_pdf/d4/7b/JCB_201404032.PMC4164941.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"473:544) http://dx.doi.org/10.1038/nature0953 4 Ackermann, B.L., M.J. Berna, J.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1146/an nurev   .anchem.1.031207.11285 5 Aitchison, J.D., and T. Galitski.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1083/jcb.20030204 1 Aitchison, J.D., and M.P.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1534/   genetics.111.12780 3 Alber, F., S. Dokudovskaya, L.M.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nature0640 4 Alberts, B.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)80922- 8 Aldridge, B.B., J.M.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/ncb149 7 Alon, U.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nrg210 2 Ashall, L., C.A.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.116486 0 Barlowe, C., L. Orci, T. Yeung, M. Hosobuchi, S. Hamamoto, N. Salama,  M.F.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1016/0092-8674(94)90138- 4 Baryshnikova, A., M. Costanzo, C.L.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1146/annurev-genom-082509-14173 0 Barzel, B., and A.-L. Barabási.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"9:750. http://dx.doi.org/10.1038/nphys279 7to avoid an explosion in the number of parameters using algo - rithms for rational reduction of the model complexity (Bongard  and Lipson, 2007; Likhoshvai and Ratushny, 2007).",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1242/jcs.10137 8 Farrah, T., E.W.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1002/pmic.20110051 5 Fernandez-Martinez, J., J. Phillips, M.D.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1083/jcb.20110900 8 Ferrell, J.E.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j   .cell.2011.03.00 6 Finnigan, G.C., V .",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nmeth.286 9 Gillet, L.C., P. Navarro, S. Tate, H. Röst, N. Selevsek, L. Reiter, R. Bonner,  and R. Aebersold.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1074/mcp.O111.01671 7 Gingras, A.-C., M. Gstaiger, B. Raught, and R. Aebersold.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nrm220 8 Goffeau, A., B.G.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.274.5287.54 6 Grün, D., L. Kester, and A. van Oudenaarden.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1038/nmeth.293 0 Gupta, I., S. Clauder-Münster, B. Klaus, A.I.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"10:719. http://dx.doi.org/10   .1002/msb.13506 8 Guttman, M., P. Russell, N.T.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1016/j.cell.2013.06.00 9 Hakenberg, J., S. Schmeier, A. Kowald, E. Klipp, and U. Leser.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1089/153623104138836 6 Hartwell, L.H., J.J. Hopfield, S. Leibler, and A.W.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.10.00 7 Hillenmeyer, M.E., E. Fung, J. Wildenhain, S.E.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.115002 1 Hillenmeyer, M.E., E. Ericson, R.W.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1146/   annurev-biochem-060109-15103 0 Hoffmann, A., A. Levchenko, M.L.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.107191 4 Holman, S.W., P.F.G.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/   10.1016/j.cell.2010.05.01 9 Bennett, M.R., W.L.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/   10.1038/nature0721 1 Bisson, N., D.A.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nbt.190 5 Bongard, J., and H. Lipson.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2007.10.05 3 Braberg, H., H. Jin, E.A.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2013.07.03 3 Brandman, O., J.E.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.111383 4 Breker, M., M. Gymrek, and M. Schuldiner.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1083/jcb.20130112 0 Brenner, S. 2010.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1098/rstb.2009.022 1 Chatr-aryamontri, A., B.-J.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1093/nar/gks115 8 Chen, W.W., M. Niepel, and P.K.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1101/gad.194541 0 Cheng, A.C., R.G.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nbt127 3 Claydon, A.J., and R. Beynon.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1039/c4mb00001 c Collins, B.C., L.C.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nmeth.270 3 Costanzo, M., A. Baryshnikova, J. Bellay, Y .",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1126/science.118082 3 Danziger, S.A., A.V .",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1093/nar/gkt93 8 de Duve, C. 1964.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/0022-5193(64)90065- 7 De Duve, C., H. Beaufay, P. Jacques, Y. Rahman-Li, O.Z.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nature1123 3 Doerr, A.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"10:23. http://dx.doi.org/10.1038/nmeth.228 6 Doolittle, W.F.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
http://dx.doi.org/10.1038/nbt.246 3,Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"167:1099– 1112. http://dx.doi.org/10.1083/jcb.20040411 9 Martin, R.J., J.R. Kusel, and A.J.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.2307/328266 3 Marx, V. 2013.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/   10.1038/nmeth.228 5 Mast, F.D., L.D.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.tcb.2014.02.00 3 Matessi, C., and S. Karlin.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1002/wsbm.3 3 Milgram, S. 1967.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1073/pnas.121691811 0 Mogilner, A., J. Allard, and R. Wollman.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1126/science.121638 0 Mudge, J.M., A. Frankish, and J. Harrow.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1101/gr.161315.11 3 Nurse, P. 2008.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1038/454424 a Nurse, P., and J. Hayles.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.04 5 Pang, W.L., A. Kaur, A.V.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1371/journal.pcbi.100288 0 Payne, W.E., and J.I.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1093/nar/25.1.5 7 Pelechano, V., W. Wei, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nprot.2014.12 1 Picotti, P., B. Bodenmiller, and R. Aebersold.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nmeth.229 1 Picotti, P., M. Clément-Ziza, H. Lam, D.S.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nature1183 5 Politis, A., F. Stengel, Z.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nmeth.284 1 Price, J.C., S. Guan, A. Burlingame, S.B.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1529/   biophysj.108.13406 4 Ratushny, A.V., S.A. Ramsey, and J.D.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"781:415– 433. http://dx.doi.org/10.1007/978-1-61779-276-2_2 1 Ratushny, A.V., I. Shmulevich, and J.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1371/journal.pcbi.100209 1 Ratushny, A.V., R.A. Saleem, K. Sitko, S.A. Ramsey, and J.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"8:577. http://dx.doi.org/10.1038/msb.2012.1 0Ingolia, N.T., S. Ghaemmaghami, J.R.S.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/   science.116897 8 Ingolia, N.T., L.F. Lareau, and J.S.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2011.10.00 2 Jung, S., J.J. Smith, P.D.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1074/mcp.O112.01916 6 Karr, J.R., J.C. Sanghvi, D.N.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"150:389– 401. http://dx.doi.org/10.1016/j.cell.2012.05.04 4 Kitano, H. 2002.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.106949 2 Klemm, S., S. Semrau, K. Wiebrands, D. Mooijman, D.A.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/   nmeth.291 0 Koboldt, D.C., K.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2013.09.00 6 Koonin, E.V.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2013.02.00 8 Koumandou, V.L., B. Wickstead, M.L.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.3109/10409238.2013.82144 4 Kowald, A., and S. Schmeier.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1007/978-1-60761-987-1_1 9 Kuiken, H.J., and R.L.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.2217/fon.10.13 1 Labib, K., and A. Gambus.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/   10.1016/j.tcb.2007.04.00 2 Lambert, J.-P., G. Ivosev, A.L.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.122418 6 Lee, J.C., M. Espéli, C.A.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"155:57– 69. http://dx.doi.org/10.1016/j.cell.2013.08.03 4 Lee, A.Y., R.P.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.125021 7 Likhoshvai, V., and A. Ratushny.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1142/S021972000700283 7 Liti, G., D.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1038/nature0774 3 Litvak, V., S.A. Ramsey, A.G. Rust, D.E.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1038/ni.172 1 Litvak, V., A.V.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1038/nature1142 8 Mardis, E.R.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
http://dx.doi.org/10.1146/annurev-   anchem-062012-09262 8,Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1146/ annurev.physchem.012809.10345 7 Vizeacoumar, F.J., N. van Dyk, F.S.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/3091 8 Weissman, J.S.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"21:3825.  http://dx.doi.org/10.1091/mbc.E10-04-037 0 Welch, J.S., T.J. Ley, D.C. Link, C.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2012.06.02 3 Wurtmann, E.J., A.V.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1111/mmi.1256 4 Yen, K., V. Vinayachandran, and B.F. Pugh.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2013.08.04 3 Yi, E.C., M. Marelli, H. Lee, S.O.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nature1230 8Rhee, H.S., and B.F. Pugh.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.01 3 Rhee, H.S., and B.F. Pugh.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1038/nature1079 9 Roguev, A., S. Bandyopadhyay, M. Zofall, K. Zhang, T. Fischer, S.R.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.116260 9 Rout, M.P., J.D.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10   .1083/jcb.148.4.63 5 Rubakhin, S.S., E.V.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1371/journal   .pone.001195 3 Schmidt, M., and H. Lipson.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science   .116589 3 Schuldiner, M., S.R.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"186:305– 311. http://dx.doi.org/10.1083/jcb.20090709 3 Smith, J.J., and J.D.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nrm370 0 Smith, J.J., S.A. Ramsey, M. Marelli, B. Marzolf, D. Hwang, R.A. Saleem, R.A.  Rachubinski, and J.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"3:115.  http://dx.doi.org/10.1038/msb410015 7 Smith, J.J., L.R.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"7:455. http://dx.doi   .org/10.1038/msb.2010.11 0 Smith, J.J., R.A. Saleem, and J.D.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1007/978-1-61779-276-2_1 6 Stagg, S.M., C. Gürkan, D.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1038/nature0433 9 Stark, C., B.-J.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1093/nar/gkj10 9 Tong, A.H.Y., and C. Boone.",Non-OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1126/science.106581 0 Toyama, B.H., J.N.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1016/j.cell.2013.07.03 7 Toyoshima, M., H.L.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi.org/10.1073/   pnas.112111910 9 Tsai, T.Y.-C., Y.S.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
"http://dx.doi   .org/10.1126/science.115695 1 Tuck, A.C., and D. Tollervey.",OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
http://dx.doi.org/10.1016/j.cell.2013.07.04 7,OADS,/arxiv_data1/oa_pdf/3a/32/JCB_201405027.PMC4164942.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"20:1809– 1818. http://dx.doi.org/10.1016/j.cub.2010.09.03 2 Iizuka-Kogo, A., T. Ishidao, T. Akiyama, and T. Senda.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1242/dev.0283 0 Johnston, C.A., K. Hirono, K.E.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/   10.1016/j.cell.2009.07.04 1 Johnston, C.A., D.S.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1073/   pnas.110436510 8 Kiyomitsu, T., and I.M.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/j.cell.2013.06.01 0 Konno, D., G. Shioi, A. Shitamukai, A. Mori, H. Kiyonari, T. Miyata, and F.  Matsuzaki.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/   10.1074/jbc.M30984320 0 Lechler, T., and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi   .org/10.1038/nature0392 2 Machicoane, M., C.A.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1083/jcb.20140104 9 Mahoney, Z.X., B. Sammut, R.J. Xavier, J. Cunningham, G. Go, K.L.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1073/   pnas.060932610 3 Morin, X., and Y. Bellaïche.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"21:102– 119. http://dx.doi.org/10.1016/j.devcel.2011.06.01 2 Morin, X., F. Jaouen, and P. Durbec.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1038/nn198 4 Naim, E., A. Bernstein, J.F.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1038/   nature1233 5 Noatynska, A., M. Gotta, and P. Meraldi.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1083/jcb.20110103 9 Postiglione, M.P., C. Jüschke, Y. Xie, G.A.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/j.neuron.2011   .09.02 2 Quyn, A.J., P.L.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/j.stem.2009.12.00 7 Rivera, C., I.F.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
http://dx.doi.org/10.1002/dvdy.2203 6miRNA efficiency.,OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/j.bbamem.2007.08.02 9 Bellaïche, Y., A. Radovic, D.F.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/j.cub.2013.07.01 7 Das, R.M., N.J. Van Hateren, G.R.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10   .1016/j.ydbio.2006.02.02 0 Elias, S., M.S.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/   j.stemcr.2014.02.01 1 Fink, J., N. Carpi, T. Betz, A. Bétard, M. Chebah, A. Azioune, M. Bornens, C.  Sykes, L. Fetler, D. Cuvelier, and M. Piel.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1369/jhc.7A7234.200 7 Guilgur, L.G., P. Prudêncio, T. Ferreira, A.R.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"139:503– 513. http://dx.doi.org/10.1242/dev.07102 7 Hao, Y ., Q.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1038/nmeth.201 9 Siegrist, S.E., and C.Q.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/   10.1016/j.cell.2005.09.04 3 Théry, M., V. Racine, A. Pépin, M. Piel, Y. Chen, J.B. Sibarita, and M. Bornens.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1038/nature0578 6 Willard, F.S., R.J. Kimple, and D.P.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1038/nature0979 3 Woods, D.F., and P.J.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/0092-8674(81)90009- X Yu, F., X. Morin, Y. Cai, X. Yang, and W. Chia.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80676- 5 Yu, F., X. Morin, R. Kaushik, S. Bahri, X. Yang, and W. Chia.",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"116:887– 896. http://dx.doi.org/10.1242/jcs.0029 7 Zheng, Z., H. Zhu, Q. Wan, J. Liu, Z. Xiao, D.P.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1083/   jcb.20091002 1 Zhu, J., Y .",OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
"http://dx.doi.org/10.1038/   emboj.2011.42 8 Žigman, M., M. Cayouette, C. Charalambous, A. Schleiffer, O. Hoeller, D.  Dunican, C.R.",Non-OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
http://dx.doi   .org/10.1016/j.neuron.2005.09.03 0,OADS,/arxiv_data1/oa_pdf/65/7c/JCB_201405060.PMC4164945.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201312062/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10   .1038/emboj.2011.25 5 Miller, E.A., and R. Schekman.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1016/j   .ceb.2013.04.00 5 Miller, E., B. Antonny, S. Hamamoto, and R. Schekman.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"21:6105– 6113. http://dx.doi.org/10.1093/emboj/cdf60 5 Mironov, A.A., A.A. Mironov Jr., G.V.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"5:583– 594. http://dx.doi.org/10.1016/S1534-5807(03)00294- 6 Montegna, E.A., M. Bhave, Y. Liu, D. Bhattacharyya, and B.S.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1371/journal.pone.003115 6 Nakańo, A., and M. Muramatsu.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1083/jcb   .109.6.267 7 Nogueira, C., P. Erlmann, J. Villeneuve, A.J.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.7554/eLife.0278 4 Okamoto, M., K. Kurokawa, K. Matsuura-Tokita, C. Saito, R. Hirata, and A.  Nakano.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1242/jcs.10006 5 Saito, K., H. Kajiho, Y. Araki, H. Kurosu, K. Kontani, H. Nishina, and T. Katada.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1016/S0076-6879(05)03023- 5 Saito, K., M. Chen, F. Bard, S. Chen, H. Zhou, D. Woodley, R. Polischuk, R.  Schekman, and V. Malhotra.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.12.02 5 Saito, K., K. Yamashiro, Y. Ichikawa, P. Erlmann, K. Kontani, V. Malhotra,  and T. Katada.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1091/mbc.E11-02-014 3 Soderholm, J., D. Bhattacharyya, D. Strongin, V. Markovitz, P.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi   .org/10.1016/S1534-5807(04)00129- 7 Stagg, S.M., C. Gürkan, D.M.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1038/nature0433 9 Tabata, K.V., K. Sato, T. Ide, T. Nishizaka, A. Nakano, and H. Noji.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10   .1038/emboj.2009.26 9 Venditti, R., T. Scanu, M. Santoro, G. Di Tullio, A. Spaar, R. Gaibisso, G.V.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1126/science.122494 7 Watson, P., A.K.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
http://dx.doi.org/10.1034/j.1600-0854.2001.20704.,Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1091/mbc.E12-05-035 6 Yoshihisa, T., C. Barlowe, and R. Schekman.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
http://dx.doi.org/10.1126/science.845164 4are grateful to the members of the Leica Microsystems Imaging Center at the  University of Tokyo for technical help with image acquisition and Dr. David   Russell for the pCMV5 plasmid.,Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1038/365347a 0 Beznoussenko, G.V., S. Parashuraman, R. Rizzo, R. Polishchuk, O. Martella, D.  Di Giandomenico, A. Fusella, A. Spaar, M. Sallese, M.G.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi   .org/10.7554/eLife.0200 9 Bharucha, N., Y. Liu, E. Papanikou, C. McMahon, M. Esaki, P.D.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1091/mbc.E13-04-018 5 Bi, X., J.D.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1016/j.devcel   .2007.10.00 6 Bonfanti, L., A.A. Mironov Jr., J.A.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81723- 7 Brandizzi, F., and C. Barlowe.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1016/   j.cub.2005.06.06 5 Cutrona, M.B., G.V.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10   .1016/j.ceb.2005.06.00 4 Glick, B.S., and A. Luini.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1101/ cshperspect.a00521 5 Iinuma, T., A. Shiga, K. Nakamoto, M.B.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"282:17632– 17639. http://dx.doi.org/10.1074/jbc.M61123720 0 Ivan, V., G. de Voer, D. Xanthakis, K.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1091/mbc.E08-03-024 6 Jin, L., K.B.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1038/nature1082 2 Kuehn, M.J., J.M.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1038/3443 8 Kung, L.F., S. Pagant, E. Futai, J.G.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi.org/10.1038/emboj.2011.44 4 Lord, C., S. Ferro-Novick, and E.A.",OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
"http://dx.doi   .org/10.1101/cshperspect.a01336 7 Luini, A.",Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
http://dx.doi.org/10.4161/cl.1.1.1469 3,Non-OADS,/arxiv_data1/oa_pdf/c4/31/JCB_201312062.PMC4164946.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201403108/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1083/jcb.20131011 4 Audhya, A., F. Hyndman, I.X.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1083/jcb.20050612 4 Babst, M., D.J.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/S1534-   5807(02)00220- 4 Bajorek, M., H.L.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1038/nsmb.162 1 Bakan, A., L.M.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/   10.1093/bioinformatics/btr16 8 Beauchamp, K.A., Y .S.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1021/ct200781 4 Berendsen, H.J.C., J.P.M.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1002/prot.1038 9 Darnell, S.J., D. Page, and J.C. Mitchell.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1002/prot.2147 4 de Vries, S.J., A.D. van Dijk, M. Krzeminski, M. van Dijk, A. Thureau, V .",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1002/prot.2172 3 Dobro, M.J., R.Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1021/ja026939 x Eswar, N., B. Webb, M.A.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
http://dx.doi.org/10.1371/ journal.pcbi.100057 51 with respect to the hinge in the middle of the structure.,Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/   10.1016/j.devcel.2006.03.01 3 Ohi, M., Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1251/bpo7 0 Papadopoulos, J.S., and R. Agarwala.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1093/bioinformatics/btm07 6 Pettersen, E.F., T.D.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1002/jcc.2008 4 Pires, R., B. Hartlieb, L. Signor, G. Schoehn, S. Lata, M. Roessle, C. Moriscot, S.  Popov, A. Hinz, M. Jamin, et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/   10.1016/j.str.2009.04.00 7 Price, D.J., and C.L.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1063/1.180811 7 Roy, A., A. Kucukural, and Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
5:725– 738. http://dx.doi.org/10.1038/nprot.2010.,OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1021/ct400314 y Schmid, S.L., and V .A.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/   10.1146/annurev-cellbio-100109-10401 6 Shim, S., L.A. Kimpler, and P.I.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1111/j.1600-   0854.2007.00584. x Siegel, L.M., and K.J.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/0926-6585(66)90333- 5 Srinivasan, J., M.W.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10   .1007/s00214005046 0 Stuchell-Brereton, M.D., J.J. Skalicky, C. Kieffer, M.A.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1038/nature0617 2 Teis, D., S. Saksena, and S.D.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.08.01 3 Teis, D., S. Saksena, B.L.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1038   /emboj.2009.40 8 Teo, H., O. Perisic, B. González, and R.L.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.devcel.2004.09.00 3 van Heel, M., G. Harauz, E.V .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1006/jsbi.1996.000 4 Wang, L., and A. Audhya.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.ymeth.2014.03.02 8 Zhang, Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"9:40. http://dx.doi.org/10.1186/1471-2105-9-4 0 Zhu, X., and J.C. Mitchell.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1002/prot.2309 4Fyfe, I., A.L.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/   10.1074/jbc.M111.26641 1 Ghazi-Tabatabai, S., S. Saksena, J.M.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.str.2008.06.01 0 Götz, A.W., M.J. Williamson, D. Xu, D. Poole, S. Le Grand, and R.C.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1021/ct200909 j Guizetti, J., and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/   j.tcb.2011.11.00 7 Guizetti, J., L. Schermelleh, J. Mäntler, S. Maar, I. Poser, H. Leonhardt, T.  Müller-Reichert, and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1126/science.120184 7 Hanson, P.I., R. Roth, Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1083/jcb.20070703 1 Hayward, S., and R.A. Lee.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.05.01 5 Henne, W.M., N.J. Buchkovich, Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.cell.2012.08.03 9 Hierro, A., J.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1038/nature0291 4 Humphrey, W., A. Dalke, and K. Schulten.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/0263-7855(96)00018- 5 Hurley, J.H., and P.I.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"11:556– 566. http://dx.doi.org/10.1038/nrm293 7 Kieffer, C., J.J. Skalicky, E. Morita, I.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.05.01 4 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Lata, S., G. Schoehn, A. Jain, R. Pires, J. Piehler, H.G.",Non-OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1126/science.116107 0 Lata, S., M. Roessle, J. Solomons, M. Jamin, H.G.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1016/j.jmb.2008   .03.03 0 Li, D.W., and R. Brüschweiler.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1002/anie.20100189 8 Ludtke, S.J., P.R.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10.1006/jsbi.1999.417 4 Martinelli, N., B. Hartlieb, Y .",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi   .org/10.1016/j.jmb.2012.02.04 4 McCullough, J., L.A. Colf, and W.I.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"82:663– 692. http://dx.doi.org/10.1146/annurev-biochem-072909-10105 8 Mongan, J., C. Simmerling, J.A.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
"http://dx.doi.org/10   .1021/ct600085 e Morita, E., L.A. Colf, M.A.",OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
http://dx.doi.org/10.1016/j.chom.2011   .02.00 4,OADS,/arxiv_data1/oa_pdf/6b/0b/JCB_201403108.PMC4164947.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1016/S0092-8674(85)80028- 3 Ishida, R., M. Sato, T. Narita, K.R.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/   10.1083/jcb.126.6.134 1 Ivessa, A.S., and V.A.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1101/gad.103370 2 Joshi, R.S., B. Piña, and J. Roca.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1038/emboj.2009.39 1 Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Hiraga, and H. Suzuki.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90172- B Kegel, A., H. Betts-Lindroos, T. Kanno, K. Jeppsson, L. Ström, Y. Katou, T.  Itoh, K. Shirahige, and C. Sjögren.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"309:1581– 1584. http://dx.doi.org/10.1126/science.111610 2 Kobayashi, T., D.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1101/gad.12.24.382 1 Kosco, K.A., C.G.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/   10.1091/mbc.12.9.287 0 Koshland, D., and L.H.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"238:1713– 1716. http://dx.doi.org/10.1126/science.331783 8 Kouzine, F., A. Gupta, L. Baranello, D. Wojtowicz, K. Ben-Aissa, J. Liu, T.M.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"20:396– 403. http://dx.doi.org/10.1038/nsmb.251 7 Lavoie, B.D., E. Hogan, and D. Koshland.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/   10.1101/gad.115040 4 Machín, F., J. Torres-Rosell, A. Jarmuz, and L. Aragón.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1083/jcb.20040808 7 Mirabella, A., and M.R.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1242/jcs.07873 3 Nash, R.S., T. V olpe, and B. Futcher.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1126/   science.107475 7 Neurohr, G., A. Naegeli, I. Titos, D. Theler, B. Greber, J. Díez, T. Gabaldón,  M. Mendoza, and Y. Barral.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1126/science.120157 8 Oliveira, R.A., R.S.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1038/ncb201 8 Paliulis, L.V., and R.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1016/j.cub   .2004.11.05 2 Pearson, C.G., P .S.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1091/mbc.E03-03-018 0 Postow, L., N.J. Crisona, B.J.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201404039/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1016/   j.cell.2006.11.04 1 Baxter, J., N. Sen, V.L.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1126/science.120153 8 Bhalla, N., S. Biggins, and A.W.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10   .1091/mbc.01-05-026 4 Chan, K.-L., P.S.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760177 7 Charbin, A., C. Bouchoux, and F. Uhlmann.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
http://dx.doi.org/10.1093/nar/gkt88 242:340–348.,Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10   .1073/pnas.163155010 0 Clemente-Blanco, A., M. Mayán-Santos, D.A.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1038/nature0765 2 D’Ambrosio, C., G. Kelly, K. Shirahige, and F. Uhlmann.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1016/   j.cub.2008.06.05 8 D’Amours, D., F. Stegmeier, and A. Amon.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1016/   S0092-8674(04)00413- 1 DiNardo, S., K. Voelkel, and R. Sternglanz.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1073/   pnas.81.9.261 6 Farcas, A.-M., P. Uluocak, W. Helmhart, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.07.03 4 Guacci, V., E. Hogan, and D. Koshland.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1083/jcb.125.3.51 7 Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M.B.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1038/   nature0694 7 Hediger, F., F.R.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
http://dx.doi.org/10.1038/nprot.2007.9 4,Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1073/   pnas.11100699 8 Schober, H., H. Ferreira, V. Kalck, L.R.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1101/gad.178750 9 Schuyler, S.C., J.Y.",Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1083/jcb.20021002 1 Severin, F., B. Habermann, T. Huffaker, and T. Hyman.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1083/jcb.143.3.68 7 Sullivan, M., T. Higuchi, V.L.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1016/S0092-8674(04)00415- 5 Taddei, A., F. Hediger, F.R.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760014 4 Taddei, A., H. Schober, and S.M.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1016/S0092-8674(02)00633- 5 Therizols, P., T. Duong, B. Dujon, C. Zimmer, and E. Fabre.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi   .org/10.1016/0092-8674(87)90518- 6 Uhlmann, F., F. Lottspeich, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1038/2183 1 Wang, J.C. 2002.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10   .1038/nrm83 1 Wang, L.H.-C., T. Schwarzbraun, M.R.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
"http://dx.doi.org/10.1007/s00412-007-0131- 7 Winey, M., and K. Bloom.",OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
http://dx.doi.org/10.1534/genetics.111.12871 0,Non-OADS,/arxiv_data1/oa_pdf/7d/c5/JCB_201404039.PMC4164948.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1038/nrg329 3 Ahlskog, J.K., J.K. Björk, A.N.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1128/MCB.01506-0 9 Åkerfelt, M., E. Henriksson, A. Laiho, A. Vihervaara, K. Rautoma, N. Kotaja,  and L. Sistonen.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1038/nrm293 8 Alastalo, T.P., M. Hellesuo, A. Sandqvist, V. Hietakangas, M. Kallio, and L.  Sistonen.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"116:3557– 3570. http://dx.doi.org/10.1242/jcs.0067 1 Anckar, J., and L. Sistonen.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"80:1089– 1115. http://dx.doi.org/10.1146/annurev-biochem-060809-09520 3 Bar-Joseph, Z., Z. Siegfried, M. Brandeis, B. Brors, Y. Lu, R. Eils, B.D.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1073/pnas.070472310 5 Björk, J.K., and L. Sistonen.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1242/dev.05095 5 Brown, S.A., A.N.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1101/gad.10.12.147 9 Chen, D., M. Dundr, C. Wang, A. Leung, A. Lamond, T. Misteli, and S. Huang.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1083/jcb.20040718 2 Christova, R., and T. Oelgeschläger.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"4:79– 82. http://dx.doi.org/10.1038/ncb73 3 Ciocca, D.R., A.P.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1007/s00204-012-0918- z Dai, C., L. Whitesell, A.B.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/j.cell.2007.07.02 0 Debec, A., and C. Marcaillou.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/S0248-4900(99)80082- 3 Delcuve, G.P., S. He, and J.R. Davie.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1002/jcb.2180 6 Fiorenza, M.T., T. Farkas, M. Dissing, D. Kolding, and V. Zimarino.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1093/nar/23.3.46 7 Gottesfeld, J.M., and D.J.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
http://dx.doi.org/10   .1016/S0968-0004(97)01045- 1Data were analyzed using the ImageJ software.,OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1093/nar/gks133 6 Pfau, S.J., and A. Amon.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/   10.1038/embor.2012.6 5 Pines, J.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1038/nrm313 2 Rallu, M., M. Loones, Y .",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/   10.1073/pnas.94.6.239 2 Richter, K., M. Haslbeck, and J. Buchner.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/   j.molcel.2010.10.00 6 Sakurai, H., and Y .",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
http://dx.doi.org/10.1111/j.1742-4658.2010.07829.,Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1091/mbc.E08-08-086 4 Santagata, S., R. Hu, N.U.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"341:1238303. http://dx.doi.org/10.1126/   science.123830 3 Sarge, K.D., V. Zimarino, K. Holm, C. Wu, and R.I. Morimoto.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1101/gad.5.10.190 2 Sarge, K.D., S.P.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/j.biochi.2012.04.01 8 Schvartzman, J.-M., R. Sotillo, and R. Benezra.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1038/nrc278 1 Shinkawa, T., K. Tan, M. Fujimoto, N. Hayashida, K. Yamamoto, E. Takaki,  R. Takii, R. Prakasam, S. Inouye, V. Mezger, and A. Nakai.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1091/mbc.E11-04-033 0 Sif, S., P.T.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1101/gad.12.18.284 2 Solimini, N.L., J. Luo, and S.J.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.09.00 7 Sotillo, R., E. Hernando, E. Díaz-Rodríguez, J. Teruya-Feldstein, C. Cordón- Cardo, S.W.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/j.ccr.2006.10.01 9 Uetake, Y., and G. Sluder.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"20:1666– 1671. http://dx.doi.org/10.1016/j.cub.2010.08.01 8 Valls, E., S. Sánchez-Molina, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1074/jbc.M50740720 0Grant, G.D., L. Brooks III, X. Zhang, J.M.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1091/mbc.E13-05-026 4 Guettouche, T., F. Boellmann, W.S.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"6:4. http://dx.doi.org/10.1186/1471-2091-6- 4 Hietakangas, V., J.K. Ahlskog, A.M. Jakobsson, M. Hellesuo, N.M. Sahlberg,  C.I.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1128/MCB.23.8.2953-2968.200 3 Hietakangas, V ., J. Anckar, H.A.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1073/pnas.050369810 2 Holmberg, C.I., V. Hietakangas, A. Mikhailov, J.O.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1093/emboj/20.14.380 0 Hong, Y., R. Rogers, M.J. Matunis, C.N.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1091/mbc   .E05-01-003 8 Kallio, M., Y. Chang, M. Manuel, T.-P. Alastalo, M. Rallu, Y. Gitton, L. Pirkkala,  M.-T. Loones, L. Paslaru, S. Larney, et al.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1093/emboj/21.11.259 1 Krishnakumar, R., and W.L.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.08.01 4 Kroeger, P.E., K.D.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
http://dx.doi   .org/10.1046/j.1365-2184.2000.00175.,Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1042/BJ2005119 0 Luo, J., N.L.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi   .org/10.1016/j.cell.2009.02.02 4 Martínez-Balbás, M.A., A. Dey, S.K.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/0092-   8674(95)90231- 7 Mathew, A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/   10.1016/j.cell.2012.06.03 1 Michelotti, E.F., S. Sanford, and D. Levens.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1038/   4228 2 Nakahata, K., M. Miyakoda, K. Suzuki, S. Kodama, and M. Watanabe.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"18:332– 343. http://dx.doi.org/10.1080/0265673021012973 6 Nakai, A., and T. Ishikawa.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1093/emboj/20.11.288 5 Orth, J.D., A. Loewer, G. Lahav, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
http://dx.doi.org/10.1091/ mbc.E11-09-078 1,Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10 .1038/   emboj.2010.26 1 Vihervaara, A., and L. Sistonen.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"127:261– 266. http://dx.doi.org/10.1242/jcs.13260 5 Vihervaara, A., C. Sergelius, J. Vasara, M.A.H.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1073/   pnas.130527511 0 Weaver, B.A., A.D.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/j.ccr.2006.12.00 3 Weber, C.M., J.G.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"17:1500– 1507. http://dx.doi.org/10.1038/nsmb.192 6 Wei, Y., L. Yu, J. Bowen, M.A.",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80718- 7 Westerheide, S.D., J. Anckar, S.M.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
"http://dx.doi.org/10.1126/science   .116594 6 Whitfield, M.L., L.X.",OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
http://dx.doi.org/10   .1126/science.110647 8,Non-OADS,/arxiv_data1/oa_pdf/f6/0a/JCB_201402002.PMC4164949.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.jmb.2011.06.04 7 Angst, B.D., L.A. Nilles, and K.J.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.jsb.2011.07.00 9 Asimaki, A., P. Syrris, D. Ward, L.G.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
http://dx.doi.org/10.1111/j.1600-0560.2008.01112.,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1093/eurheartj/ehl09 5 Basso, C., B. Bauce, D. Corrado, and G. Thiene.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20071213 3 Bauce, B., A. Rampazzo, C. Basso, E. Mazzotti, I. Rigato, A. Steriotis, G.  Beffagna, A. Lorenzon, M. De Bortoli, K. Pilichou, et al.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.hrthm.2011.06.02 6 Bornslaeger, E.A., C.M.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.134.4.98 5 Borrmann, C.M., C. Grund, C. Kuhn, I. Hofmann, S. Pieperhoff, and W.W.  Franke.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.ejcb.2006.02.00 9 Cabral, R.M., D. Tattersall, V. Patel, G.D. McPhail, E. Hatzimasoura, D.J.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1242/jcs.08415 2 Chausovsky, A., A.D. Bershadsky, and G.G.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"9:1133– 1140. http://dx.doi.org/10.1016/j.hrthm.2012.03.00 3 Choi, H.J., and W.I.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"409:800– 812. http://dx.doi.org/10.1016/j.jmb.2011.04.04 6 Claycomb, W.C., N.A.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi   .org/10.1073/pnas.95.6.297 9 Cowin, P., and B. Burke.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/S0955-0674(96)80049- 4MT studies For MT stability studies, cells were treated with 1 µM demecolcine/colce - mid (Sigma-Aldrich) at 37°C for the indicated time points.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201312110/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1091/mbc.10.6.203 3 Kaplan, S.R., J.J. Gard, L. Carvajal-Huerta, J.C. Ruiz-Cabezas, G. Thiene,  and J.E.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/   10.1016/S1054-8807(03)00107- 8 Kapplinger, J.D., A.P.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.jacc.2010.12   .036 Klessner, J.L., B.V. Desai, E.V.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1091/mbc.E08-04-035 6 Kodama, A., I. Karakesisoglou, E. Wong, A. Vaezi, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00813- 4 Komarova, Y., C.O.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb   .20080717 9 Kowalczyk, A.P., E.A.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"274:18145– 18148. http://dx.doi.org/10.1074/jbc.274.26.1814 5 Laird, D.W. 2006.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1042/BJ2005192 2 Lansbergen, G., and A. Akhmanova.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1111/j.1600- 0854.2006.00400. x Lauf, U., B.N.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20060910 9 Leung, C.L., K.J.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/ 10  .1016/S0962-8924(01)02180- 8 Ligon, L.A., and E.L. Holzbaur.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
8:808– 819. http://dx.doi.org/10.1111/j.1600-0854.2007.00574.,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10   .1093/hmg/ddt50 8 Meyers, C., and L.A. Laimins.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1007/s00018-007-6360- 3 Musil, L.S., and D.A.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/   10.1083/jcb.115.5.135 7 Nekrasova, O.E., E.V .",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/   10.1083/jcb.20110605 7 Noorman, M., M.A.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2009.03.01 6Cox, M.G., P.A.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"123:2690– 2700. http://dx.doi.org/10.1161/CIRCULATIONAHA.110.98828 7 Delmar, M., and W.J.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.110.22341 2 Franke, W.W., C.M.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.ejcb.2005.11.00 3 Fredriksson, S., M. Gullberg, J. Jarvius, C. Olsson, K. Pietras, S.M.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.cub   .2010.05.02 2 Gallicano, G.I., P. Kouklis, C. Bauer, M. Yin, V. Vasioukhin, L. Degenstein, and  E. Fuchs.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.143.7.200 9 Getsios, S., C.L.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20080904 4 Godsel, L.M., S.N.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20051003 8 Gomes, J., M. Finlay, A.K.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/   10.1093/eurheartj/ehr47 2 Green, K.J., and C.L.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1038/sj.jid.570101 5 Green, K.J., D.A.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi   .org/10.1016/j.cub.2007.12.05 0 Gundersen, G.G., E.R.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1172/JCI6522 0 Hayashi, I., and M. Ikura.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1074/jbc.M30577320 0 Hudson, T.Y ., L. Fontao, L.M.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/   S0091-679X(04)78026- 7 Huen, A.C., J.K. Park, L.M.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20020609 8 Jamora, C., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1038/ncb0402-e10 1 Jaqaman, K., D. Loerke, M. Mettlen, H. Kuwata, S. Grinstein, S.L.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
http://dx.doi.org/10.1038/   nmeth.123 7,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
http://dx.doi.org/10.1046/j.0022-202x.2001.01664.,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"55:1401) http://dx.doi.org/10.1016/j.jacc.2009.11.02 0 Yang, Y., C. Bauer, G. Strasser, R. Wollman, J.P. Julien, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"98:229– 238. http://dx.doi.org/10.1016/S0092-8674(00)81017- X Yang, Z., N.E.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"99:646– 655. http://dx.doi.org/10.1161/01.RES.0000241482.19382.c 6 Yin, T., S. Getsios, R. Caldelari, A.P.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1074/jbc.M109.01346 6Saffitz, J.E.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
http://dx.doi   .org/10.1111/j.1540-8167.2006.00365.,Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20130601 9 Shaw, R.M., A.J.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/j.cell.2006.12.03 7 Shtutman, M., A. Chausovsky, M. Prager-Khoutorsky, N. Schiefermeier, S.  Boguslavsky, Z. Kam, E. Fuchs, B. Geiger, G.G.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.4161/cc.636 2 Simpson, C.L., D.M.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1038/nrm317 5 Skube, S.B., J.M.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1002/cm.2040 9 Slep, K.C., S.L.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20041011 4 Smith, E.A., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1038/nmeth94 7 Solan, J.L., and P.D.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi   .org/10.1042/BJ2008231 9 Stappenbeck, T.S., E.A.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.123.3.69 1 Su, L.K., M. Burrell, D.E.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1016/S0960-   9822(03)00416- 0 Sumigray, K.D., H. Chen, and T. Lechler.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.20110400 9 Sumigray, K., K. Zhou, and T. Lechler.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1371/journal.pone.010182 4 Sun, D., C.L.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi   .org/10.1083/jcb.20111203 4 Tirnauer, J.S., S. Grego, E.D.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1091/mbc.02-04-021 0 V asioukhin, V ., E. Bowers, C. Bauer, L. Degenstein, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1038/ncb1201-107 6 Vaughan, K.T.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/   10.1083/jcb.20050915 0 Wacker, I.U., J.E.",OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"http://dx.doi.org/10.1083/jcb.117.4.81 3 Whittock, N.V., H. Wan, S.M.",Non-OADS,/arxiv_data1/oa_pdf/46/81/JCB_201312110.PMC4164953.pdf
"Available  from: http://globocan.iarc.fr , accessed on November 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/70/b2/IJMR-139-802.PMC4164991.pdf
Available  from: http://clinicaltrials.gov/show/NCT00602160  NLM IdentifierNCT00602160 .,Non-OADS,/arxiv_data1/oa_pdf/ae/d1/IJMR-139-805.PMC4164992.pdf
Available from:  http://clinicaltrials.gov/show/NCT01781637 NLM  IdentifierNCT01781637.,Non-OADS,/arxiv_data1/oa_pdf/ae/d1/IJMR-139-805.PMC4164992.pdf
Available from:  http://clinicaltrials.gov/ show/NCT01157117 NLM IdentifierNCT01157117 .,Non-OADS,/arxiv_data1/oa_pdf/ae/d1/IJMR-139-805.PMC4164992.pdf
European Association of Urology: Guidelines on prostate 20.  cancer Available from: http://www.uroweb.org /gls/pdf/09_ Prostate_Cancer_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a8/d6/IJMR-139-851.PMC4164997.pdf
SNPs were identified via literature search and an  established dbSNP (The Single Nucleotide  Polymorphism database of The National Center for  Biotechnology Information; NCBI) http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/c7/58/IJMR-139-873.PMC4165000.pdf
"The definition of macro- geographical regions and sub-regions ( http://unstats.un.org/unsd/methods/m49/m49regin.ht m) is according to the united Nations; Regions: AFRI (Africa), AMER (Americas),  ASIA (Asia), EuRO (Europe), and OCE (Oceania), subdivided in: E (Eastern), M (Middle), C (Central), N (Northern), S (Southern), SE (South-Eastern), and W (Western).",Non-OADS,/arxiv_data1/oa_pdf/b5/c7/IJMR-139-892.PMC4165002.pdf
"It reflects its geographical localization as well as due to the similarity of specific TB genotypes circulating in Russia (a majority of Beijing genotypes) with those  prevalent in Central, Eastern and South-Eastern Asia **The three letter country codes are according to http://en.wikipedia.org/wiki/ISO_3166-1_alpha- 3; countrywide distribution is only shown for SITs with ≥5% of a given SITs  as compared to their total number in the SITVIT2 database GUPTA  et al: TB GENOTyPIC DIVERSITy IN NORTHERN INDIA  897",Non-OADS,/arxiv_data1/oa_pdf/b5/c7/IJMR-139-892.PMC4165002.pdf
"Available from : 24. https://www.news-medical.net/health/Selenium   -Toxicity.aspx , accessed on May 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/29/IJMR-139-927.PMC4165006.pdf
In silico studies : OT amino acid sequence was fed to  the MS-Digest software (http://prospector.ucsf.edu/ prospector/cgi-bin/msform.cgi?form=msdiges t) and  digested in silico  with various gastric and intestinal  proteases to identify the possible proteolytic sites.,OADS,/arxiv_data1/oa_pdf/30/98/IJMR-139-933.PMC4165007.pdf
The  sequences obtained (n=9) were analyzed for their  homologies using Basic Local Alignment Search  Tool (BLAST) (http://blast.ncbi.nlm.nih.gov/Blast.,OADS,/arxiv_data1/oa_pdf/64/12/IJMR-139-940.PMC4165008.pdf
"Available from: http://www.who.int/mediacentre/ factsheets/fs328/en/ , accessed on January 24, 2013.",OADS,/arxiv_data1/oa_pdf/64/12/IJMR-139-940.PMC4165008.pdf
Available from: http://www.cred.be.,Non-OADS,/arxiv_data1/oa_pdf/22/db/JEHP-3-81.PMC4165091.pdf
Available from: http://www.nursingworld.org/ MainMenuCategories/WorkplaceSafety/Healthy‑Work‑Environment/ DPR/TheLawEthicsofDisasterResponse [Last accessed on  2013 Feb 17].,Non-OADS,/arxiv_data1/oa_pdf/22/db/JEHP-3-81.PMC4165091.pdf
Available  from: http://www.who.int/ihr/publications/combi_toolkit_outbreaks/en 4.,OADS,/arxiv_data1/oa_pdf/69/db/JEHP-3-105.PMC4165094.pdf
Available from: http://www.home.,Non-OADS,/arxiv_data1/oa_pdf/a6/10/JEHP-3-100.PMC4165095.pdf
Available from: http://www.cdc.hbi.ir.,Non-OADS,/arxiv_data1/oa_pdf/cd/af/JEHP-3-86.PMC4165096.pdf
Available from: http://www.icponline.org/featurearticles/ f7‑01.htm[Last accessed on 2001].,Non-OADS,/arxiv_data1/oa_pdf/45/eb/JEHP-3-95.PMC4165104.pdf
Available from: http://eprints.rclis.org/ archive/00014146.,OADS,/arxiv_data1/oa_pdf/45/eb/JEHP-3-95.PMC4165104.pdf
Available from: http://www.ala.org/acrl/nili/ ilit1st.html [last accessed on 2009 Sep 30].,Non-OADS,/arxiv_data1/oa_pdf/45/eb/JEHP-3-95.PMC4165104.pdf
Available from: http://www.webpages.uidaho.edu/~mbolin/ issa‑blessing‑daura.htm.,Non-OADS,/arxiv_data1/oa_pdf/45/eb/JEHP-3-95.PMC4165104.pdf
Available from: http://www.Goums.Ac.Ir.,Non-OADS,/arxiv_data1/oa_pdf/66/9a/JEHP-3-76.PMC4165105.pdf
Available from: http://www.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/66/9a/JEHP-3-76.PMC4165105.pdf
Available from: http://www.newswise.com/articles/ view/567499/?sc=rsmn the [Last accessed date on 2014 Apr 09].,Non-OADS,/arxiv_data1/oa_pdf/66/9a/JEHP-3-76.PMC4165105.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pubmed/15743644.,Non-OADS,/arxiv_data1/oa_pdf/66/9a/JEHP-3-76.PMC4165105.pdf
Available from: http://www.iranculture.org.,Non-OADS,/arxiv_data1/oa_pdf/f3/66/JEHP-3-78.PMC4165106.pdf
Available from: http://www.childinfo.org/mortality.html  [Last  accessed on 2013 May 22].,Non-OADS,/arxiv_data1/oa_pdf/0c/8c/JEHP-3-87.PMC4165107.pdf
[Persian] Available from: http://www.alogift.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
Available at: http://www.hbs.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
"?Loyal college, Chennai600034, Loyola Institute  of Business Administration; 2008. p. 5.Available at: http://www.ssa.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
Available from: http://www.mie.sagepub.com/ content/12/2/27.abstract.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
"Dissertation  for the Degree Doctor of PhilosophyPublisherOhio University,  June, 1998Available at: http://books.google.com/books/about/An_ Examinination_i_e_Examination_of_the.html?id=o5_NtgAACAAJ.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
Available from: http://www.academicjournals.org/AJBM.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
Available from: http://www.noormags.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/JEHP-3-104.PMC4165111.pdf
Available from: http://www.aensiweb.com/ aeb/2013/1466‑1472.pdf.,Non-OADS,/arxiv_data1/oa_pdf/19/aa/JEHP-3-84.PMC4165122.pdf
Available from: http://www.upfroum.com/chapter 5.htm.,Non-OADS,/arxiv_data1/oa_pdf/19/aa/JEHP-3-84.PMC4165122.pdf
Available from: http://www.ipaq.ki.se/ scoring.pdf [Last cited on 2008 Jan 27].,Non-OADS,/arxiv_data1/oa_pdf/1e/35/JEHP-3-94.PMC4165126.pdf
Available from: http://ideas.repec.org/p/ris/albaec/2010_014.,Non-OADS,/arxiv_data1/oa_pdf/1e/35/JEHP-3-94.PMC4165126.pdf
Map was created in software Generic Mapping Tools (GMT v3.1.1; http://gmt.soest.hawaii.edu/).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6380 | DOI: 10.1038/srep06380 2,OADS,/arxiv_data1/oa_pdf/23/76/srep06380.PMC4165270.pdf
"Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: He, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/23/76/srep06380.PMC4165270.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/5d/srep06375.PMC4165272.pdf
Available from: http://www.ohri.ca/ programs/clinical_ epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/80/e1/cea0043-1333.PMC4165304.pdf
(8-11-2010) Available from: http://www.anaphy- laxis.org/content/programs/programs_research_deaths.asp.,Non-OADS,/arxiv_data1/oa_pdf/80/e1/cea0043-1333.PMC4165304.pdf
"Although four of the six SNPs achieved nominal  significance in initial analysis, thus implicating CFI genomic  variation with AMD disease susceptibility, no single SNP  maintained marginal significance after Bonferroni correction  for multiple testing.Molecular Vision  2014; 20:1253-1257 <http://www.molvis.org/molvis/v 20/1253 > Received 13 February 2014 | Accepted 11 September 2014 | Published 13 September 2014© 2014 Molecular Vision 1253Complement factor I and age-related macular degeneration Philip Alexander,1 Jane Gibson,2 Angela J. Cree,1 Sarah Ennis,3 Andrew J. Lotery1 (The first two authors contributed equally to this study.)",Non-OADS,/arxiv_data1/oa_pdf/78/c5/mv-v20-1253.PMC4165324.pdf
Molecular Vision  2014; 20:1253-1257 <http://www.molvis.org/molvis/v 20/1253 > © 2014 Molecular Vision  1254Seddon et al.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/mv-v20-1253.PMC4165324.pdf
Molecular Vision  2014; 20:1253-1257 <http://www.molvis.org/molvis/v 20/1253 > © 2014 Molecular Vision  1255Table  1.,Non-OADS,/arxiv_data1/oa_pdf/78/c5/mv-v20-1253.PMC4165324.pdf
Molecular Vision  2014; 20:1253-1257 <http://www.molvis.org/molvis/v 20/1253 > © 2014 Molecular Vision  1256an undisclosed CFI sequence variation in 55% of patients  with advanced dry AMD and suggested that this variation  was prognostic of treatment response [ 15].,Non-OADS,/arxiv_data1/oa_pdf/78/c5/mv-v20-1253.PMC4165324.pdf
"Molecular Vision  2014; 20:1253-1257 <http://www.molvis.org/molvis/v 20/1253 > © 2014 Molecular Vision  1257AJ, Ripp R, Rudolph G, Ryu E, Sahel JA, Schaumberg DA,  Scholl HP, Schwartz SG, Scott WK, Shahid H, Sigurdsson  H, Silvestri G, Sivakumaran TA, Smith RT, Sobrin L, Souied  EH, Stambolian DE, Stefansson H, Sturgill-Short GM,  Takahashi A, Tosakulwong N, Truitt BJ, Tsironi EE, Uitter - linden AG, van Duijn CM, Vijaya L, Vingerling JR, Vithana  EN, Webster AR, Wichmann HE, Winkler TW, Wong TY,  Wright AF, Zelenika D, Zhang M, Zhao L, Zhang K, Klein  ML, Hageman GS, Lathrop GM, Stefansson K, Allikmets  R, Baird PN, Gorin MB, Wang JJ, Klaver CC, Seddon JM,  Pericak-Vance MA, Iyengar SK, Yates JR, Swaroop A, Weber  BH, Kubo M, Deangelis MM, Leveillard T, Thorsteinsdottir  U, Haines JL, Farrer LA, Heid IM, Abecasis GR.",Non-OADS,/arxiv_data1/oa_pdf/78/c5/mv-v20-1253.PMC4165324.pdf
"Our previous studies have  demonstrated that increased production and activity of MMPs  play an important role in patients with dry eye [ 12] and the  murine dry eye model [ 2,13-15].Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > Received 13 May 2014 | Accepted 10 September 2014 | Published 12 September 2014© 2014 Molecular Vision 1243Osmoprotectants suppress the production and activity of matrix  metalloproteinases induced by hyperosmolarity in primary  human corneal epithelial cells Ruzhi Deng,1,2 Zhitao Su,1,3 Xia Hua,1,4 Zongduan Zhang,1,2 De-Quan Li,1 Stephen C. Pflugfelder1 1Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, TX; 2School of  Optometry and Ophthalmology, Wenzhou Medical University, Wenzhou, China; 3Second Affiliated Hospital, School of Medicine,  Zhejiang University, Hangzhou, China; 4Tianjin Eye Hospital, Tianjin Medical University, Tianjin, China Purpose:  Hyperosmolarity has been recognized as a proinflammatory stress in the pathogenesis of dry eye disease.",Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
"Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1244Traditional approaches to reduce tear hyperosmolarity  in dry eye include use of hypotonic tear substitutes, which  have relatively short persistence in the eye.",Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
"Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1245(Hs00942589_m1), MMP-9 (Hs00234579_m1), MMP-2  (Hs01548724_m1), MMP-3 (Hs00233962_m1), and MMP-7  (Hs00159163_ml).",Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1246 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1247 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
"Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1248Erythritol at 10–20 mM suppressed the mRNA expres - sion of MMP-9, MMP-2, and MMP-7, but not MMP-13 and  MMP-3.",Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
"Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1249shown in Figure 4, mainly in the proforms, 72 kDa MMP-2  and 92 kDa MMP-9 were secreted in the culture media by  normal primary HCECs, with barely or weak detected bands  of the activated forms, 62 kDa MMP-2 and 82 kDa MMP-9.",Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
"Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1250[40,41].",Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1251requires Transglutaminase-2 in human corneal epithelial  cells.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
Molecular Vision  2014; 20:1243-1252 <http://www.molvis.org/molvis/v 20/1243 > © 2014 Molecular Vision  1252at the advancing pterygium head.,Non-OADS,/arxiv_data1/oa_pdf/96/9b/mv-v20-1243.PMC4165325.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2014 |  86  | e51400 | Page 1 of 7Video Article Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors Steven J. Smith1, Stephen H. Hughes1 1HIV Drug Resistance Program, National Cancer Institute Correspondence to: Stephen H. Hughes at hughesst@mail.nih.gov URL: http://www.jove.com/video/51400 DOI: doi:10.3791/51400 Keywords: Immunology, Issue 86, HIV, cytotoxicity, infectivity, luciferase, drug resistance, integrase, reverse transcriptase Date Published: 4/9/2014 Citation: Smith, S.J., Hughes, S.H.",Non-OADS,/arxiv_data1/oa_pdf/26/9f/jove-86-51400.PMC4165338.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51400/ Introduction The availability of drugs targeting several essential steps in the HIV-1 viral life cycle has led to combination drug therapy (called highly active anti retroviral therapy, or HAART) that has greatly improved the treatment of HIV-1 infections, and the long term survival of patients.",Non-OADS,/arxiv_data1/oa_pdf/26/9f/jove-86-51400.PMC4165338.pdf
Germline rearrangements in 146 glioma families (from the Gliogene Consortium; http://www.gliogene.org/) were examined using multiplex ligation-dependent probe ampliﬁcation.,OADS,/arxiv_data1/oa_pdf/a3/cc/nou052.PMC4165415.pdf
"This is an Open Access article distributed underthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),whichpermits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/cc/nou052.PMC4165415.pdf
"For more information about the GliogeneConsortium, refer to the following Web site: http://www.gliogene.org.",Non-OADS,/arxiv_data1/oa_pdf/a3/cc/nou052.PMC4165415.pdf
"Available at: http://www.mirecc.va.gov/docs/visn6/3_PTSD_CheckList_and_Scoring.pdf.Accessed February 22, 2014.Cameron et al Journal of Clinical Psychopharmacology &Volume 34, Number 5, October 2014 564 www.psychopharmacology.com *2014 Lippincott Williams & Wilkins Copyright © 2014 Lippincott Williams & Wilkins.",Non-OADS,/arxiv_data1/oa_pdf/2d/b7/jcp-34-559.PMC4165471.pdf
"Washington, DC: Council for Responsible Nutrition; 2010 Available at: http://www.crnusa.org/prpdfs/CRNPR10ConsumerSurveyUsage+Confidence.pdf.",Non-OADS,/arxiv_data1/oa_pdf/36/96/jcp-34-595.PMC4165472.pdf
Available at: http://www.apd.army.mil/pdffiles/r70_25.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/96/jcp-34-595.PMC4165472.pdf
"28 Thus,  *Correspondence to: Hidehito Kuroyanagi; Email: kuroyana.end@tmd.ac.jp Submitted: 12/20/2013; Revised: 02/28/2014; Accepted: 03/06/2014http://dx.doi.org/10.4161/worm.28459Comprehensive analysis of mutually exclusive  alternative splicing in C. elegans hidehito Kuroyanagi1,*, Satomi t akei1, and Yutaka Suzuki2 1Laboratory of Gene Expression; m edical r esearch i nstitute; t okyo m edical and Dental u niversity; Bunkyo-ku, t okyo, Japan;   2Department of m edical Genome Science; u niversity of t okyo; Kashiwa, Chiba, Japan Keywords:  alternative splicing, intron, mutually exclusive exons, NMD; pre-mRNA processing, proteome diversity Abbreviations:  GO, gene ontology; ME, mutually exclusive; NMD, nonsense-mediated mRNA decay; nt, nucleotide; pre-mRNA,  precursor messenger RNA; PTC, premature termination codon; RT-PCR, reverse transcription-polymerase chain reaction mutually exclusive selection of one exon in a cluster of exons is a rare form of alternative pre-m rna splicing, yet  suggests strict regulation.",Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Sequences of the primers used in  the RT-PCR assays are available upon request to Kuroyanagi H. A list of the GO terms was retrieved from the Gene Ontology  website (http://www.geneontology.org/).,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Sequence logos were generated by using WebLogo3 49 at http://weblogo.threeplusone.com/create.cgi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nat Rev Neurosci  2007; 8:819-31;  PMID:17895907 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nat Rev  Mol Cell Biol  2005 ; 6:386-98; PMID:15956978 ;  http://dx.doi.org/10.1038/nrm1645 6.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nat Rev Genet 2010 ; 11:345-55;  PMID:20376054 ; http://dx.doi.org/10.1038/nrg2776 7.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nature   2010 ; 463:364-8; PMID:20010808 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Cell 2000 ; 101:671- 84; PMID:10892653 ; http://dx.doi.org/10.1016/ S0092-8674(00)80878-8 9.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Cell 2005 ; 123:1-3; PMID:16213205 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
PLoS One  2010 ; 5:e10946 ;  PMID:20532173 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Biosystems  2013 ; 114:31-8; PMID:23850531 ;  http://dx.doi.org/10.1016/j.biosystems.2013.07.003 13.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Cell 1989 ;  56:749-58; PMID:2924347 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Hum Mol Genet 2002 ; 11:1561-7; PMID:12045209 ;  http://dx.doi.org/10.1093/hmg/11.13.1561 15.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
J Biol Chem 2001 ; 276:4158 -67; PMID:11042206 ;  http://dx.doi.org/10.1074/jbc.M006151200 16.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
J Biol Chem   2011 ; 286:10007 -16; PMID:21282112 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Cell 2005 ; 123:65- 73; PMID:16213213 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Genome Res 2011 ; 21:342- 8; PMID:21177968 ; http://dx.doi.org/10.1101/ gr.114645.11021.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Development  2003 ; 130:3757 - 66; PMID:12835392 ; http://dx.doi.org/10.1242/ dev.00604 22.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nat Methods  2006 ; 3:909- 15; PMID :17060915 ; http://dx.doi.org/10.1038/ nmeth944 23.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Mol Cell Biol   2007 ; 27:8612 -21; PMID:17923701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Genes Dev 2008 ; 22:360-74; PMID:18230701 ;  http://dx.doi.org/10.1101/gad.1620608 26.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
J Biol Chem 2001 ; 276:11913 -21;  PMID:11110798 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
PLoS Genet  2013 ; 9:e1003337 ; PMID:23468662 ;  http://dx.doi.org/10.1371/journal.pgen.1003337,Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Genes Dev   1993 ; 7:1885 -97; PMID:8104846 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Hum Mol Genet   2001 ; 10:2661 -9; PMID:11726553 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Development  2005 ;  132:3197-207; PMID:15983401 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
J Biol Chem 1998 ;  273:8268 -77; PMID:9525933 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nature  2001 ;  409:860-921; PMID:11237011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
J Mol Biol  1995 ; 251:603- 13; PMID:7666414 ; http://dx.doi.org/10.1006/ jmbi.1995.0459 38.,Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Mol Cell Neurosci   2007 ; 34:642-52; PMID:17321753 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
"WormBook - Molecular biology -:  http://www.wormbook.org , 2012 :1-21.",Non-OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Cell Mol Life Sci 2009 ; 66:3895 -907;  PMID:19688295 ; http://dx.doi.org/10.1007/ s00018-009-0120-5 43.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nucleic Acids Res   2013 ; 41:4015 -25; PMID:23416545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
RNA  2005 ; 11:248- 53; PMID :15661845 ; http://dx.doi.org/10.1261/ rna.7221605 45.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Nucleic Acids Res 2002 ; 30:3360 - 7; PMID:12140320 ; http://dx.doi.org/10.1093/nar/ gkf465 47.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
PLoS Comput Biol  2006 ; 2:e86;  PMID:16839192 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
Genome Res   2004 ; 14:1188 -90; PMID:15173120 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
J Cell Biol   2006 ; 175:217-23; PMID:17043142 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/f5/worm-3-e28459.PMC4165533.pdf
"11 samples was  noticeably infected with a dense coating of bacteria on the surface of the worms, and the worms also exhibited a swollen Worm-stars and half-worms Novel dangers and novel defense Jonathan Hodgkin*, Laura C Clark, and Maria J Gravato-Nobre Department of Biochemistry; University of Oxford; Oxford, UK Keywords:  bacterial infection,  coryneform, Leucobacter, nematode trapping, autotomy, glycosylation, trade-off *Correspondence to: Jonathan Hodgkin;   Email: jonathan.hodgkin@bioch.ox.ac.uk Submitted: 01/06/2014Accepted: 01/21/2014http://dx.doi.org/10.4161/worm.27939 Commentary to: Hodgkin  J, Félix  MA, Clark LC ,  Stroud  D, Gravato-Nobre  MJ.",Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
PLoS Biol 2011; 9:e1000586;  http://dx.doi.org/10.1371/journal.pbio.1000586 ;  PMID:21283608 4.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
BMC Evol Biol 2011; 11:339-57; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Curr Biol 2000; 10:1615- 8; PMID:11137017 ; http://dx.doi.org/10.1016/ S0960-9822(00)00867-86.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
FEMS Microbiol Lett  2006; 264:145-51;  PMID:17010162 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Int J Syst  Evol Microbiol 2011; 61:2353-7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Curr  Biol 2008; 18:481-9; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Curr Biol 2013; 23:83- 6; http://dx.doi.org/10.1016/j.cub.2012.11.035 ;  PMID:23246407 13.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Biol Rev Camb Philos Soc 2007;  82:481-510;  PMID:17624964 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Trans R Soc Trop Med Hyg 1957;  51:132-6;  PMID:13422573 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Nematologica 1981; 27:117-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Nematology 2005; 7:363-73; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Genetics 2005; 171:1033-45;   PMID:16079230 ; http://dx.doi.org/10.1534/ genetics.105.045716 20.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Genetics 2011; 187:141- 55; http://dx.doi.org/10.1534/genetics.110.122002 ;  PMID:20980242 21.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
J Biol Chem 2010; 285:17662- 72; http://dx.doi.org/10.1074/jbc.M109.065433 ;  PMID:20385555 22.,OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Behaviour 1993; 126:155- 69; http://dx.doi.org/10.1163/156853993X00092 24.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
Nat Neurosci 2012;  15:107-12 ; http://dx.doi.org/10.1038/nn.2975 ;  PMID:22081161 25.,Non-OADS,/arxiv_data1/oa_pdf/82/6e/worm-3-e27939.PMC4165538.pdf
"At the level of circuits, we describe how neuropeptide signaling adds a dynamic new language of communication to the nervous system, and we highlight From genes to circuits and behaviors Neuropeptides expand the coding potential of the nervous system Sarah G Leinwand1,2 and Sreekanth H Chalasani1,2,* 1Neurosciences Graduate Program; University of California San Diego; La Jolla, CA USA; 2Molecular Neurobiology Laboratory; The Salk Institute for Biological  Studies; La Jolla, CA USA Keywords:  neuropeptide, insulin,  proprotein convertase, neural circuit, sensory neuron, salt, multisensory *Correspondence to Sreekanth H Chalasani;   Email: schalasani@salk.edu Submitted: 11/27/2013Revised: 12/21/2013Accepted: 01/03/2014http://dx.doi.org/10.4161/worm.27730",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Nat Neurosci 2010;  13: 615-21;  PMID:20364145 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
J Neurosci 2010; 30:7889-99;  PMID:20534837 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
EMBO J 2013; 32:1745-60; PMID:23665919 ;  http://dx.doi.org/10.1038/emboj.2013.91 6.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Neuron 2006; 51:613-25; PMID :16950159 ;  http://dx.doi.org/10.1016/j.neuron.2006.07.0247.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
J Neurosci 2009; 29:6734- 51; PMID:19458242 ; http://dx.doi.org/10.1523/ JNEUROSCI.1350-09.2009 8.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Nat Neurosci 2013; 16:1461- 7; PMID:24013594 ; http://dx.doi.org/10.1038/ nn.3511 9.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
J Cell Biol  2008; 180:483-91;  PMID:18250196 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
WormBook 2008;  1-36;  PMID:18819171 ; http://dx.doi.org/10.1895/ wormbook.1.142.1 12.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Bioessays 2000; 22:545-53;  PMID:10842308 ; http://dx.doi.org/10.1002/ (SICI)1521-1878(200006)22:6<545::AID-BIES7>3.0.CO;2-F 14.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
J Neurochem 2006;  98:1999-2012;  PMID:16945111 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Cell Tissue Res 2006; 326:583-98;  PMID:16847638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
J Neurosci  2007; 27:10176-84;  PMID :17881523 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Genes Dev 2001; 15:672- 86; PMID:11274053 ; http://dx.doi.org/10.1101/ gad.867301 19.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Proc Natl Acad Sci U S A 2005; 102:11047-52; PMID:16040806 ; http://dx.doi.org/10.1073/ pnas.050235710220.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Invert Neurosci 2009; 9:57-75; PMID:19756790 ; http://dx.doi.org/10.1007/ s10158-009-0090-1 21.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Bioessays  2012; 34:458-65;  PMID:22396302 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Bioessays 2001; 23:261-9;  PMID:11223883 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Cell 1993; 74:515-27; PMID:8348618 ;  http://dx.doi.org/10.1016/0092-8674(93)80053-H 26.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Science  2008; 320:803-7;  PMID:18403676 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Curr Biol  2007; 17:1847-57;  PMID:17964166 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
EMBO J 2011; 30:1376-88; PMID:21304490 ;  http://dx.doi.org/10.1038/emboj.2011.13 29.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Trends Cogn Sci 2006; 10:278- 85; PMID:16713325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Nat Neurosci 2000; 3:431-2; PMID:10769380 ; http://dx.doi.org/10.1038/74797 31.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Neuron 2004; 44:521-33;  PMID:15504331 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Cell 2011; 145:133-44;  PMID:21458672 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
Nature  2013; 501:179-84;  PMID:24025838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/f4/worm-3-e27730.PMC4165544.pdf
"The use of targeted  agents in lung cancer patients harboring epidermal growth REVIEW http://dx.doi.org/10.4046/trd.2014.77.2.49 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:49-54 49Address for correspondence: Mee Sook Roh, M.D., Ph.D. Department of Pathology, Dong-A University College of Medicine, 32  Daesingongwon-ro, Seo-gu, Busan 602-714, Korea Phone:  82-51-240-2833, Fax: 82-51-243-7396 E-mail: msroh@dau.ac.kr Received:  Jun.",Non-OADS,/arxiv_data1/oa_pdf/1a/07/trd-77-49.PMC4165659.pdf
"4, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/1a/07/trd-77-49.PMC4165659.pdf
Molecular pathology of lung cancer http://dx.doi.org/10.4046/trd.2014.77.2.49  51 www.e-trd.org10q11.2 that encodes a receptor tyrosine kinase involved in  neural crest development20.,Non-OADS,/arxiv_data1/oa_pdf/1a/07/trd-77-49.PMC4165659.pdf
"Molecular pathology of lung cancer http://dx.doi.org/10.4046/trd.2014.77.2.49  53 www.e-trd.org1) Adenocarcinoma: Statistical driver analysis yielded pre - viously reported and novel lung adenocarcinoma genes and  these included lung adenocarcinoma genes with non-synony - mous mutation frequencies consistent with previous reports:  TP53  (50%), KRAS (27%), EGFR (17%), STK11 (15%), KEAP1  (12%), NF1 (11%), BRAF (8%), and SMAD4 (3%).",Non-OADS,/arxiv_data1/oa_pdf/1a/07/trd-77-49.PMC4165659.pdf
"Until 2000, it was a com - mon conclusion that lung cancer screening does not reduce REVIEW http://dx.doi.org/10.4046/trd.2014.77.2.55 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:55-59 55Address for correspondence: Young Sik Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ce/af/trd-77-55.PMC4165660.pdf
"3, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ce/af/trd-77-55.PMC4165660.pdf
Lung cancer screening post NLST http://dx.doi.org/10.4046/trd.2014.77.2.55  57 www.e-trd.orgNELSON trial and UKLS are under conduction and the results  will be published.,Non-OADS,/arxiv_data1/oa_pdf/ce/af/trd-77-55.PMC4165660.pdf
Lung cancer screening post NLST http://dx.doi.org/10.4046/trd.2014.77.2.55  59 www.e-trd.orgscreening for lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/ce/af/trd-77-55.PMC4165660.pdf
Available  from: http://www.lung.org/lung-disease/lung-cancer/lung- cancer-screening-guidelines/lung-cancer-screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/af/trd-77-55.PMC4165660.pdf
"Efforts are being made  to achieve these goals and studies using microRNA (miRNA)  have gained a lot of attention recently, ranging from those on REVIEW http://dx.doi.org/10.4046/trd.2014.77.2.60 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:60-64 60Address for correspondence: Hye Cheol Jeong, M.D., Ph.D. Division of Respiratory and Critical Care Medicine, Department of  Internal Medicine, CHA Bundang Medical Center, CHA University College  of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam 463-712, Korea Phone:  82-31-780-6142, Fax: 82-31-780-6143 E-mail: jhcmd@cha.ac.kr Received:  Jun.",Non-OADS,/arxiv_data1/oa_pdf/7f/1a/trd-77-60.PMC4165661.pdf
"3, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/7f/1a/trd-77-60.PMC4165661.pdf
Clinical aspect of microRNA in lung cancer http://dx.doi.org/10.4046/trd.2014.77.2.60  61 www.e-trd.orgMicroRNA and Cancer It has been reported that abnormal miRNAs are also de - tected in hematologic malignancies and solid cancers.,Non-OADS,/arxiv_data1/oa_pdf/7f/1a/trd-77-60.PMC4165661.pdf
Clinical aspect of microRNA in lung cancer http://dx.doi.org/10.4046/trd.2014.77.2.60  63 www.e-trd.orgblood in lung cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/7f/1a/trd-77-60.PMC4165661.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.77.2.65 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:65-72 65Address for correspondence: Choong Jae Lee, Ph.D. Department of Pharmacology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 301-747, Korea Phone:  82-42-580-8255, Fax: 82-42-585-6627, E-mail: LCJ123@cnu.ac.kr *Hyun Jae Lee and Jiho Ryu contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/trd-77-65.PMC4165662.pdf
"5, 2014 Accepted:  May 21, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/63/0b/trd-77-65.PMC4165662.pdf
Morus alba  L. and airway mucin http://dx.doi.org/10.4046/trd.2014.77.2.65  67 www.e-trd.orgconstant temperature (22.5oC) and humidity (55%).,Non-OADS,/arxiv_data1/oa_pdf/63/0b/trd-77-65.PMC4165662.pdf
"Morus alba  L. and airway mucin http://dx.doi.org/10.4046/trd.2014.77.2.65  69 www.e-trd.org3 weeks resulted in significant increase in mucin secretion  and mucosubstances (acidic mucins) in tracheal tissues,  compared with the normal control group.",Non-OADS,/arxiv_data1/oa_pdf/63/0b/trd-77-65.PMC4165662.pdf
"Morus alba  L. and airway mucin http://dx.doi.org/10.4046/trd.2014.77.2.65  71 www.e-trd.org10−4 M, respectively (Figure 5A).",Non-OADS,/arxiv_data1/oa_pdf/63/0b/trd-77-65.PMC4165662.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.77.2.73 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:73-80 73Address for correspondence: Hui Jung Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/17/ed/trd-77-73.PMC4165663.pdf
"23, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/17/ed/trd-77-73.PMC4165663.pdf
"Vitamin D inhibits expression and activity of MMP http://dx.doi.org/10.4046/trd.2014.77.2.73  75 www.e-trd.orgsamples was reacted with oxidant (1.4% chloramines T in ace - tate-citric acid buffer; Sigma, St. Louis, MO, USA) and Ehrlich’ s  reagent (0.4% p-dimethylaminobenzaldehyde; Sigma) in 60%  perchloric acid (Fisher Chemical, Fair Lawn, NJ, USA) at 65oC  for 25 minutes, and hydroxyproline content was determined  by spectrophotometer at 550 nm.",Non-OADS,/arxiv_data1/oa_pdf/17/ed/trd-77-73.PMC4165663.pdf
"Vitamin D inhibits expression and activity of MMP http://dx.doi.org/10.4046/trd.2014.77.2.73  77 www.e-trd.org25(OH)D, and 67.7±9.1% inhibition by 1,25(OH)2D) (Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/17/ed/trd-77-73.PMC4165663.pdf
Vitamin D inhibits expression and activity of MMP http://dx.doi.org/10.4046/trd.2014.77.2.73  79 www.e-trd.orgbinding it modulates various cellular functions.,Non-OADS,/arxiv_data1/oa_pdf/17/ed/trd-77-73.PMC4165663.pdf
"This report describes a recently  discovered case of venlafaxine-induced interstitial lung dis - ease (ILD).CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.2.81 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:81-84 81Address for correspondence: Seung-Ick Cha, M.D.",Non-OADS,/arxiv_data1/oa_pdf/94/11/trd-77-81.PMC4165664.pdf
"29, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/94/11/trd-77-81.PMC4165664.pdf
"Venlafaxine-induced ILD http://dx.doi.org/10.4046/trd.2014.77.2.81  83 www.e-trd.orgcytes, 3% eosinophils, and 80% macrophages.",Non-OADS,/arxiv_data1/oa_pdf/94/11/trd-77-81.PMC4165664.pdf
"Intratho - racic involvement of IgG4-RD has been reported by several  investigators and shows various manifestations, including  pulmonary nodules, round ground glass opacities (GGOs), CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.2.85 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:85-89 85Address for correspondence: Jin Woo Song, M.D.",Non-OADS,/arxiv_data1/oa_pdf/b6/82/trd-77-85.PMC4165665.pdf
"17, 2014 Revised:  May 13, 2014 Accepted:  May 28, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/b6/82/trd-77-85.PMC4165665.pdf
"A case of IgG4-related lung disease http://dx.doi.org/10.4046/trd.2014.77.2.85  87 www.e-trd.orgwith IgG4 antibody (1:1,600, Binding Site, Birmingham, UK)  was performed.",Non-OADS,/arxiv_data1/oa_pdf/b6/82/trd-77-85.PMC4165665.pdf
A case of IgG4-related lung disease http://dx.doi.org/10.4046/trd.2014.77.2.85  89 www.e-trd.orgmainly in solid lesions of IgG4-related lung disease.,Non-OADS,/arxiv_data1/oa_pdf/b6/82/trd-77-85.PMC4165665.pdf
"She subsequently developed a confused CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.2.90 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:90-93 90Address for correspondence: Eun Young Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/03/bb/trd-77-90.PMC4165666.pdf
"17, 2014 Revised:  May 19, 2014 Accepted:  May 29, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/03/bb/trd-77-90.PMC4165666.pdf
"Pulmonary embolism of hyaluronic acid http://dx.doi.org/10.4046/trd.2014.77.2.90  91 www.e-trd.orgwas as follows: white blood cells, 21,080/ mL (neutrophils 91%);  hemoglobin, 11 g/dL; platelets, 240,000/μL.",Non-OADS,/arxiv_data1/oa_pdf/03/bb/trd-77-90.PMC4165666.pdf
Pulmonary embolism of hyaluronic acid http://dx.doi.org/10.4046/trd.2014.77.2.90  93 www.e-trd.org7.,Non-OADS,/arxiv_data1/oa_pdf/03/bb/trd-77-90.PMC4165666.pdf
"CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.2.94 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:94-97 94Address for correspondence: Young-Ki Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/54/1f/trd-77-94.PMC4165667.pdf
"Department of Internal Medicine, Kangnam Sacred Heart Hospital,  Hallym University College of Medicine, 1 Singil-ro, Yeongdeungpo-gu,  Seoul 150-950, Korea  Phone:  82-2-829-5114, Fax: 82-2-848-9821 E-mail: km2071@unitel.co.kr  Received:  Jan. 29, 2014 Revised:  May 20, 2014 Accepted:  May 30, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/54/1f/trd-77-94.PMC4165667.pdf
Empyema necessitatis in peritoneal dialysis http://dx.doi.org/10.4046/trd.2014.77.2.94  95 www.e-trd.orgdiagnosis.,Non-OADS,/arxiv_data1/oa_pdf/54/1f/trd-77-94.PMC4165667.pdf
Empyema necessitatis in peritoneal dialysis http://dx.doi.org/10.4046/trd.2014.77.2.94  97 www.e-trd.orgchronic renal disease.,Non-OADS,/arxiv_data1/oa_pdf/54/1f/trd-77-94.PMC4165667.pdf
http://ci5.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/cb/36/CEJU-67-00380.PMC4165681.pdf
"The National Register of Neoplasms, The M. Skłodowska–Curie Centre of Oncology – Curie.http://onkologia.org.pl/ References",Non-OADS,/arxiv_data1/oa_pdf/cb/36/CEJU-67-00380.PMC4165681.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 25774 - http://dx.doi.org/10.3402/ljm.v9.25774 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ec/00/LJM-9-25774.PMC4165722.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 25774 - http://dx.doi.org/10.3402/ljm.v9.25774",Non-OADS,/arxiv_data1/oa_pdf/ec/00/LJM-9-25774.PMC4165722.pdf
Available from: http://www.plos.org/about/ plos/history/ [cited 4 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/ec/00/LJM-9-25774.PMC4165722.pdf
A vailable from: http://www.moore.,Non-OADS,/arxiv_data1/oa_pdf/ec/00/LJM-9-25774.PMC4165722.pdf
"Available from: https://gagivesday.org/c/GGD/a/cachexia [cited 4 September 2014].Editorial Citation: Libyan J Med 2014, 9: 25774 - http://dx.doi.org/10.3402/ljm.v9.25774 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ec/00/LJM-9-25774.PMC4165722.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/89/0f/thnov04p1072.PMC4165775.pdf
"The multispectral  FMI  system  from Technische Universität München &  Helmholtz  Zentrum  (http://www.helmholtz -muenc hen.de ) produced in collaboration with SurgOptix  (SurgOptix Inc.,  Redwood Shores, CA, USA)  has the  advantage of  being able to  correct for the attenuation   of the excitation of light  and also can be applied to  clinical cancer resear ch [7, 15, 17, 57- 59].",Non-OADS,/arxiv_data1/oa_pdf/89/0f/thnov04p1072.PMC4165775.pdf
Another surgical navigation system is the GXMI  Navigator  developed in  our Key Laboratory of Mole c- ular Imaging  at the Chinese Academy of Sciences  (http://www.3dmed.net/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/0f/thnov04p1072.PMC4165775.pdf
National Cancer  Institute http://www.cancer.gov/aboutnci/budget_planning_leg/plan -2013.,Non-OADS,/arxiv_data1/oa_pdf/89/0f/thnov04p1072.PMC4165775.pdf
http://clinicaltrials.gov/show/NCT01508572   140.,Non-OADS,/arxiv_data1/oa_pdf/89/0f/thnov04p1072.PMC4165775.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/dc/a1/thnov04p1123.PMC4165776.pdf
"4, Issue 11      http://www.thno.org 1133 TThheerraannoossttiiccss   2014; 4(11): 1133-1144. doi: 10.7150/thno.9945  Short Research Communication  Ultrasound-Mediated Gene and Drug Delivery Using a  Microbubble-Liposome Particle System  Young Il Yoon1,2,3*, Yong-Su Kwon4*, Hee-Sang Cho4, Sun-Hee Heo5, Kyeong Soon Park5, Sang Gyu Park5,  Soo-Hong Lee5, Seung Il Hwang1,2, Young Il Kim1, Hwan Jun Jae1, Gook-Jun Ahn7, Young-Seok Cho8,  Hakho Lee9, Hak Jong Lee1,2,3,10, Tae-Jong Yoon4   1.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
© Ivyspring International Publishe r. This is an open-access article distributed under the terms of the Creative Commons License  (http://creativecommons.org/  licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1134 netic nanoparticles, quantum dots or novel metal na- noparticles as substrates [3, 4].",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1135 film solution, and excess dye was removed by cen- trifugation (5 min, 13,000 rpm).",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1136 the culture media, and the cells were allowed to grow  for another 24 hr.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1137 T1-weighted images were obtained by using 3D  Volumetric Interpolated Breath Hold Examination (VIBE) sequence with TR, 5.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1138 We next evaluated the MB-Lipo’s echogenicity,  i.e., the capability of the particles to return US signals.",OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1139 The MB-Lipo could also be used to deliver siR- NA for therapeutic applicat ions.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1140   Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1141 MBs (Fig.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1142   Figure 6.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1143 in a site-specific and time-specific manner.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
http://www.thno.org/v04p1133s1.pdf  Acknowledgements   We thank Dr. Shao (MGH) for critically review- ing the manuscript.,Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
"4, Issue 11    http://www.thno.org 1144 37.",Non-OADS,/arxiv_data1/oa_pdf/07/33/thnov04p1133.PMC4165777.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a1/41/thnov04p1145.PMC4165778.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/22/keu135.PMC4165844.pdf
"prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year rando- mized study, 2008, http://arthritis-research.com/content/10/6/R128 (8 March 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f4/22/keu135.PMC4165844.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jidREFERENCES Bastian BC, Xiong J, Frieden IJ et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/1d/jid2014195a.PMC4165863.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/VA Kinsler et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/1d/jid2014195a.PMC4165863.pdf
"Revidierte Form Manual , 2000. http://www.kindl.org/deutsch/manual/.",Non-OADS,/arxiv_data1/oa_pdf/05/75/ijo2014145a.PMC4165864.pdf
"Deliverable 8.1, IDEFICS study, 2007. http://www.ide ﬁcs.eu/Ide ﬁcs/ UserFiles/File/D8_1_ExistingGuidelines_Final.pdf (last access May 2014).",Non-OADS,/arxiv_data1/oa_pdf/05/75/ijo2014145a.PMC4165864.pdf
EFSA Journal 2010; 8: 1459 (http://www.efsa.europa.eu/en/efsajournal/pub/1459.htm).,Non-OADS,/arxiv_data1/oa_pdf/05/75/ijo2014145a.PMC4165864.pdf
Available at http://www.euro.who.int/__data/assets/pdf_ ﬁle/0010/119926/E70041.pdf.,OADS,/arxiv_data1/oa_pdf/05/75/ijo2014145a.PMC4165864.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Adherence to targets of obesity intervention E Kovács et al S151 © 2014 Macmillan Publishers Limited International Journal of Obesity (2014) S144 –S151",Non-OADS,/arxiv_data1/oa_pdf/05/75/ijo2014145a.PMC4165864.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Internati onal Journal of Obesity website ( http://www.nature.com/ijo)Reference values of children ’s blood fatty acids M Wolters et al S98 International Journal of Obesity (2014) S86 –S98 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/26/65/ijo2014139a.PMC4165865.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 557 Korean J Urol 2014;55:557-567http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .557&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.557 Review Article Open Mini-Flank Partial Nephrectomy: An Essential  Contemporary Operation Paul Russo, Roy Mano Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA Secondary to the widespread use of the mode rn imaging techniques of computed tomog- raphy, magnetic resonance imaging, and ultrasound, 70% of renal tumors today are  detected incidentally with a median tumor si ze of less than 4 cm.",Non-OADS,/arxiv_data1/oa_pdf/a3/62/kju-55-557.PMC4165917.pdf
"Keywords:  Chronic kidney failure; Methods; Nephrectomy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 7 May, 2014 accepted 21 July, 2014 Corresponding Author: Paul Russo Urology Service, Department of Surgery, Memorial Sloan  Kettering Cancer Center, 1275  York Avenue, New York, NY 10065, USA  TEL: +1-646-422-4391  FAX: +1-212-988-0760 E-mail: RussoP@MSKCC.org INTRODUCTION In the last 20 yea rs partial nephrectom y (PN) has emerged  as a critical operation for the treatment of renal cortical tumors.",Non-OADS,/arxiv_data1/oa_pdf/a3/62/kju-55-557.PMC4165917.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 568 Korean J Urol 2014;55:568-573http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .568&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.568 Review Article  Current Status of Renal Biopsy for Small Renal Masses Seung Beom Ha, Cheol Kwak Department of Urology, Seoul National University Hospital, Seoul, Korea  Small renal masses (SRMs) are defined as radiologically enhancing renal masses of  less than 4 cm in maximal diameter.",Non-OADS,/arxiv_data1/oa_pdf/70/50/kju-55-568.PMC4165918.pdf
"Keywords:  Biopsy; Kidney neoplasms; Watchful waiting This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 April, 2014 accepted 26 June, 2014 Corresponding Author: Cheol Kwak Department of Urology, Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul  110-744, KoreaTEL: +82-2-2072-2999 FAX: +82-2-742-4665 E-mail: mdrafael@snu.ac.kr INTRODUCTION  Unlike other urological maligna ncies, localized renal cell  carcinoma (RCC) is treated by surgical extirpation only, without the undertaking of a preoperative renal mass biop-sy, because radiologic studies including ultrasonography (US), contrast-enhanced comp uted tomography (CT), and  magnetic resonance imaging (M RI) provide relatively suf- ficient information about the probability of malignancy of  a renal mass [1].",Non-OADS,/arxiv_data1/oa_pdf/70/50/kju-55-568.PMC4165918.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 574 Korean J Urol 2014;55:574-580http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .574&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.574 Original Article - Urological Oncology Prognostic Factors for Urachal Cancer: A Bayesian  Model-Averaging Approach In Kyong Kim1, Joo Yong Lee1, Jong Kyou Kwon1, Jae Joon Park1, Kang Su Cho2, Won Sik Ham1,  Sung Joon Hong1, Seung Choul Yang1, Young Deuk Choi1,3 1Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, 2Department of  Urology, Gangnam Severance Hospital, Urological Science In stitute, Yonsei University College of Medicine, Seoul, 3Robot and Minimal  Invasive Surgery Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Purpose:  This study was conducted to evaluate prognostic factors and cancer-specific   survival (CSS) in a cohort of 41 patients wi th urachal carcinoma by use of a Bayesian  model-averaging approach.",Non-OADS,/arxiv_data1/oa_pdf/80/74/kju-55-574.PMC4165919.pdf
"Keywords:  Follow-up studies; Su rvival; Urachal cancer This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 5 June, 2014 accepted 3 July, 2014 Corresponding Author: Young Deuk Choi Department of Urology and Robot and Minimal Invasive Surgery  Center, Severance Hospital,  Yonsei University College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 120-752,  KoreaTEL: +82-2-2228-2317 FAX: +82-2-312-2538 E-mail: youngd74@yuhs.ac INTRODUCTION The urachus is a vestigial tubular structure that connects  the urinary bladder to the allantois during early embryonic development [1].",Non-OADS,/arxiv_data1/oa_pdf/80/74/kju-55-574.PMC4165919.pdf
"3.0.3; R Foundation for Statistical Computing, Vienna, Austria; http://www.r-project.org) by using BMA for a Bayesian model-averaging approach.",Non-OADS,/arxiv_data1/oa_pdf/80/74/kju-55-574.PMC4165919.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 581 Korean J Urol 2014;55:581-586http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .581&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.581 Original Article - Endourology/Urolithiasis Pilot Study of Low-Dose Nonenhanced Computed Tomography With   Iterative Reconstruction for Diagnosis of Urinary Stones Sang Ho Park, Kyung Do Kim, Young Tae Moon, Soon Chul Myung, Tae Hyoung Kim, In Ho Chang,   Jong Kyou Kwon1 Department of Urology, Chung-Ang University College of Medicine, Seoul, 1Department of Urology, Severance Hospital, Urological Science   Institute, Yonsei University College of Medicine, Seoul, Korea Purpose:  To evaluate the efficacy of low-dose computed tomography (LDCT) for detect- ing urinary stones with the use of an iter ative reconstruction technique for reducing  radiation dose and image noise.",Non-OADS,/arxiv_data1/oa_pdf/f5/10/kju-55-581.PMC4165920.pdf
"Keywords:  Computer-assisted image processi ng; Radiation; Urinary calculi This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 April, 2014 accepted 15 July, 2014 Corresponding Author: Kyung Do KimDepartment of Urology,  Chung-Ang University Hospital,  Chung-Ang University College of Medicine, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755,  KoreaTEL: +82-2-6299-1806 FAX: +82-2-6294-1406 E-mail: kim14141@hanafos.com INTRODUCTION Urinary stones are one of the most prevalent diseases in  the field of urology, but about 34% of ureteral stones cannot  be detected by simple x-rays, and radiopaque stones are of-ten difficult to locate within the exact lesion [1].",Non-OADS,/arxiv_data1/oa_pdf/f5/10/kju-55-581.PMC4165920.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 587 Korean J Urol 2014;55:587-592http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .587&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.587 Original Article - Endourology/Urolithiasis Diagnostic Efficacy of Contrast-Enhanced Ultrasound for Small  Renal Masses Tae Hoon Oh, Young Hwan Lee1, Ill Young Seo  Departments of Urology and 1Radiology, Institute of Wonkwang Medical Science, Wo nkwang University School of Medicine, Iksan, Korea Purpose:  Ultrasound (US) is highly sensitive in  the detection of renal masses.",Non-OADS,/arxiv_data1/oa_pdf/91/96/kju-55-587.PMC4165921.pdf
"Keywords:  Angiomyolipoma; Contrast media; Re nal cell carcinoma; Ultrasonography This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 June, 2014 accepted 1 August, 2014 Corresponding Author: Ill Young Seo Department of Urology, Institute  of Wonkwang Medical Science, Wonkwang University School of  Medicine and Hospital, 895  Muwang-ro, Iksan 570-974, Korea  TEL: +82-63-859-1333  FAX: +82-63-842-1455 E-mail: seraph@wku.ac.kr  INTRODUCTION Ultrasound (US) is a reliable imaging technique for the ear- ly diagnosis of renal cell carcinoma (RCC).",Non-OADS,/arxiv_data1/oa_pdf/91/96/kju-55-587.PMC4165921.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 593 Korean J Urol 2014;55:593-598http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .593&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.593 Original Article - Infection/Inflammation The Real Practice of Antibiotic Prophylaxis for Prostate Biopsy in   Korea Where the Prevalence of Quinolone-Resistant Escherichia  coli Is High  Dae Hyun Kim, Sang Rak Bae1, Woo Suk Choi, Hyoung Keun Park, Sung Hyun Paick,  Hyeong Gon Kim, Yong Soo Loh  Departement of Urology, Konkuk University Medical Center, Seoul, 1Departement of Urology, The Catholic University of Korea, Uijeongbu   St. Mary's Hospital, Uijeongbu, Korea Purpose:  Transrectal ultrasonography-guided pr ostate biopsy (TRUS-Bx) is an essen- tial procedure for diagnosing prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/73/29/kju-55-593.PMC4165922.pdf
"Keywords:  Antibiotic prophylaxi s; Biopsy; Guideline This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 16 May, 2014 accepted 28 July, 2014 See Editorial on page 597.",Non-OADS,/arxiv_data1/oa_pdf/73/29/kju-55-593.PMC4165922.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 599 Korean J Urol 2014;55:599-607http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .599&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.599 Original Article - Sexual Dysfunction Nonresponders to Daily Paroxetine and Another SSRI in Men With   Lifelong Premature Ejaculation: A Pharmacokinetic  Dose-Escalation Study for a Rare Phenomenon Paddy KC Janssen1,2, Daan Touw3, Dave H. Schweitzer4, Marcel D. Waldinger1,5 1Division of Pharmacology, Utrecht Institut e for Pharmaceutical Sciences, Faculty of BetaSciences, Utrecht University, Utrecht,  2Department of Central Hospital Ph armacy, Viecuri Hospital, Venlo, 3Apotheek Haagse Ziekenhuizen, HagaZiekenhuis, Den Haag,  4Department of Internal Medicine and Endocrinology, Reinier de Graaf Groep of Hospitals, Delft-Voorburg, 5Department of Neurosexology,   HagaZiekenhuis, Den Haag, The Netherlands Purpose:  Nonresponse to any sele ctive serotonin reuptake inhibitor (SSRI) treatment   is rare.",Non-OADS,/arxiv_data1/oa_pdf/6b/da/kju-55-599.PMC4165923.pdf
"Keywords:  5-HT1A (C-1019G) polymorphism; CY P2D6; Leptin; Life long premature   ejaculation; Paroxetine hemihydrate This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 June, 2014 accepted 4 August, 2014 Corresponding Author: Marcel D. Waldinger  Division of Pharmacology,  Utrecht Institute for Pharmaceutical Sciences,  Utrecht University,  Universiteitslaan 99, 3584 CG Utrecht, The Netherlands TEL: +31 20 6404466 FAX: +31 20 3419621E-mail: md@waldinger.demon.nl",Non-OADS,/arxiv_data1/oa_pdf/6b/da/kju-55-599.PMC4165923.pdf
Available from: http://www.crystalchem.com/rat-insulin-elisa-kit.html.,Non-OADS,/arxiv_data1/oa_pdf/6b/da/kju-55-599.PMC4165923.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 608 Korean J Urol 2014;55:608-614http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .608&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.608 Original Article - Sexual Dysfunction Effect of Improvement in Lower Urinary Tract Symptoms on Sexual   Function in Men: Tamsulosin Monotherapy vs.",Non-OADS,/arxiv_data1/oa_pdf/40/bb/kju-55-608.PMC4165924.pdf
"Keywords:  Erectile dysfunction; Lower urinar y tract symptoms; Overactive urinary   bladder This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 11 June, 2014 accepted 29 July, 2014 Corresponding Author: Kwangsung ParkDepartment of Urology,  Chonnam National University  Hospital, Chonnam National University Medical School, 42  Jebong-ro, Dong-gu, Gwangju  501-757, KoreaTEL: +82-62-220-6701 FAX: +82-62-227-1643 E-mail: kpark@chonnam.ac.kr INTRODUCTION Lower urinary tract symptoms (LUTS) and sexual dysfunc- tion are frequently observed in aged men.",Non-OADS,/arxiv_data1/oa_pdf/40/bb/kju-55-608.PMC4165924.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 615 Korean J Urol 2014;55:615-619http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .615&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.615 Original Article - Pediatric Urology Does the Mod ıfıed STING Method Increase the Success Rate in the   Management of Moderate or H ıgh-Grade Reflux?",Non-OADS,/arxiv_data1/oa_pdf/9e/e6/kju-55-615.PMC4165925.pdf
"Keywords:  Dextranomer; Endoscopy; Injectio ns; Surgical; Vesico-ureteral reflux This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 April, 2014 accepted 5 August, 2014 Corresponding Author: Osman Raif Karabacak  Department of Urology, Ministry  of Health Ankara Diskapi Yildirim Beyazit Education and  Research Hospital, Ankara,  TurkeyTEL: +90 312 5962197 FAX: +90 312 3186690 E-mail: osmanraifkarabacak@ gmail.com INTRODUCTION Correction of vesicoureteral reflux (VUR) with endoscopic in- jections was first described by Matouschek [1] and has been widely accepted since the pioneering work of O’Donnell and Puri [2].",Non-OADS,/arxiv_data1/oa_pdf/9e/e6/kju-55-615.PMC4165925.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 620 Korean J Urol 2014;55:620-623http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .620&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.620 Case Report Two Different Surgical Approaches for Prostatic Stromal Sarcoma:   Robot-Assisted Laparoscopic Radical Prostatectomy and Open  Radical Cysto-Prostatectomy With Ileal Conduit Seock Hwan Choi, Tae-Hwan Kim, Ghil Suk Yoon1, Sung Kwang Chung, Bup Wan Kim,  Tae Gyun Kwon Departments of Urology and 1Pathology, Kyungpook National University School of Medicine, Daegu, Korea Stromal sarcoma of the prostate is very  rare and shows rapid growth, which con- sequently is related to poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/d2/df/kju-55-620.PMC4165926.pdf
"Keywords:  Prostatectomy; Robotics; Sarcoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 August, 2012 accepted 4 December, 2012 Corresponding Author: Tae Gyun Kwon Department of Urology, Kyungpook National University  Medical Center, Kyungpook  National University School of Medicine, 807 Hoguk-ro, Buk-gu,  Daegu 702-210, Korea TEL: +82-53-200-3012FAX: +82-53-200-2029 E-mail: tgkwon@knu.ac.kr INTRODUCTION Prostatic stromal sarcoma (PSS)  is quite rare, accounting  for only 0.1% to 0.2% of all prostate cancers [1].",Non-OADS,/arxiv_data1/oa_pdf/d2/df/kju-55-620.PMC4165926.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 624 Korean J Urol 2014;55:624-627http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .624&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.624 Case Report Renal Pelvic Urothelial Carcinoma With Vena Caval Thrombus  Mimicking Renal Cell Carcinoma Richilda Red Diaz1, Jong Kyou Kwon1, Joo Yong Lee1, Ji Hae Nahm2, Kang Su Cho3, Won Sik Ham1,  Nam Hoon Cho2, Young Deuk Choi1,4 1Department of Urology, Urological Science Institute, Severan ce Hospital, Yonsei University College of Medicine, Seoul, 2Department of  Pathology, Yonsei University College of Medicine, Seoul, 3Department of Urology, Urological Science Institute, Gangnam Severance  Hospital, Yonsei University College of Medicine, Seoul, 4Clinical Trials Center for Medical Devices, Severance Hospital, Yonsei University  College of Medicine, Seoul, Korea A 61-year-old man presented with a right renal mass with a vena caval thrombus on  computed tomography that was consistent wi th renal cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/8e/a4/kju-55-624.PMC4165927.pdf
"Keywords:  Renal cell carcinoma; Thrombos is; Transitional cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 September, 2012 accepted 8 November, 2012 Corresponding Author: Young Deuk Choi Department of Urology, Urological Science Institute and  Clinical Trial Center for Medical  Devices, Severance Hospital, Yonsei University College of  Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-752, Korea TEL: +82-2-2228-2317 FAX: +82-2-312-2538E-mail: youngd74@yuhs.ac INTRODUCTION Renal masses are now most frequently diagnosed inciden- tally.",Non-OADS,/arxiv_data1/oa_pdf/8e/a4/kju-55-624.PMC4165927.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 628 Korean J Urol 2014;55:628http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9 .628&domain=pdf&date_stamp=2014-09-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.628 Letter  Letter to the Editor: Vienna Nomogram-Based Prostate Biopsy: Can   It Be a Much Better Diagnostic Tool Than Other Conventional  Prostate Biopsies?",Non-OADS,/arxiv_data1/oa_pdf/01/fc/kju-55-628.PMC4165928.pdf
"Christopher Chee Kong Ho, Siew Eng Ho, Srijit Das Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia Corresponding Author: Christopher Chee Kong HoDepartment of Surgery, Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak,  Cheras, 56000 Kuala Lumpur, Malaysia TEL: +60391455555, FAX: +60391456684E-mail: chrisckho2002@yahoo.com This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 April, 2014 accepted 25 July, 2014 To the editor: I read with great interest the original article by Teo et al.",Non-OADS,/arxiv_data1/oa_pdf/01/fc/kju-55-628.PMC4165928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6402 | DOI: 10.1038/srep06402 6",Non-OADS,/arxiv_data1/oa_pdf/34/ec/srep06402.PMC4165940.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/fa/srep06387.PMC4165941.pdf
"http://CRAN.R-project.org/package 5gplots) of CRAN R. In the hierarchical-based clustering, distances among different clusters wereevaluated using the ‘‘average linkage’’ (http://stat.ethz.ch/R-manual/R-devel/ library/stats/html/hclust.html) method.",OADS,/arxiv_data1/oa_pdf/67/d1/srep06393.PMC4165942.pdf
http://CRAN.R-project.org/package 5vegan) of CRAN R. Then we also select the bio-markers which are considered as abundant taxa that have high correlation with the meta-data and clustering results.,OADS,/arxiv_data1/oa_pdf/67/d1/srep06393.PMC4165942.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/d1/srep06393.PMC4165942.pdf
http://hdl.handle.net/10366/121386 (2012).,Non-OADS,/arxiv_data1/oa_pdf/39/3f/srep06389.PMC4165979.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/3f/srep06389.PMC4165979.pdf
The images were thresholded using standard image processing tools in ImageJ (http://rsb.info.nih.gov/ij/) to enable tracking of the eyes.,OADS,/arxiv_data1/oa_pdf/35/e6/srep06388.PMC4165980.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6388 | DOI: 10.1038/srep06388 8,Non-OADS,/arxiv_data1/oa_pdf/35/e6/srep06388.PMC4165980.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6388 | DOI: 10.1038/srep06388 9",Non-OADS,/arxiv_data1/oa_pdf/35/e6/srep06388.PMC4165980.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/61/94/srep06386.PMC4165981.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6386 | DOI: 10.1038/srep06386 7",Non-OADS,/arxiv_data1/oa_pdf/61/94/srep06386.PMC4165981.pdf
"Symptoms of anxiety and depression across follow-up time points In unadjusted models, caseness affective symptoms at ages 43, 53 and 60–64 were inversely associated with SBP at age 60–64 (supplementary Table 1, http://links.lww.com/HJH/ A361).",Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jhype-32-1590.PMC4166011.pdf
"A similar but weaker negative association was observed for DBP (supplementary Table 2, http://links.lww.com/ HJH/A361).",Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jhype-32-1590.PMC4166011.pdf
"In supplementary Table 3, http://links.lww.com/HJH/A361, Model 3 shows that SBP at age 36 had a little impact.",Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jhype-32-1590.PMC4166011.pdf
Available at: http://quickfacts.census.gov/qfd/states/00000.html.,OADS,/arxiv_data1/oa_pdf/34/00/mcg-48-752.PMC4166012.pdf
"December 17, 2004.Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf4/K043366.pdf.",Non-OADS,/arxiv_data1/oa_pdf/34/00/mcg-48-752.PMC4166012.pdf
"Factors predictive of 1-month antibody response in children with perinatally acquired HIV For results of analysis of factors predictive of 1-month antibody response in children with paHIV , see Table, Supplemental Digital Content 1 (http://links.lww.com/ QAD/A548).",Non-OADS,/arxiv_data1/oa_pdf/b1/4f/aids-28-2033.PMC4166014.pdf
"The results of the Community Acquired Pneumonia IMmunization Trial in Adults (CAPITA), a large-scale randomized trial investigating efﬁcacy of PCV13 in adults above 65 years of age (http://clinicaltrials.gov/show/NCT00744263) may provide some data to this effect, but will still not be directly applicable to adolescent risk groups.",Non-OADS,/arxiv_data1/oa_pdf/b1/4f/aids-28-2033.PMC4166014.pdf
2013. http://apps.who.int/iris/bitstream/10665/85321/1/ 9789241505727_eng.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/b1/4f/aids-28-2033.PMC4166014.pdf
"1A and B, Supplementary Digital Content 1, http://links.lww.com/JIT/A344).",Non-OADS,/arxiv_data1/oa_pdf/a1/71/cji-37-383.PMC4166015.pdf
"2A, Supplementary Digital Content 2,http://links.lww.com/JIT/A345) and IgG (Supplementary Fig.",Non-OADS,/arxiv_data1/oa_pdf/a1/71/cji-37-383.PMC4166015.pdf
"3A and B, Supple- mentary Digital Content 3, http://links.lww.com/JIT/A346) were signiﬁcantly elevated after boosting of DRibble-loadedB cells.",Non-OADS,/arxiv_data1/oa_pdf/a1/71/cji-37-383.PMC4166015.pdf
"3, http://links.lww.com/JIT/A346).",Non-OADS,/arxiv_data1/oa_pdf/a1/71/cji-37-383.PMC4166015.pdf
"4, SupplementaryDigital Content 4, http://links.lww.com/JIT/A347).",Non-OADS,/arxiv_data1/oa_pdf/a1/71/cji-37-383.PMC4166015.pdf
Eyenet 2010:31-3. http://www.aao.org/publications/eyenet/201005/strabismus.cfm.,Non-OADS,/arxiv_data1/oa_pdf/55/58/ABR-3-179.PMC4166057.pdf
Available from: http://www.news24.com/Columnists/Archive/TumoMokone/Poverty-no-excuse-for-cheating-20040727[Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/ABR-3-174.PMC4166061.pdf
Available from:  http://www.iol.co.za/sport/safa-to-probe-amajita-age-cheats-claims-1.491111 [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/ABR-3-174.PMC4166061.pdf
Available from: http://www.sunlightnet.com/international/html/BAZadik2003.pdf  [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/cd/ea/ABR-3-174.PMC4166061.pdf
Available: http://www.ginasthma.,Non-OADS,/arxiv_data1/oa_pdf/ba/93/ATM-9-187.PMC4166064.pdf
Available from: http://www.ihi.org/knowledge/Pages/Tools/ HowtoGuidePreventVAP.aspx [Last accessed on 2012 Oct].,OADS,/arxiv_data1/oa_pdf/6c/a4/ATM-9-221.PMC4166069.pdf
Available from: http://www.who.int/roadsafety/decade_of_action/plan/english.pdf [Lasted accessed on 2014 January 5].,Non-OADS,/arxiv_data1/oa_pdf/3d/3c/ATM-9-236.PMC4166072.pdf
Available from: http://www.who.int/healthinfo/ global_burden_disease/GBD_report_2004update_full.pdf  [Lasted accessed on 2014 January 3].,Non-OADS,/arxiv_data1/oa_pdf/3d/3c/ATM-9-236.PMC4166072.pdf
"Ministry of Economy and Planning, Central Department of  Statistics and Information; 2009-2010, Available from: http://www.cdsi.gov.sa/english/ [Last accessed 2013 December 28].",Non-OADS,/arxiv_data1/oa_pdf/3d/3c/ATM-9-236.PMC4166072.pdf
"AAA Foundation for Traffic Safety; 2010, Available from: https://www.aaafoundation.org/sites/default/files/2010DrowsyDrivingReport_1.pdf [Accessed on 2013 November 6].",OADS,/arxiv_data1/oa_pdf/3d/3c/ATM-9-236.PMC4166072.pdf
Available from: http://www-nrd.nhtsa.dot.gov/Pubs/811346.pdf [Last accessed on 2013 Dec 10].,OADS,/arxiv_data1/oa_pdf/3d/3c/ATM-9-236.PMC4166072.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseJuly 2014 |  89  | e51410 | Page 1 of 7Video Article Human Neutrophil Flow Chamber Adhesion Assay Yebin Zhou1, Dennis F. Kucik2,3,4, Alexander J. Szalai5, Jeffrey C. Edberg5 1Genetics and Genomic Sciences Graduate Program, University of Alabama at Birmingham 2Birmingham Veterans Affairs Medical Center 3Department of Pathology, University of Alabama at Birmingham 4Department of Biomedical Engineering, University of Alabama at Birmingham 5Department of Medicine, University of Alabama at Birmingham Correspondence to: Jeffrey C. Edberg at jedberg@uab.edu URL: http://www.jove.com/video/51410 DOI: doi:10.3791/51410 Keywords: Immunology, Issue 89, neutrophil adhesion, flow chamber, human umbilical vein endothelial cell (HUVEC), purified ligand Date Published: 7/2/2014 Citation: Zhou, Y., Kucik, D.F., Szalai, A.J., Edberg, J.C. Human Neutrophil Flow Chamber Adhesion Assay.",Non-OADS,/arxiv_data1/oa_pdf/7f/a3/jove-89-51410.PMC4166108.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51410/ Introduction Genetic variants in both β 2 integrins and in ICAM ligands are now recognized to be associated with the development of autoimmune disease1,2.",Non-OADS,/arxiv_data1/oa_pdf/7f/a3/jove-89-51410.PMC4166108.pdf
http://dx.doi.org/10.1016/S0140-6736(11)61651-6 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1093/cid/cir325 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
41:839 – 847. http://dx.doi.org/10.1086/432804 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1086/ 599369 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.2217/17460913.4.2.201 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1016/j.jprot.2013.06.003 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1371/journal.pone.0075266 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1128/IAI.72.1.295- 300.2004 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
180: 6149 – 6158. http://dx.doi.org/ 10.4049/jimmunol.180.9.6149 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
J. Immunol.174:6449 – 6455. http://dx.doi.org/10.4049/jimmunol.174.10.6449 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1074/ jbc.270.28.16514 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
4:180. http://dx.doi.org/10.3389/ﬁmmu.2013.00180 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1038/35100529 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
19:423– 474. http://dx.doi.org/10.1146/annurev.immunol.19.1.423 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
172: 6324 – 6329. http://dx.doi.org/10.4049/ jimmunol.172.10.6324 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
201: 866 – 870. http://dx.doi.org/10.1086/650696 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1003846 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
Medicine (Baltimore) 89:403– 425. http://dx.doi.org/ 10.1097/MD.0b013e3181fd8ec3 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
Science 321: 691– 696. http://dx.doi.org/10.1126/ science.1158298 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1126/ science.1081902 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1007/ BF02171010 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1016/ j.micinf.2004.08.009 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.1016/0882-4010(87)90007-6 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.1016/0014-5793(92)80909-Z .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1016/j.immuni.2005.11.011 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
68:6162– 6167. http://dx.doi.org/10.1128/IAI.68.11.6162- 6167.2000 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.1038/ni.1976 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1016/j.immuni.2005.12.007 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1038/nri1310 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1016/S1286-4579(00)00396-8 .,OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
114: 602– 608. http://dx.doi.org/10.1046/j.1523- 1747.2000.00917.x .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
8:59 – 67. http://dx.doi.org/10.1177/ 09680519020080010601 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.1084/jem.20111453 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
179: 6933– 6942. http://dx.doi.org/10.4049/jimmunol.179.10.6933 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/ 10.1038/nri2075 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1371/ journal.pone.0067976 .,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
http://dx.doi.org/10.1002/eji.201242532 .IL-1 and Group B Streptococcal Infection September/October 2014 Volume 5 Issue 5 e01428-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/3f/5e/mBio.01428-14.PMC4166122.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005687).,Non-OADS,/arxiv_data1/oa_pdf/46/20/bmjopen-2014-005687.PMC4166134.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006156).,Non-OADS,/arxiv_data1/oa_pdf/e4/21/bmjopen-2014-006156.PMC4166137.pdf
http://www.wacountry.,Non-OADS,/arxiv_data1/oa_pdf/e4/21/bmjopen-2014-006156.PMC4166137.pdf
"Discovery Programme, 2014. http://discovery-programme.org/symptom_study.php 44.",Non-OADS,/arxiv_data1/oa_pdf/e4/21/bmjopen-2014-006156.PMC4166137.pdf
"Western Australia: Department of Health, 2014. http://www.datalinkage-wa.org.au/ 45.",Non-OADS,/arxiv_data1/oa_pdf/e4/21/bmjopen-2014-006156.PMC4166137.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005216).,Non-OADS,/arxiv_data1/oa_pdf/5b/6d/bmjopen-2014-005216.PMC4166138.pdf
2007. http://www.bcs.com/documents/affiliates/ bacr/BACR%20Standards%202007.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/5b/6d/bmjopen-2014-005216.PMC4166138.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006304).,Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
"OECD Publishing, 2011. http://dx.doi.org/10.1787/ 9789264122314-en (accessed 28 Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
2011. https://www.ranzcp.org/Files/Resources/College_Statements/Position_Statements/ps71-pdf.aspx (accessed 28 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
http://www.health.gov.au/internet/ publications/publishing.nsf/Content/mental-pubs-f-plan09-toc(accessed 28th Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
Health Evidence Network report http://www.euro.who.int/__data/assets/pdf_file/0008/74690/E83685.pdf (accessed 28 Jul 2014).,OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
"UnitedKindom, 2012. http://www.jcpmh.info/good-services/primary-mental-health-services/ (accessed 28 Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
http://aphcri.anu.edu.au/research/network-research/research-programs/ relationship-between-sub-acute-care-and-primary-health (accessed 28 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
http://myregion.gov.au/profile/adelaide-hills-fleurieu-and-kangaroo-island/data/population/age(accessed 28 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/3a/f4/bmjopen-2014-006304.PMC4166139.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005277).,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
http://www.noo.org.uk/4.,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
2009. http://www.nice.org.uk/PH17(accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
2012;http://wsff.org.uk/sites/wsff.org.uk/files/Changing_The_ Game_For_Girls_Final_0.pdf (accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
2012. http://www.dclani.gov.uk/ypbas_2010_sports_bulletin.pdf (accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
2012. http://www.culture.gov.uk/publications/8945.aspx (accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
http://www.hpa.org.uk/web/ HPAweb&Page&HPAwebAutoListDate/Page/1278943979953(accessed Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/07/bmjopen-2014-005277.PMC4166140.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005945).,Non-OADS,/arxiv_data1/oa_pdf/fa/21/bmjopen-2014-005945.PMC4166141.pdf
"Perth, 2012. http://www.healthinfonet.ecu.edu.au (accessed 2013).",Non-OADS,/arxiv_data1/oa_pdf/fa/21/bmjopen-2014-005945.PMC4166141.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005376).,Non-OADS,/arxiv_data1/oa_pdf/5a/6a/bmjopen-2014-005376.PMC4166142.pdf
http://www.nice.org.uk/Guidance/InDevelopment/gid-tag442 24.,Non-OADS,/arxiv_data1/oa_pdf/5a/6a/bmjopen-2014-005376.PMC4166142.pdf
Juni 2005. http://www.ordiprax.dk,Non-OADS,/arxiv_data1/oa_pdf/c7/15/pharmpract-04-074.PMC4166147.pdf
http://www.benzo.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/c7/15/pharmpract-04-074.PMC4166147.pdf
URL: http://www.ine.es/es  3- Estudio de los magrebíes con diabetes inmigr ados a la ciudad de Barcelona.,Non-OADS,/arxiv_data1/oa_pdf/9f/9d/pharmpract-04-079.PMC4166148.pdf
Díaz Casas M. URL:  http://www.fsf.es/cast/r ecerca/investigación01  4- Inmigración y diabetes.,Non-OADS,/arxiv_data1/oa_pdf/9f/9d/pharmpract-04-079.PMC4166148.pdf
URL : http://www.diabetes.bayer.es  5- OMS.,Non-OADS,/arxiv_data1/oa_pdf/9f/9d/pharmpract-04-079.PMC4166148.pdf
"URL: http://www.who.int/diabetes/facts/world_figures/en/  6- Ruiz Ramos M, Roche F, Gálvez P, Fernández D, Vi ciana F, Hernández JA, Canto V. Diferencias por género en el  estado de salud de una población de la Wilaya de Tet uán (Marruecos).",Non-OADS,/arxiv_data1/oa_pdf/9f/9d/pharmpract-04-079.PMC4166148.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/de/dddt-8-1331.PMC4166210.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1331–1334Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1331Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6561 0aminaphtone in the control of gingival  bleeding in children José Maria Pereira de  godoy1,2 Mara lucia Macedo Paizan3 1Department of cardiology and  cardiovascular surgery, Faculdade  de Medicina de são José do rio  Preto (F aMerP), são José do  rio Preto, 2conselho nacional  de Desenvolvimento científico  e T ecnológico (cn Pq), Brasília,   3FaMerP , são José do rio Preto, Brazil correspondence: Jose Maria Pereira de  godoy Department of cardiology and  cardiovascular surgery, Faculdade de  Medicina de são José do rio Preto  (FaMerP), 1306 avenida constituição,  são José do rio Preto, são Paulo  15025120, Brazil email godoyjmp@riopreto.com.b r Journal name: Drug Design, Development and Therapy Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Pereira de Godoy and Macedo Paizan Running head recto: Aminaphtone and gingival bleeding DOI: http://dx.doi.org/10.2147/DDDT.S65610 Aim:  The objective of the current study was to evaluate the efficacy of aminaphtone to control  gum bleeding.",Non-OADS,/arxiv_data1/oa_pdf/34/de/dddt-8-1331.PMC4166210.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDove pres s Drug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/34/de/dddt-8-1331.PMC4166210.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/de/dddt-8-1331.PMC4166210.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/f9/ott-7-1593.PMC4166211.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1593–1599OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1593Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OTT .S6716 5Arsenic trioxide-based therapy in relapsed/ refractory multiple myeloma patients:   a meta-analysis and systematic review Xuepeng He Kai Yang Peng Chen Bing Liu Yuan Zhang Fang wang Zhi Guo Xiaodong Liu Jinxing Lou Huiren Chen Department of Hematology,    General Hospital of Beijing   Military Area of PLA, Beijing,    People’s Republic of China Correspondence: Xuepeng He   Department of Hematology,   General Hospital of Beijing Military   Area of PLA, Beijing  100700,   People’s Republic of China   Tel +86 010 8400 8139  email xuepenghemd@gmail.co mAbstract:  Multiple myeloma (MM) is a clonal malignancy characterized by the proliferation of  malignant plasma cells in the bone marrow and the production of monoclonal immunoglobulin.",Non-OADS,/arxiv_data1/oa_pdf/68/f9/ott-7-1593.PMC4166211.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/68/f9/ott-7-1593.PMC4166211.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/f9/ott-7-1593.PMC4166211.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/ndt-10-1715.PMC4166212.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1715–1719Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1715OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6838 9Muhammed emin Özcan1  Bahri i˙nce2 ayhan Bingöl3 simge ertürk3 Meriç Adil Altınöz4 hasan hüseyin Karadeli1 abdulkadir Koçer5 Talip asil1 1Deparment of Neurology,  Medical Faculty, Bezmialem Vakıf  University, istanbul, Turkey;  2Department of Psychiatry, Bakırköy  research and Training hospital for  Psychiatry, istanbul, Turkey; 3Mayıs  Psychology center, istanbul, Turkey;  4Department of Molecular Biology  and genetics, haliç University,  istanbul, Turkey; 5Department  of Neurology, Medical Faculty,  i˙stanbul Medeniyet University,  göztepe, istanbul, Turkey correspondence: Muhammed emin  Özcan Department of Neurology, Bezmialem  Vakif University, Medical Faculty, adnan  Menderes Bulvarı 34093 Fatih, I ˙stanbul,  Turkey  Tel +90 212 453 1700 email emozcan@gmail.co m association between smoking and cognitive  impairment in multiple sclerosis Purpose:  Although smoking is known to cause various symptoms in multiple sclerosis (MS)  patients, there have been no reports regarding the relationship between smoking and cognitive  impairment in MS.",Non-OADS,/arxiv_data1/oa_pdf/71/d2/ndt-10-1715.PMC4166212.pdf
"As such, the quality of life for these patients  becomes further compromised as the degree of cognitive impairment increases.3 Due  to the limited treatment options for MS,4 it is critical to understand what agents may  worsen clinical symptoms.Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Özcan et al Running head recto: Association of smoking and cognitive impairment in multiple sclerosis DOI: http://dx.doi.org/10.2147/NDT.S68389",Non-OADS,/arxiv_data1/oa_pdf/71/d2/ndt-10-1715.PMC4166212.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/71/d2/ndt-10-1715.PMC4166212.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1719association of smoking and cognitive impairment in multiple sclerosis Acknowledgment We would like to thank all volunteers for their participation  in this study.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/ndt-10-1715.PMC4166212.pdf
Available from: http://www.turkstat.gov.tr/PreHaberBultenleri.,Non-OADS,/arxiv_data1/oa_pdf/71/d2/ndt-10-1715.PMC4166212.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 945–962International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  945RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S4676 1Distinguishing adult-onset asthma from COPD:   a review and a new approach Michael J Abramson1 Jennifer L Perret2,3 Shyamali C Dharmage2 vanessa M McDonald4 Christine F McDonald3 1School of Public Health and  Preventive Medicine, Monash  University,  2Centre for epidemiology  and Biostatistics, University of  Melbourne, Melbourne, Australia;   3Department of Respiratory and   Sleep Medicine,  Austin Health,   Heidelberg, Australia;  4Priority   Research Centre for Asthma and   Respiratory Disease, University of   Newcastle, Newcastle, Australia Correspondence: Michael J Abramson   School of Public Health and Preventive   Medicine, Monash University, The Alfred   Centre, Melbourne, vIC  3004, Australia   Tel +61 3 9903 0573  Fax +61 3 9903 0556  email michael.abramson@monash.ed uAbstract:  Adult-onset asthma and chronic obstructive pulmonary disease (COPD) are major  public health burdens.",Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Available from: http://www.asthmahandbook.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Available from: http://www.nhlbi.nih.gov/resources/docs/cht-book.htm .,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Available from: http://www.aihw.gov.au/publication- detail/?id=1073742015 9.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Available from: http://www.goldcopd.org/ guidelines-global-strategy-for-diagnosis-management.html .,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Available  from: http://www.copdx.org.au /.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Available from: http://www.asthmahandbook.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/07/copd-9-945.PMC4166213.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/jpr-7-547.PMC4166214.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 547–554Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  547ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6695 6effect of delayed intrathecal administration of  capsaicin on neuropathic pain induced by chronic  constriction injury of the sciatic nerve in rats Kun Zhang1 somayaji Ramamurthy1 Thomas J Prihoda2 Maxim s eckmann1 1Department of anesthesiology,    2Department of Pathology,    University of Texas health   science center at san antonio,    san antonio, TX, Usa correspondence: Maxim s eckmann   Department of anesthesiology, University   of Texas health science center at san   antonio,  7703 Floyd curl Drive,   san antonio, TX  78229, Usa   Tel +1 210 450 9850  Fax +1 210 450 6095  email eckmann@uthscsa.ed uPurpose:  The current study was designed to examine the antinociceptive effect of intrathecally  administered capsaicin, a transient receptor potential vanilloid  1 receptor agonist, in a rat model  of neuropathic pain induced by unilateral sciatic nerve chronic constriction injury.",Non-OADS,/arxiv_data1/oa_pdf/3e/89/jpr-7-547.PMC4166214.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/3e/89/jpr-7-547.PMC4166214.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/89/jpr-7-547.PMC4166214.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/4d/amep-5-289.PMC4166215.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2014:5 289–297Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  289OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/AMEP .S6676 2incorporating the principles of the patient-   centered medical home into a student-run   free clinic Megan c riddle1,* Jiahui lin3,* Jonathan B steinman2 Joshua D salvi2 Margaret M reynolds3 Anne s Kastor3,† christina harris4 carla Boutin-Foster3 1Department of Psychiatry and  Behavioral sciences, University  of Washington, 2Weill cornell/ rockefeller/ sloan-Kettering Tri- institutional MD–PhD Program,   3Department of internal Medicine,   Weill cornell Medical college, new  Y ork, nY, 4Department of Medicine,   Division of general internal Medicine,   VA greater los Angeles healthcare  system, David geffen school of  Medicine at UclA, lA, UsA *These authors contributed equally   to this work †Anne s Kastor passed away on July 5,    2013. correspondence: Megan c riddle   University of Washington, Box 356560,  1959 NE Pacific Street, Seattle, WA  98195-6560, UsA   Email riddlem2@uw.ed uAbstract:  As the health care delivery landscape changes, medical schools must develop creative  strategies for preparing future physicians to provide quality care in this new environment.",Non-OADS,/arxiv_data1/oa_pdf/3e/4d/amep-5-289.PMC4166215.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/3e/4d/amep-5-289.PMC4166215.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/4d/amep-5-289.PMC4166215.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/12/imcrj-7-127.PMC4166216.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2014:7 127–131International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  127Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6642 1pneumolabyrinth secondary to temporal bone  fracture: a case report and review of the literature andrea Bacciu1 Vincenzo Vincenti1 sampath Chandra prasad1 Daniela tonni1 elisa Ventura2 salvatore Bacciu1 enrico pasanisi1 1Department of Clinical and  experimental Medicine, Unit  of audiology and paediatric  otolaryngology, 2Department   of Neuroradiology, University   Hospital of parma, parma, Italy Correspondence: andrea Bacciu   Department of Clinical and experimental   Medicine, otolaryngology Unit,   University Hospital of parma,   Via Gramsci 14, 43100 parma, Italy   tel +39 521 703 205   email andreabacciu@yahoo.i tAbstract:  Pneumolabyrinth following temporal bone fracture is an extremely rare condition.",Non-OADS,/arxiv_data1/oa_pdf/e7/12/imcrj-7-127.PMC4166216.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/e7/12/imcrj-7-127.PMC4166216.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/12/imcrj-7-127.PMC4166216.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/f8/ott-7-1583.PMC4166217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1583–1591OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1583Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6762 4Mir-206 functions as a tumor suppressor   and directly targets K-ras in human   oral squamous cell carcinoma Feiou lin1 linjie Yao2 Jin Xiao3 DengFeng liu3 Zhenyu ni1 1Department of Orthodontics,   2Department of Pedodontics,   3Department of Oral and Maxillofacial  surgery, school and hospital of  stomatology, Wenzhou Medical  University, Wenzhou, People’s  republic of china correspondence: Zhenyu ni   Department of Orthodontics, school  and hospital of stomatology, Wenzhou  Medical University, 113, Xue Yuan West  road, lu cheng Distriction, Wenzhou,  People’s republic of china   T el +86 577 88063012   Fax +86 577 88063666   email manunizy@163.co mPurpose:  MicroRNA-206 (miR-206) has been proven to be downregulated in many human  malignancies and is correlated with tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/a4/f8/ott-7-1583.PMC4166217.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a4/f8/ott-7-1583.PMC4166217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/f8/ott-7-1583.PMC4166217.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006145).,Non-OADS,/arxiv_data1/oa_pdf/18/7b/bmjopen-2014-006145.PMC4166244.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. von Karsa L, Anttila A, Ronco G, et al.Cancer screening in the European Union: Report on the implementation of the CouncilRecommendation on cancer screening .",Non-OADS,/arxiv_data1/oa_pdf/18/7b/bmjopen-2014-006145.PMC4166244.pdf
"International Agency for Research on Cancer, 2008. http://ec.europa.eu/health/ph_ determinants/genetics/documents/cancer_screening.pdf (accessed17 Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/18/7b/bmjopen-2014-006145.PMC4166244.pdf
"Evaluationsbericht 2005–2007—Ergebnisse des Mammographie-Screening-Programms in Deutschland, 2009. http://www.mammo-programm.de/cms_upload/datenpool/evaluationsbericht05 –07_web.pdf (accessed 8 Feb 2013).",Non-OADS,/arxiv_data1/oa_pdf/18/7b/bmjopen-2014-006145.PMC4166244.pdf
"Evaluationsbericht 2008–2009—Ergebnisse des Mammographie-Screening-Programms in Deutschland, 2012. http://www.mammo-programm.de/cms_ upload/datenpool/evaluationsbericht_2008 –2009_web.pdf (accessed 8 Feb 2013).",Non-OADS,/arxiv_data1/oa_pdf/18/7b/bmjopen-2014-006145.PMC4166244.pdf
http://www.bertelsmann-stiftung.de/cps/rde/xbcr/SID-FCFCA9D6-98D819E4/bst/gemo_nl_012014-web.pdf (accessed17 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/18/7b/bmjopen-2014-006145.PMC4166244.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005223).,Non-OADS,/arxiv_data1/oa_pdf/32/b4/bmjopen-2014-005223.PMC4166245.pdf
http://www.pcmh.ahrq.gov/portal/server.pt/community/pcmh__home/1483/pcmh_defining_the_pcmh_v2 (accessed 30 Jun 2013).,OADS,/arxiv_data1/oa_pdf/32/b4/bmjopen-2014-005223.PMC4166245.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005931).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/bmjopen-2014-005931.PMC4166246.pdf
2012. http://www.pcc-cic.org.uk/article/ nhs-dental-contract-pilots (accessed 3.10.13).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/bmjopen-2014-005931.PMC4166246.pdf
2009. http://www.bda.org/dentists/policy-research/bda-policies/local-commissioning/index.aspx 19.,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/bmjopen-2014-005931.PMC4166246.pdf
2013. http://www.gdc-uk.org/Dental professionals/Standards/Pages/Direct-Access.aspx (accessed 4.10.13).,Non-OADS,/arxiv_data1/oa_pdf/6f/d5/bmjopen-2014-005931.PMC4166246.pdf
"2004. http://www.nice.org.uk/CG019NICEguideline Pavitt SH, et al.BMJ Open 2014; 4:e005931.",Non-OADS,/arxiv_data1/oa_pdf/6f/d5/bmjopen-2014-005931.PMC4166246.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005651).,Non-OADS,/arxiv_data1/oa_pdf/9b/15/bmjopen-2014-005651.PMC4166247.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/15/bmjopen-2014-005651.PMC4166247.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005399).,Non-OADS,/arxiv_data1/oa_pdf/fe/a8/bmjopen-2014-005399.PMC4166249.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 25.,Non-OADS,/arxiv_data1/oa_pdf/fe/a8/bmjopen-2014-005399.PMC4166249.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006096).,Non-OADS,/arxiv_data1/oa_pdf/89/90/bmjopen-2014-006096.PMC4166251.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/2f/dddt-8-1381.PMC4166254.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1381–1390Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1381Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/DDDT .S7057 0Diverse pathomechanisms leading to the  breakdown of cellular estrogen surveillance  and breast cancer development: new therapeutic  strategies Zsuzsanna Suba National institute of Oncology,   Budapest, HungaryAbstract:  Recognition of the two main pathologic mechanisms equally leading to breast cancer  development may provide explanations for the apparently controversial results obtained by sexual  hormone measurements in breast cancer cases.",Non-OADS,/arxiv_data1/oa_pdf/b0/2f/dddt-8-1381.PMC4166254.pdf
"Keywords:  sexual steroids, hyperandrogenism, hyperestrogenism, insulin resistance, estrogen  receptors, estrogen resistance Introduction There is a prevailing concept suggesting a linear cause–effect relationship between  serum levels of sexual steroids and the clinical manifestations of certain diseases, such  as breast cancer, especially in postmenopausal women.1–3 Nevertheless, the associations  between circulating concentrations of androgens and estrogens with breast cancer and  related risk factors are not well understood until now.4 Results of studies on correlations  between endogenous sexual steroid levels and breast cancer risk have yielded a wide  range of controversies in both premenopausal and postmenopausal cases.Correspondence: Zsuzsanna Suba National institute of Oncology, Surgical  and Molecular Tumor Pathology Centre,  H-1122 Ráth György Str 7–9, Budapest,  Hungary Tel +36 1 224 8600 or +36 620 923 5605 Fax +36 1 224 8620 email subazdr@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2014 Volume: 8 Running head verso: Suba Running head recto: Diverse pathomechanisms leading to breast cancer development DOI: http://dx.doi.org/10.2147/DDDT.S70570",Non-OADS,/arxiv_data1/oa_pdf/b0/2f/dddt-8-1381.PMC4166254.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b0/2f/dddt-8-1381.PMC4166254.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/2f/dddt-8-1381.PMC4166254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/19/amep-5-299.PMC4166255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 299–306Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  299OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S6668 1levels of empathy in undergraduate emergency  health, nursing, and midwifery students:   a longitudinal study Brett Williams1 T ed Brown2 Malcolm Boyle1 lisa McKenna3 claire Palermo4 Jamie Etherington1 1Department of community  Emergency health and Paramedic  Practice, 2Department of  Occupational Therapy, 3school of  nursing and Midwifery, Faculty  of Medicine, nursing and health  sciences, Monash University–Peninsula  campus, Frankston, 4Department  of nutrition and Dietetics, Faculty  of Medicine, nursing and health  sciences, Monash University–Berwick  campus, Berwick, Vic, Australia correspondence: Brett Williams   Department of community Emergency   health and Paramedic Practice,   Monash University–Peninsula campus,   Building h, PO Box 527,   McMahons road,   Frankston 3199, Vic, Australia   Tel +61 399 044 283   Fax +61 399 044 252   Email brett.williams@monash.ed uPurpose:  This research examines the extent and nature of empathy among emergency health  (paramedic), nursing, and midwifery students at one Australian university and investigates the  longitudinal changes in empathy levels across the course of study.",Non-OADS,/arxiv_data1/oa_pdf/80/19/amep-5-299.PMC4166255.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/80/19/amep-5-299.PMC4166255.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/19/amep-5-299.PMC4166255.pdf
"Available from:   https://www.aamc.org/initiatives/mso p. Accessed October 9, 2012.",Non-OADS,/arxiv_data1/oa_pdf/80/19/amep-5-299.PMC4166255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/bd/opth-8-1831.PMC4166256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1831–1836Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1831Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6776 0Unexpected and permanent central visual loss  after removal of intraocular silicone oil antonio toso ezio Cappello simonetta Morselli Department of Ophthalmology,   saint Bassiano Hospital, Bassano  del Grappa, ItalyAbstract:  Here we report a case of unexplained sudden visual loss after removal of silicone  oil for rhegmatogenous retinal detachment repair.",Non-OADS,/arxiv_data1/oa_pdf/46/bd/opth-8-1831.PMC4166256.pdf
"Preoperative visual acuity was count fingers (February Correspondence: antonio toso Department of Ophthalmology, saint  Bassiano Hospital, Via dei Lotti 40,  Bassano del Grappa 36061, Italy email antonio.toso@gmail.co m Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Toso et al Running head recto: Central visual loss after removal of intraocular silicone oil DOI: http://dx.doi.org/10.2147/OPTH.S67760",Non-OADS,/arxiv_data1/oa_pdf/46/bd/opth-8-1831.PMC4166256.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/46/bd/opth-8-1831.PMC4166256.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1836toso et al solid reasons to suspect that glaucoma played an important  etiological role in this case.,Non-OADS,/arxiv_data1/oa_pdf/46/bd/opth-8-1831.PMC4166256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/b5/ijn-9-4305.PMC4166257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4305–4315International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4305OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6341 4Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Zhang et al Running head recto: Eudragit-coated NLC for ophthalmic use DOI: http://dx.doi.org/10.2147/IJN.S63414 Nanostructured lipid carrier surface modified  with eudragit rs 100 and its potential ophthalmic  functions Wenji Zhang1,3,* Xuedong li2,* Tiantian Ye3 Fen chen3 shihui Yu3 Jianting chen3 Xinggang Yang3 Na Yang2 Jinsong Zhang2 Jinlu liu2 Weisan Pan3 Jun Kong2 1Department of Pharmaceutics, school  of Traditional chinese Medicine, shenyang  Pharmaceutical University, shenyang,   People’s republic of china; 2Department  of Ophthalmology, The Fourth affiliated  hospital of china Medical University, eye  hospital of china Medical University, Key  lens research laboratory of liaoning  Province, shenyang, People’s republic  of china; 3Department of Pharmaceutics,   school of Pharmacy, shenyang  Pharmaceutical University, shenyang,   People’s republic of china *These authors contributed equally  to this work correspondence: Jun Kong   Department of Ophthalmology, The Fourth  Affiliated Hospital of China Medical University,  eye hospital of china Medical University, Key  lens research laboratory of liaoning Province,  shenyang 110005, People’s republic of china   Tel +86 13 06652 1123   Fax +86 24 2352 8875   email kongjun@hotmail.co m     Weisan Pan   Department of Pharmaceutics, school of  Pharmacy, shenyang Pharmaceutical University,  103 Wenhua road, shenyang, 110016, People’s  republic of china   Tel +86 24 2398 6313   Fax +86 24 2395 3241   email pwstfzy@126.co m Abstract:  This study was carried out to evaluate the ocular performance of a cationic Eudragit  (EDU) RS 100-coated nanostructured lipid carrier (NLC).",Non-OADS,/arxiv_data1/oa_pdf/1f/b5/ijn-9-4305.PMC4166257.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1f/b5/ijn-9-4305.PMC4166257.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 4315eudragit-coated Nlc for ophthalmic use carried by improved EDU RS 100-NLC into the aqueous  humor through the cornea barrier.,Non-OADS,/arxiv_data1/oa_pdf/1f/b5/ijn-9-4305.PMC4166257.pdf
Available from: http://eudragit.evonik.com/ product/eudragit/en/products-services/eudragit-products/sustained- release-formulations/rs-30-d/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1f/b5/ijn-9-4305.PMC4166257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/ijn-9-4277.PMC4166308.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4277–4291International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4277OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6253 8Carboxyl-modified single-wall carbon nanotubes  improve bone tissue formation in vitro and repair  in an in vivo rat model antonio Barrientos-Durán1,5,*  ellen M carpenter2  Nicole I zur Nieden3  Theodore I Malinin4  Juan Carlos Rodríguez- Manzaneque5  laura P Zanello1,* 1Department of Biochemistry,   University of california riverside,   riverside, ca, Usa; 2Department of  Psychiatry and Biobehavioral sciences,   Ucla school of Medicine, south los  Angeles, CA, USA; 3Department of  Cell Biology and Neuroscience, Stem  Cell Center, College of Natural and  Agricultural Sciences, University of  california riverside, riverside, ca,   Usa; 4Tissue Bank, Department of  Orthopedics, University of Miami  Miller school of Medicine, Miami, Fl,   Usa; 5Pfizer-University of granada- Junta de andalucía centre for  Genomics and Oncological Research  (geNYO),granada, spain *These authors contributed equally  to this work correspondence: antonio Barrientos- Durán   Pfizer-University of Granada-Junta  de andalucía centre for genomics  and Oncological Research (GENYO),  avenida de la Ilustración 114,  18016 granada, spain   T el +34 958 715 500   Fax +34 958 637 071   email antonio.barrientos@genyo.e sAbstract:  The clinical management of bone defects caused by trauma or nonunion fractures  remains a challenge in orthopedic practice due to the poor integration and biocompatibility  properties of the scaffold or implant material.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/ijn-9-4277.PMC4166308.pdf
"Examples of these nanomaterials include carbon  nanotubes (CNTs), an allotrope form of carbon5,6 that shows excellent  properties to be Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Barrientos-Durán et al Running head recto: Improved osteogenesis by COOH–SWCNTs-based grafts DOI: http://dx.doi.org/10.2147/IJN.S62538",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/ijn-9-4277.PMC4166308.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/ijn-9-4277.PMC4166308.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 4291Improved osteogenesis by COOH–SWCNTs-based grafts Figure S3 Composition of haematoxylin-eosin images depicting fourteen  perforations of human DBM soaked in COOH-SWCNTs, on rat pectoris muscle.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/ijn-9-4277.PMC4166308.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/39/ijn-9-4293.PMC4166309.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4293–4304International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4293OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6801 2Improving effects of chitosan nanofiber scaffolds  on osteoblast proliferation and maturation Ming-hua ho1,2 Mei-hsiu liao3 Yi-ling lin2 chien-hao lai3 Pei-I lin3 ruei-Ming chen2–4 1Department of chemical engineering,   National Taiwan University of science  and T echnology, Taipei, Taiwan; 2cell  Physiology and Molecular Image  research center and Department of  anesthesiology, Wan Fang hospital,   3graduate Institute of Medical  sciences, Taipei Medical University,   Taipei, Taiwan; 4anesthetics and  T oxicology research center, Taipei  Medical University hospital, Taipei,   Taiwan correspondence: ruei-Ming chen   graduate Institute of Medical sciences,  college of Medicine, Taipei Medical  University, 250 Wu-Xing st, Taipei,  110, Taiwan   Tel +886 2 2736 1661 ext 3222   Fax +886 2 8662 1119   email rmchen@tmu.edu.t w Abstract:  Osteoblast maturation plays a key role in regulating osteogenesis.",Non-OADS,/arxiv_data1/oa_pdf/2b/39/ijn-9-4293.PMC4166309.pdf
"Thus, to develop innovative biomaterials for therapy of bone diseases, it is important Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Ho et al Running head recto: Effects of chitosan nanofibers on osteoblast maturation DOI: http://dx.doi.org/10.2147/IJN.S68012",Non-OADS,/arxiv_data1/oa_pdf/2b/39/ijn-9-4293.PMC4166309.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2b/39/ijn-9-4293.PMC4166309.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 4304ho et al 15.,Non-OADS,/arxiv_data1/oa_pdf/2b/39/ijn-9-4293.PMC4166309.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/e7/ndt-10-1721.PMC4166310.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1721–1725Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1721OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6694 1Masamichi ishioka1 Norio sugawara1 ayako Kaneda1 Noriyuki Okubo2 Kaori iwane2 ippei Takahashi2 Norio Yasui-Furukori1 1Department of Neuropsychiatry,   2Department of social Medicine,   graduate school of Medicine,   hirosaki University, hirosaki, Japan correspondence: Norio Yasui-Furukori Department of Neuropsychiatry,  graduate school of Medicine, hirosaki  University, Zzifu-cho 5, hirosaki city,  aomori 036-8562, Japan Tel +81 172 395 066 Fax +81 172 395 067 email yasufuru@cc.hirosaki-u.ac.j p The Yamaguchi fox/pigeon-imitation test,  a brief cognitive performance rating tool,  in a community-dwelling population: normative  data for Japanese subjects – a preliminary studyJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Ishioka et al Running head recto: Y amaguchi fox/pigeon-imitation test DOI: http://dx.doi.org/10.2147/NDT.S66941 Introduction:  Screening tools for dementia should be valid and easy to complete and have a  low psychological burden.",Non-OADS,/arxiv_data1/oa_pdf/a3/e7/ndt-10-1721.PMC4166310.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/a3/e7/ndt-10-1721.PMC4166310.pdf
"Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1725Yamaguchi fox/pigeon-imitation test Against the background of rapid growth of the Japanese  population, the number of individuals of advanced age has  notably increased.",Non-OADS,/arxiv_data1/oa_pdf/a3/e7/ndt-10-1721.PMC4166310.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/49/ndt-10-1707.PMC4166311.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1707–1714Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1707OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S6761 7chun-lin chu1–3 Yu chen1,3,4 Kun-hao Jiang1,3,5 Jiun-liang chen1,3,5 chin-Pang lee1–3 Yeuk-lun chau1,2 ching-Yen chen1–3 1Men’s health center, 2Department  of Psychiatry, chang gung Memorial  hospital at linkou, 3school  of Medicine, chang gung University,   4Department of Urology, 5Department  of Traditional chinese Medicine,   chang gung Memorial hospital  at linkou, Taoyuan, Taiwan correspondence: ching-Yen chen Department of Psychiatry, chang gung  Memorial hospital at linkou, 5 Fu-shin  street, guei-shan, Taoyuan 333, Taiwan Tel +886 3 328 1200 ext 2439 Fax +886 3 328 0267 email 56phantom@gmail.co mValidity and clinical utilization of the chinese  version of the gotland Male Depression scale   at a men’s health polyclinic Introduction:  Symptoms of depression in males, such as aggression and irritability, are  different from those in females.",Non-OADS,/arxiv_data1/oa_pdf/e4/49/ndt-10-1707.PMC4166311.pdf
"Sex is becoming an increasingly important issue in understanding  physical and emotional health, and depression in particular.2 Past studies have sug - gested that depression in men is reported and diagnosed less often.3 Epidemiological Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Chu et al Running head recto: Chinese version of Gotland Male Depression Scale DOI: http://dx.doi.org/10.2147/NDT.S67617",Non-OADS,/arxiv_data1/oa_pdf/e4/49/ndt-10-1707.PMC4166311.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e4/49/ndt-10-1707.PMC4166311.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1714chu et al (Gotland 男性憂鬱量表 ) 在過去幾個月裡 ，你或你的行為是否有所改變？如果有，是在那些方面？  完全 有些 非常 完全  没有 同意 同意 同意 (0) (1) (2) (3) 1.,Non-OADS,/arxiv_data1/oa_pdf/e4/49/ndt-10-1707.PMC4166311.pdf
"Key Words :  Cerebral infarction volume · Heat shock protein · Occlusion time.Laboratory Investigation • Received : December 24, 2013  • Revised : March 19, 2014  • Accepted : June 11, 2014 • Address for reprints : Sung-Kon Ha, M.D., Ph.D.  Department of Neurosurgery, Ansan Hospital, Korea University Medical Center, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-707, Korea  Tel : +82-31-412-5053,  Fax : +82-31-412-5054,  E-mail : sungkha@yahoo.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 307-312, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.307 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/5e/d7/jkns-55-307.PMC4166325.pdf
"Key Words :  Carotid stent · Stroke · Carotid occlusion · Thrombolysis.Clinical Article • Received : January 27, 2014  • Revised : March 26, 2014  • Accepted : June 11, 2014 • Address for reprints : Jun Kyeung Ko, M.D., Ph.D.  Department of Neurosurgery, Medical Research Institute, Pusan National University Hospital, 305 Gudeok-ro, Seo-gu, Busan 602-739, Korea   Tel : +82-51-240-7937,  Fax : +82-51-244-0282,  E-mail : redcheek09@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 313-320, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.313 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/eb/04/jkns-55-313.PMC4166326.pdf
"Key Words :  Complication · Intracranial meningioma · Infratentorial · Recurrence · Surgical outcome · Survival.Clinical Article • Received : December 24, 2013  • Revised : May 1, 2014  • Accepted : June 11, 2014 • Address for reprints : Kyung-Sub Moon, M.D., Ph.D.  Department of Neurosurgery, Brain Tumor Clinic & Gamma Knife Center, Chonnam National University Hwasun Hospital and Medical School, 322 Seoyang-ro, Hwasun-    e up, Hwasun 519-763, Korea  Tel : +82-61-379-7666,  Fax : +82-61-379-7673,  E-mail : moonks@chonnam.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 321-330, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.321 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/f8/a3/jkns-55-321.PMC4166327.pdf
"Department of Neurosurgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727,    K orea  Tel : +82-2-440-6144,  Fax : +82-2-440-7494,  E-mail : spinekim@khu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 331-336, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.331 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/e3/05/jkns-55-331.PMC4166328.pdf
"Department of Orthopaedic Surgery, Second Affiliated Hospital of Wenzhou Medical University, 109 Xueyuanxi Road, Wenzhou 325000, China  Tel : +86-577-88829799,  Fax : +86-577-88816191,  E-mail : spine-xu@163.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 337-342, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.337 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/18/b2/jkns-55-337.PMC4166329.pdf
"Department of Orthopedic Surgery, Inje University Haeundae Paik Hospital, 875 Haeundae-ro, Haeundae-gu, Busan 612-896, Korea  Tel : +82-51-797-0240,  Fax : +82-51-797-0249,  E-mail : alla1013@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 343-347, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.343 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/82/28/jkns-55-343.PMC4166330.pdf
"Key Words :  Intracranial hemorrhages · Epidural hematoma · Craniotomy · Multiple lesions.Clinical Article • Received : September 2, 2013  • Revised : December 27, 2013  • Accepted : June 13, 2014 • Address for reprints : Sun-Chul Hwang, M.D., Ph.D.  Department of Neurosurgery, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 420-767, Korea  Tel : +82-32-621-5291,  Fax : +82-32-621-5016,  E-mail : sunchulh@schmc.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 348-352, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.348 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/c3/32/jkns-55-348.PMC4166331.pdf
"Department of Neurosurgery, Eulji University Eulji Hospital, 68 Hangeulbiseok-ro, Nowon-gu, Seoul 139-872, Korea  Tel : +82-2-970-8266,  Fax : +82-2-979-8268,  E-mail : grimi2@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 353-356, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.353 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/78/6d/jkns-55-353.PMC4166332.pdf
"Key Words :  Anterior communicating artery aneurysm · Computed tomography · Computed tomography angiography · Lamina rostralis ·                      Subarachnoid hemorrhage.Case Report • Received : January 15, 2014  • Revised : April 6, 2014  • Accepted : June 11, 2014 • Address for reprints : Ealmaan Kim, M.D., Ph.D.  Department of Neurosurgery, Dongsan Medical Center, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea  Tel : +82-53-250-7823,  Fax : +82-53-250-7356,  E-mail : bach1158@dsmc.or.kr  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 357-361, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.357 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/99/e5/jkns-55-357.PMC4166333.pdf
"Department of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel : +82-2-590-2658,  Fax : +82-2-594-4248,  E-mail : ssjeun@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 362-364, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.362 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/16/73/jkns-55-362.PMC4166334.pdf
"Key Words :  Spinal epidural lipomatosis · Korean · Idiopathic.Case Report • Received : October 21, 2013  • Revised : January 9, 2014  • Accepted : June 11, 2014 • Address for reprints : Sang Pyung Lee, M.D., Ph.D.  Department of Neurosurgery, Cheju Halla Hospital, 65 Doryeong-ro, Jeju 690-766, Korea  Tel : +82-64-740-5035,  Fax : +82-64-740-5676,  E-mail : sangpyung@yahoo.co.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 365-369, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.365 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/6a/48/jkns-55-365.PMC4166335.pdf
"Key Words :  Cauda equina syndrome · Chronic inflammatory demyelinating polyneuropathy · Charcot-Marie-Tooth disease · Laminectomy.Case Report • Received : September 2, 2013  • Revised : December 27, 2013  • Accepted : June 13, 2014 • Address for reprints : Seung Won Park, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Huekseok-ro, Dongjak-gu, Seoul 156-755, Korea  Tel : +82-2-6299-1610,  Fax : +82-2-821-8409,  E-mail : nspsw@cau.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 370-374, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.370 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/6d/ea/jkns-55-370.PMC4166336.pdf
"Department of Neurosurgery, Daegu Catholic University College of Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea  Tel : +82-53-650-4258,  Fax : +82-53-650-4932,  E-mail : gneuros@cu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 375-378, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.375 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/3e/dc/jkns-55-375.PMC4166337.pdf
"Key Words :  Brainstem · Cavernous hemangioma · Hiccup · Medulla oblongata · Surgery.Case Report • Received : October 14, 2013  • Revised : February 9, 2014  • Accepted : June 11, 2014 • Address for reprints : Kyung-Sub Moon, M.D., Ph.D.  Department of Neurosurgery, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital and Medical School,    3 22 Seoyang-ro, Hwasun-eup, Hwasun 519-763, Korea  Tel : +82-61-379-7666,  Fax : +82-61-379-7673,  E-mail : moonks@chonnam.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 379-382, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.379 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/4f/ce/jkns-55-379.PMC4166338.pdf
"Department of Neurosurgery, Rush University Medical Center, 1725 West Harrison, Suite 855, Chicago, IL 60610, USA  Tel : +1-312-942-1854,  Fax : +1-312-563-3358,  E-mail : lee_tan@rush.edu • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     w hich permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (6) : 383-386, 2014http://dx.doi.org/10.3340/jkns.2014.55.6.383 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kronline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/91/aa/jkns-55-383.PMC4166339.pdf
"Department 	o f 	N eurosurgery, 	J eju	N ational 	U niversity 	H ospital, 	1 5	A ran	1 3-gil, 	J eju	6 90-767, 	K orea 	Tel	:	+ 82-64-717-1624, 	 	F ax	:	+ 82-64-717-1131, 	 	E -mail 	:	n schangsub@jejunu.ac.kr •	This	i s 	a n 	O pen 	A ccess 	a rticle 	d istributed 	u nder	t he	t erms 	o f	t he	C reative 	C ommons 	A ttribution 	N on-Commercial 	L icense 	( http://creativecommons.org/licenses/by-nc/3.0) 	 		 	 which 	p ermits 	u nrestricted 	n on-commercial 	u se,	d istribution, 	a nd	r eproduction 	i n	a ny	m edium, 	p rovided 	t he	o riginal 	w ork	i s	p roperly 	c ited.J Korean Neurosurg Soc 55  (6) : 387-387, 	 2014http://dx.doi.org/10.3340/jkns.2014.55.6.387 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr RE : The Early Detection of Recurrence of Malignant  Peripheral Nerve Sheath Tumor by Frequent Magnetic Resonance Imaging Chang Sub Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/fa/58/jkns-55-387.PMC4166340.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1819–1825Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1819Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6490 4Plasma homocysteine and genetic variants   of homocysteine metabolism enzymes in patients  from central greece with primary open-angle  glaucoma and pseudoexfoliation glaucoma Fani Zacharaki1 georgios M hadjigeorgiou2 georgios g Koliakos3 Margaux a Morrison4 aspasia Tsezou5 Dimitrios Z Chatzoulis1 Pavlina almpanidou1 Konstantina T opouridou3 Constantinos h Karabatsas1 Maria Pefkianaki1 Margaret M Deangelis4 evangelia e Tsironi1 1Department of Ophthalmology,    2Department of neurology, Faculty   of Medicine, University   of Thessaly, larissa, 3Department  of Biochemistry, Medical school,   aristotles University of Thessaloniki,   Thessaloniki, greece; 4Department   of Ophthalmology and Visual sciences,   John a Moran eye Center, University  of Utah, salt lake City, UT, Usa;   5Department of Biology, Faculty   of Medicine, University of Thessaly,   larissa, greece Correspondence: Fani Zacharaki   Frimley Park hospital, Portsmouth road,  gU16 7UJ, Camberley, surrey, UK   T el +44 75 4949 5990   email fani_zacharaki@hotmail.co mBackground:  The purpose of this study was to investigate plasma homocysteine levels   and polymorphisms in genes encoding enzymes in the metabolic pathway of homocysteine  in association with primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma  (PXFG).",Non-OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
There is increasing evidence that anatomic or functional abnormalities  of the optic nerve head vessels compromising the microcirculation and perfusion might  play a role in the pathogenesis of the disease.2–4Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Zacharaki et al Running head recto: Homocysteine and open-angle glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S64904,Non-OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
Linkage disequilibrium  (r2) between single nucleotide polymorphisms on the same  chromosome was determined using the Haploview program  (http://www.broad.mit.edu/mpg/haploview /).,OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
Available from: http://www.eugs.org/eng/ EGS_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1825homocysteine and open-angle glaucoma 34.,Non-OADS,/arxiv_data1/oa_pdf/14/fa/opth-8-1819.PMC4166342.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/3a/opth-8-1827.PMC4166343.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1827–1830Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1827Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6861 8endothelial keratoplasty with infant   donor tissue akira Kobayashi Hideaki Y okogawa Natsuko Yamazaki toshinori Masaki Kazuhisa sugiyama Department of Ophthalmology,   Kanazawa University Graduate school  of Medical science, Kanazawa, JapanAbstract:  Here we report a case of endothelial keratoplasty with infant donor tissue obtained  after brain death.",Non-OADS,/arxiv_data1/oa_pdf/50/3a/opth-8-1827.PMC4166343.pdf
"Correspondence: akira Kobayashi Department of Ophthalmology,  Kanazawa University Graduate school  of Medical science, 13-1 takara-machi,  Kanazawa-shi, Ishikawa-ken   920-8641, Japan  email kobaya@kenroku.kanazawa-u.ac.j p Journal name: Clinical Ophthalmology Article Designation: Case Report Y ear: 2014 Volume: 8 Running head verso: Kobayashi et al Running head recto: Endothelial keratoplasty with infant donor tissue DOI: http://dx.doi.org/10.2147/OPTH.S68618",Non-OADS,/arxiv_data1/oa_pdf/50/3a/opth-8-1827.PMC4166343.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/50/3a/opth-8-1827.PMC4166343.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/3a/opth-8-1827.PMC4166343.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/cc/opth-8-1801.PMC4166344.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1801–1817Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1801Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6500 3A new classification of glaucomas Constantin-Dan Bordeianu Private Practice, Ploiesti, Prahova,   romania Correspondence: Constantin-Dan  Bordeianu   15, Cameliei st, Bl 26, sc B, et i, ap 26  Ploiesti, 100091, Prahova, romania   Tel +40 244 598915; +40 720 328040   Fax +40 244 598915   email bordmail3@yahoo.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Bordeianu Running head recto: A new classification of glaucomas DOI: http://dx.doi.org/10.2147/OPTH.S65003 Purpose:  To suggest a new glaucoma classification that is pathogenic, etiologic, and  clinical.",Non-OADS,/arxiv_data1/oa_pdf/da/cc/opth-8-1801.PMC4166344.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/da/cc/opth-8-1801.PMC4166344.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1817A new classification of glaucomas  10.,Non-OADS,/arxiv_data1/oa_pdf/da/cc/opth-8-1801.PMC4166344.pdf
Available from: http://omim.org/entry/606657?search =6 06657&highlight =Accessed June 2014.,Non-OADS,/arxiv_data1/oa_pdf/da/cc/opth-8-1801.PMC4166344.pdf
Available from: http://omim.org/entry/Accessed June  2014.,Non-OADS,/arxiv_data1/oa_pdf/da/cc/opth-8-1801.PMC4166344.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-7-1563.PMC4166345.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1563–1569OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1563Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6537 3hiF1α is an independent prognostic factor   for overall survival in advanced primary   epithelial ovarian cancer – a study   of the OVcaD consortium elena ioana Braicu1 hrvoje luketina1 rolf richter1 Dan cacsire castillo-T ong2 sandrina lambrechts4 sven Mahner5 nicole concin6 Monika Mentze1 robert Zeillinger2,3 ignace Vergote4 Jalid sehouli1 1Department of gynecology, european  competence center for Ovarian  cancer, charité – Universitätsmedizin  Berlin, Berlin, germany; 2Department  of Obstetrics and gynecology,  comprehensive cancer center,  Medical University of Vienna, 3ludwig  Boltzmann cluster Translational  Oncology, general hospital of  Vienna, Vienna, austria; 4Department  of Obstetrics and gynecology,  Universitaire Ziekenhuizen leuven,  Katholieke Universiteit leuven, leuven,  Belgium; 5Department of gynecology  and gynecologic Oncology, University  Medical center hamburg-eppendorf,  hamburg, germany; 6Department of  Obstetrics and gynecology, innsbruck  Medical University, innsbruck, austria correspondence: elena ioana Braicu   Department of gynecology,   european competence center   for Ovarian cancer, campus Virchow   clinic, charité – University hospital   of Berlin, augustenburger Platz 1,   13353 Berlin, germany   email elena.braicu@charite.d ePurpose:  Hypoxia is a common phenomenon encountered in solid cancers, leading to chemo­ therapy resistance and therefore to aggressiveness of the disease.",Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-7-1563.PMC4166345.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer ­reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-7-1563.PMC4166345.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/ff/ott-7-1563.PMC4166345.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1503–1515Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1503RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6666 0Correspondence: Lisa Kouladjian   Clinical Pharmacology and Aged  Care, Level 12 Kolling Building, Royal  North Shore Hospital, Reserve Road,  St Leonards, NSw, Australia 2065   Tel +61 2 9926 4934   Fax +61 2 9926 4053   email lisa.kouladjian@sydney.edu.a u Drug Burden Index in older adults: theoretical  and practical issues Lisa Kouladjian1 Danijela Gnjidic1,2 Timothy F Chen2 Arduino A Mangoni3 Sarah N Hilmer1 1Sydney Medical School, University of  Sydney, Kolling Institute of Medical  Research and Departments of Clinical  Pharmacology and Aged Care, Royal  North Shore Hospital, 2Faculty of  Pharmacy, University of Sydney,   Sydney, NSw , 3Department of Clinical  Pharmacology, School of Medicine,   Flinders University and Flinders  Medical Centre, Bedford Park, SA,   AustraliaAbstract:  Anticholinergic and sedative medications are commonly used in older adults and are  associated with adverse clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
"Some of the most commonly prescribed medications in older people include those  with anticholinergic (antimuscarinic)6 and sedative7,8 effects, and inappropriate use of  these medications is associated with adverse outcomes.9 For example, studies in older Journal name: Clinical Interventions in Aging Journal Designation: Review Y ear: 2014 Volume: 9 Running head verso: Kouladjian et al Running head recto: Drug Burden Index in older adults DOI: http://dx.doi.org/10.2147/CIA.S66660 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
Or use: http://dvpr.es/1pfiQA Hvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
Available from: http://www.who.int/ageing/about/facts/en/index.html#.,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
Available from: http://5cpa.com.au/programs/medication-management- initiatives/home-medicines-review /.,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
Available from:  http://www.nps.org.au/__data/assets/pdf_file/0015/130326/ NPS_Antipsychotic_Monitoring_Tool.pdf.,OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d1/f6/cia-9-1503.PMC4166346.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/cd/copd-9-935.PMC4166347.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 935–944International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  935OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6017 9a telehealth program for self-management   of COPD exacerbations and promotion of an  active lifestyle: a pilot randomized controlled trial Monique Tabak1,2 Marjolein Brusse-Keizer3 Paul van der Valk3,4 hermie hermens1,2 Miriam Vollenbroek- hutten1,2 1Telemedicine group, roessingh  research and Development,   2Telemedicine group, University  of T wente, 3Department of Pulmonary  Medicine, Medisch spectrum T wente,   4Medical school Twente, Medisch  spectrum Twente, enschede, the  netherlands Correspondence: Monique Tabak   Telemedicine group, University of  Twente, Drienerlolaan 5, PO Box 217,  enschede 7500 ae, the netherlands   Tel +31 53 489 2762   Fax +31 53 4340 849   email m.tabak@utwente.n lAbstract:  The objective of this pilot study was to investigate the use of and satisfaction with  a chronic obstructive pulmonary disease (COPD) telehealth program applied in both primary  and secondary care.",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/copd-9-935.PMC4166347.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/copd-9-935.PMC4166347.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/cd/copd-9-935.PMC4166347.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1335–1380Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1335R E V I E W open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5077 3Update on developments with SGLT2 inhibitors   in the management of type 2 diabetes Michael A Nauck Department of Internal Medicine,   Diabeteszentrum Bad Lauterberg,    Bad Lauterberg im Harz, Germany Correspondence: Michael A Nauck   Department of Internal Medicine,  Diabeteszentrum Bad Lauterberg  Kirchberg 21, D-37431 Bad Lauterberg  im Harz, Germany   Tel +49 5524 81218   Fax +49 5524 81398   Email m .nauck@diabetesz entrum.d eAbstract:  The importance of the kidney’ s role in glucose homeostasis has gained wider   understanding in recent years.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Outside of the  US and EU marketing applications for ipragliflozin, luseo - gliflozin, and tofogliflozin were submitted to Japan’ s Phar - Table  2 SGLT2 inhibitors in advanced clinical development Compound (sponsor) Development status Other information Dapagliflozin     (Bristol-Myers Squibb,   AstraZeneca)Launched in Europe   EMA approval given in November 2012   Launched in the US   FDA approval given in January 2014http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/ medicines/002322/human_med_001546.jsp&mid=WC0b01ac058001d124   http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm380829.htm Canagliflozin     (Mitsubishi Tanabe   Pharma, Janssen)Launched in the US   FDA approval given in March 2013   Launched in Europe   EMA approval given in November 2013http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm345848.htm   http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/ medicines/002649/human_med_001707.jsp&mid=WC0b01ac058001d124 Empagliflozin     (Boehringer Ingelheim,   Eli Lilly)EMA approval given in May 2014 FDA approval given in August 2014http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm407637.ht m Ipragliflozin     (Astellas, Kotobuki   Pharmaceutical)Launched in Japan   Japanese MHLW approval given in   January 2014http://www.astellas.com/en/corporate/news/detail/approval-of-suglat- tablets-a-s.html Luseogliflozin    (Taisho, Novartis)Pre-registration   Marketing application made to MHLW,   Japan in April 2013http://www.taisho-holdings.co.jp/en/ir/development/   http://www.taisho-holdings.co.jp/en/release/2013/2013041801-e.pdf Tofogliflozin    (Chugai, Kowa, Sanofi)Pre-registration   Marketing application made to MHLW,   Japan in June 2013http://www.chugai-pharm.co.jp/hc/ss/english/ir/reports_downloads/ pipeline.html   http://www.chugai-pharm.co.jp/hc/ss/english/news/detail/20121026150000.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"html Ertugliflozin [PF04971729]    (Pfizer, Merck and Co)Phase III trials commenced in October   2013http://clinicaltrials.gov/ct2/results?term=ertugliflozin   http://www.mercknewsroom.com/press-release/research-and- development-news/merck-co-inc-and-pfizer-enter-worldwide- collaboration-ag Sotagliflozin [LX4211]    (Lexicon Pharmaceuticals)aPhase III trials are expected to begin   in 2014http://www.lexgen.com/pipeline/lx4211.html Notes: aSotagliflozin [LX4211] is a dual SGLT1 and SGLT2 inhibitor.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"The estimated hazard ratio was 0.91  (95% CI 0.68, 1.22) for the risk of MACE-Plus comparing canagliflozin to all comparators (via the pre-specified  primary Cox proportional hazards model fit to all trials  including CANV AS).69 Changes in lipid profiles observed with SGLT2 inhibitor  therapy have caused some concern.88 Dose-related increases  in low-density lipoprotein cholesterol (LDL-C) were observed  with canagliflozin, as shown in a pooled analysis of data from  four 26-week placebo-controlled trials in which the mean  percentage increases from baseline in LDL-C were 4.5%  and 8.0% for 100 mg and 300 mg canagliflozin, respectively,  relative to placebo.92 Canagliflozin labeling information rec - ommends LDL-C should be monitored and treated accord - ing to standard care after initiating canagliflozin therapy.92  Statistically significant increases in high-density lipoprotein Table 3  Registered cardiovascular clinical trials of SGLT2 inhibitors Trial details Reference DECLARE TIMI58 – Dapagliflozin Effect on Cardiovascular Events     Full title:  Dapagliflozin Effect on Cardiovascular Events: A Multicenter, Randomized, Double-Blind,   Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence   of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes   Primary outcome measure:  Time to first event included in the composite endpoint of CV death,   MI or ischemic stroke   Patients:  Aged $40 years; T2DM; high risk for CV events   Estimated enrollment:  22,200 (recruiting)   Estimated study completion date:  2Q 2019http://www.clinicaltrials.gov/ct2/show/ NCT01730534 CANVAS – Canagliflozin Cardiovascular Assessment Study     Full title:  A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects   of JNJ 28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus   Primary outcome measure:  Major adverse cardiovascular events, including CV death, nonfatal MI,   and nonfatal stroke   Patients:  Aged $30 years; T2DM; high risk for CV events   Enrollment:  4,330   Estimated study completion date:  2Q 2017http://www.clinicaltrials.gov/ct2/show/ NCT01032629   Neal90 BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients   (EMPA-REG-OUTCOMETM)    Full title:  A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind   Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared   to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk   Primary outcome measure:  Time to the first occurrence of any of the following adjudicated   components of the primary composite endpoint: cardiovascular death (including fatal stroke and fatal MI),  non-fatal MI and non-fatal stroke   Patients:  Aged .18 years; T2DM; confirmed history of MI, uns table angina, multi-vessel percutaneous   coronary intervention, multi-vessel coronary artery bypass grafting, ischemic or hemorrhagic stroke,   peripheral occlusive arterial disease   Estimated enrollment:  7,000   Estimated study completion date:  2Q 2015http://www.clinicaltrials.gov/ct2/show/ NCT01131676   Zinman91 Cardiovascular Outcomes Following Treatment with Ertugliflozin in Participants with   Type 2 Diabetes Mellitus and Established Vascular Disease     Primary outcome measure:  Time to the first occurrence of any component of the composite   endpoint of cardiovascular death, non-fatal MI, or non-fatal stroke   Patients:  T2DM; established vascular disease   Estimated enrollment:  3,900 (currently recruiting)   Estimated study completion date:  2Q 2020http://www.clinicaltrials.gov/ct2/show/ NCT01986881 Abbreviations:  CV, cardiovascular; MI, myocardial infarction; Q, quarter; T2DM, type 2 diabetes mellitus; SGLT, sodium glucose co-transporter.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Available from: http://ec.europa.eu/health/documents/   community-register/2012/20121112124487/anx_124487_en.pd f.  Accessed March 31, 2014.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
Available from: http://packageinserts.bms.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Available from: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Public_assessment_report/ human/002322/WC500136024.pd f. Accessed September 17, 2013.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Public_assessment_report/human/002649/ WC500156457.pd f. Accessed December 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Available from: http://www.fda.gov/downloads/Advisory   Committees/CommitteesMeetingMaterials/Drugs/Endocrinologicand   MetabolicDrugsAdvisoryCommittee/UCM334550.pd f. Accessed  March 31, 2014.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Avail - able from: http://www.fda.gov/downloads/AdvisoryCommittees/   CommitteesMeetingMaterials/Drugs/Endocrinologicand   MetabolicDrugsAdvisoryCommittee/UCM334550.pd f. Accessed  April 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
Available from: http://www.fda.gov/downloads/   AdvisoryCommittees/CommitteesMeetingMaterials/drugs/   EndocrinologicandMetabolicDrugsAdvisoryCommittee/ucm262994.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"It has been investigated in monkeys, where it triggered glucosuria in a dose-dependent   manner, and in obese diabetic rats, where it normalized diabetes and reduced blood   glucose by 48% compared to the non-treated group.http://www.sironabiochem.com/sirona- biochem-announces-preclinical-results- of-diabetes-compound-2/ N-glucoside 9d Mitsubishi   TanabePreclinical A series of N-glucosides was synthesized for biological evaluation as human SGLT2   (hSGLT2) inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/a1/dddt-8-1335.PMC4166348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/07/cia-9-1539.PMC4166349.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1539–1549Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1539OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6880 1Xiaoshuang Ye1 lu Wei1 Xiaohua Pei1 Bei Zhu1 Jianqing Wu2 Weihong Zhao1 1Division of nephrology, Department  of geriatrics, The First Affiliated  hospital of nanjing Medical  University, nanjing, Jiangsu, People’s  republic of China; 2Division  of respiration, Department  of geriatrics, The First Affiliated  hospital of nanjing Medical  University, nanjing, Jiangsu, People’s  republic of China Correspondence: Weihong Zhao Division of nephrology, Department  of Geriatrics, The First Affiliated  hospital of nanjing Medical University,  300 guangzhou road, nanjing 210029,  Jiangsu, People’s republic of China Tel +11 86 25 6813 5063 Fax +11 86 25 8378 0170 email zhaoweihong@njmu.edu.c n Background:  No conventional creatinine- or cystatin C-based glomerular filtration rate (GFR)  estimation equation performed consistently outstandingly in elderly Chinese in our previous  studies.",Non-OADS,/arxiv_data1/oa_pdf/a1/07/cia-9-1539.PMC4166349.pdf
"Keywords:  elderly Chinese, creatinine, cystatin C, glomerular filtration rate, equation Introduction Chronic kidney disease (CKD) has increasingly been considered a research and  public health priority.1 CKD prevalence markedly increases with age.2,3 Surveys  have shown that aged CKD patients have increasingly accounted for 50% of all the  CKD patients.4,5 According to the sixth national census in China in 2010, individuals   aged 60 years numbered close to 179 million, accounting for 13.26% of the total  Chinese population, which increased by 3.36% from the previous census conducted  Application of creatinine- and/or cystatin C-based  glomerular filtration rate estimation equations  in elderly ChineseJournal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Y e et al Running head recto: Cscr-cys-based GFR estimation equations in elderly Chinese DOI: http://dx.doi.org/10.2147/CIA.S68801",Non-OADS,/arxiv_data1/oa_pdf/a1/07/cia-9-1539.PMC4166349.pdf
Available from: http://www.stats.gov.cn/tjsj/ndsj/2011/indexee.,OADS,/arxiv_data1/oa_pdf/a1/07/cia-9-1539.PMC4166349.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a1/07/cia-9-1539.PMC4166349.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a1/07/cia-9-1539.PMC4166349.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/12/17/vhrm-10-569.PMC4166367.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 569–576Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  569ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/VHRM.S6319 9economic and outcomes consequences   of TachoSil®: a systematic review Giorgio L Colombo1,2 Daria Bettoni3 Sergio Di Matteo2 Camilla Grumi3 Cinzia Molon4 Daniela Spinelli5 Gaetano Mauro6 Alessia Tarozzo4 Giacomo M Bruno2 1Department of Drug Sciences,   University of Pavia, Pavia, italy; 2Studi  Analisi Valutazioni economiche  (SAVe), Milan, italy; 3Hospital  Pharmacy, Spedali Civili Brescia,   Brescia, italy; 4Città della Salute  e della Scienza di Torino, Presidio  Molinette, T urin, italy; 5Azienda  Ospedaliero-Universitaria Pisana,    Pisa, italy; 6Scuola di Specializzazione  in Farmacia Ospedaliera, Università La  Sapienza, Roma, italy Correspondence: Giorgio L Colombo   Studi Analisi Valutazioni economiche  (SAVe), Via Previati  74, 20149 Milan, italy   Tel +39 02 4851 9230  Fax +39 02 7396 0369  email giorgio.colombo@savestudi.i tBackground:  TachoSil® is a medicated sponge coated with human fibrinogen and human  thrombin.",Non-OADS,/arxiv_data1/oa_pdf/12/17/vhrm-10-569.PMC4166367.pdf
Available from: http://www.saluter.it/ documentazione /rapporti/ emostatici_novembre2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/12/17/vhrm-10-569.PMC4166367.pdf
Available from: http://www.york.ac.uk/inst/crd/pdf/ Systematic_Reviews .,Non-OADS,/arxiv_data1/oa_pdf/12/17/vhrm-10-569.PMC4166367.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/12/17/vhrm-10-569.PMC4166367.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/17/vhrm-10-569.PMC4166367.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 105-109 http://dx.doi.org/10.5534/wjmh.2014.32.2.105 Original Articl e Received: Jun 11, 2014; Revised: Jun 30, 2014; Accepted: Jul 4,  2014 Correspondence to: Ju Tae Seo Department of Urology, Cheil General Hospital & Women ’s Healthcare Center, Kwandong University College of Medicine, 23 Toegye-ro 46-gil, Jung-gu, Seoul 100-380, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c6/3e/wjmh-32-105.PMC4166368.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 110-115 http://dx.doi.org/10.5534/wjmh.2014.32.2.110 Original Articl e Received: Jun 14, 2014; Revised: Jul 12, 2014; Accepted: Jul 24 , 2014 Correspondence to: Sang Don Lee Department of Urology, Pusan National University Yangsan Hospit al, 20 Geumo-ro, Mulgeum-eup, Yangsan 626-770, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0d/95/wjmh-32-110.PMC4166369.pdf
Geneva: WHO; c2010 [cited 2014 Jan 20]  Available from: http://www.who.int/reproductivehealth/ pub- lications/infertil ity /9789241547789/en/.,Non-OADS,/arxiv_data1/oa_pdf/0d/95/wjmh-32-110.PMC4166369.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 116-119 http://dx.doi.org/10.5534/wjmh.2014.32.2.116 Case Repor t Received: Nov 21, 2013; Revised: Jan 6, 2014; Accepted: Jan 17,  2014 Correspondence to: Hong Koo Ha Department of Urology, Pusan National University School of Medi cine, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f5/93/wjmh-32-116.PMC4166370.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 120-122 http://dx.doi.org/10.5534/wjmh.2014.32.2.120 Case Repor t Received: Jun 17, 2013; Revised: Oct 11, 2013; Accepted: Oct 14 , 2013 Correspondence to: Hwancheol Son Department of Urology, SMG-SNU Boramae Medical Center, 20 Boram ae-ro 5-gil, Dongjak-gu, Seoul 156-849, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b7/0f/wjmh-32-120.PMC4166371.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 69-75 http://dx.doi.org/10.5534/wjmh.2014.32.2.69 Original Articl e Received: Mar 27, 2014; Revised: May 2, 2014; Accepted: May 22,  2014 Correspondence to: Du Geon Moon Department of Urology, Korea University Guro Hospital, 148 Guro dong-gil, Guro-gu, Seoul 152-703, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ed/56/wjmh-32-69.PMC4166372.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 76-82 http://dx.doi.org/10.5534/wjmh.2014.32.2.76 Original Articl e Received: May 27, 2014; Revised: Jun 13, 2014; Accepted: Jun 17 , 2014 Correspondence to: Sang Don Lee Department of Urology, Pusan National University Yangsan Hospit al, 20 Geumo-ro, Mulgeum-eup, Yangsan 626-770, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e1/a7/wjmh-32-76.PMC4166373.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 83-86 http://dx.doi.org/10.5534/wjmh.2014.32.2.83 Original Articl e Received: Apr 25, 2014; Revised: Jun 5, 2014; Accepted: Jun 18,  2014 Correspondence to: Sang Rak Bae D e p a r t m e n t  o f  U r o l o g y ,  T h e  C a t h o l i c  U n i v e r s i t y  o f  K o r e a ,  U i j e o n gbu St. Mary ’s Hospital, 271 Cheonbo-ro, Uijeongbu 480-717, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2e/ea/wjmh-32-83.PMC4166374.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 87-92 http://dx.doi.org/10.5534/wjmh.2014.32.2.87 Original Articl e Received: May 5, 2014; Revised: May 10, 2014; Accepted: May 27,  2014 Correspondence to: Soo Woong Kim D e p a r t m e n t  o f  U r o l o g y ,  S e o u l  N a t i o n a l  U n i v e r s i t y  H o s p i t a l ,  1 0 1  Daehak-ro, Jongno-gu, Seoul 110-744, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b5/7d/wjmh-32-87.PMC4166375.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 93-98 http://dx.doi.org/10.5534/wjmh.2014.32.2.93 Original Articl e Received: Mar 31, 2014; Revised: May 6, 2014; Accepted: May 27,  2014 Correspondence to: Sungchan Park Department of Urology, Ulsan University Hospital, University of  Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, D o n g - g u ,  U l s a n  6 8 2 - 7 1 4 ,  K o r e a .",Non-OADS,/arxiv_data1/oa_pdf/09/1c/wjmh-32-93.PMC4166376.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2014 August 32(2): 99-104 http://dx.doi.org/10.5534/wjmh.2014.32.2.99 Original Articl e Received: Feb 11, 2014; Revised: (1st) May 7, 2014, (2nd) May 2 6, 2014; Accepted: May 27, 2014 Correspondence to: Jae Seog Hyun Department of Urology, Gyeongsang National University Hospital,  79 Gangnam-ro, Jinju 660-702, Korea.",Non-OADS,/arxiv_data1/oa_pdf/37/46/wjmh-32-99.PMC4166377.pdf
"Tel: 82-2-2258-2236, Fax: 82-2-537-1951, E-mail:  p6c8s17@catholic.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 103-109  http://dx.doi.org/10.4097/kjae.2014.67.2.103",Non-OADS,/arxiv_data1/oa_pdf/03/61/kjae-67-103.PMC4166381.pdf
"Tel: 82-32-290-3586, Fax: 82-32-290-3568, E-mail: hardmong@korea.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 110-114  http://dx.doi.org/10.4097/kjae.2014.67.2.110",Non-OADS,/arxiv_data1/oa_pdf/45/b2/kjae-67-110.PMC4166382.pdf
"Tel: 82-2-2072-2466, Fax: 82-2-747-5639,  E-mail: hppark@snu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 115-122  http://dx.doi.org/10.4097/kjae.2014.67.2.115",Non-OADS,/arxiv_data1/oa_pdf/77/c7/kjae-67-115.PMC4166383.pdf
The APACHE IV score and predicted  mortality rate calculation on the website (http://www.mecriti - calcare.net/icu_scores/apacheIV .php) was used in the present  study.,Non-OADS,/arxiv_data1/oa_pdf/77/c7/kjae-67-115.PMC4166383.pdf
"Tel: 82-62-220-6893, Fax: 82-62-232-6294, E-mail: mhyoon@chonnam.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2014 August 67(2): 123-128  http://dx.doi.org/10.4097/kjae.2014.67.2.123",Non-OADS,/arxiv_data1/oa_pdf/ee/e0/kjae-67-123.PMC4166384.pdf
"Moreover, GA, muscle relaxation, and positive-pressure  ventilation can interfere with venous return and reduce vascular  tone; thus, further compromising the CO, rendering AS patients  vulnerable to uncompensated circulatory effects caused by  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 129-132  http://dx.doi.org/10.4097/kjae.2014.67.2.129 Case Report",Non-OADS,/arxiv_data1/oa_pdf/00/66/kjae-67-129.PMC4166385.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 133-138  http://dx.doi.org/10.4097/kjae.2014.67.2.133 Case Report",Non-OADS,/arxiv_data1/oa_pdf/d1/00/kjae-67-133.PMC4166386.pdf
"Blood tests before  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 139-143  http://dx.doi.org/10.4097/kjae.2014.67.2.139 Case Report",Non-OADS,/arxiv_data1/oa_pdf/02/ce/kjae-67-139.PMC4166387.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 144-147  http://dx.doi.org/10.4097/kjae.2014.67.2.144 Case Report",Non-OADS,/arxiv_data1/oa_pdf/b6/bb/kjae-67-144.PMC4166388.pdf
"EFTGR can be regarded  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 148-152  http://dx.doi.org/10.4097/kjae.2014.67.2.148 Case Report",Non-OADS,/arxiv_data1/oa_pdf/65/62/kjae-67-148.PMC4166389.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 153 http://dx.doi.org/10.4097/kjae.2014.67.2.153 Opinion References 1.",Non-OADS,/arxiv_data1/oa_pdf/7d/32/kjae-67-153.PMC4166390.pdf
"The risk  of hemodynamic derangement by such high pressures can be  Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 75-76  http://dx.doi.org/10.4097/kjae.2014.67.2.75 Editorial",Non-OADS,/arxiv_data1/oa_pdf/d3/98/kjae-67-75.PMC4166391.pdf
"Tel: 1-713-500-6128, Fax: 1-713-500-0665, E-mail: Kiwon.Lee@uth.tmc.edu     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 77-84  http://dx.doi.org/10.4097/kjae.2014.67.2.77",Non-OADS,/arxiv_data1/oa_pdf/21/a0/kjae-67-77.PMC4166392.pdf
"Tel: 82-53-890-6520, Fax: 82-51-898-4216, E-mail: pain_kill@naver.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 85-89  http://dx.doi.org/10.4097/kjae.2014.67.2.85  Introduction Spinal anesthesia is widely used because it has many advan - tages compared to general anesthesia, such as dulling of the  stress response, reduced amount of blood loss, low cost, and  decreased morbidity and mortality rates in high risk patients [1].",Non-OADS,/arxiv_data1/oa_pdf/65/f3/kjae-67-85.PMC4166393.pdf
"Tel: 90-3742534656, Fax: 90-3742534615, E-mail: akcanakkaya@hotmail.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 90-95  http://dx.doi.org/10.4097/kjae.2014.67.2.90",Non-OADS,/arxiv_data1/oa_pdf/ab/7d/kjae-67-90.PMC4166394.pdf
"Tel: 82-62-220-3223, Fax: 82-62-223-2333, E-mail: ksh3223@Chosun.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2014 www.ekja.orgKorean J Anesthesiol 2014 August 67(2): 96-102  http://dx.doi.org/10.4097/kjae.2014.67.2.96",Non-OADS,/arxiv_data1/oa_pdf/14/e2/kjae-67-96.PMC4166395.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005629).,Non-OADS,/arxiv_data1/oa_pdf/73/e5/bmjopen-2014-005629.PMC4166414.pdf
"The Framingham Heart Study: 50 years of research success.Framingham, MA: Framingham Heart Study, 2012. http://www.nhlbi.nih.gov/about/framingham/index.html (accessed 5 Nov 2012).",Non-OADS,/arxiv_data1/oa_pdf/73/e5/bmjopen-2014-005629.PMC4166414.pdf
http://www.cdc.gov/nchs/nhanes.htm(accessed 3 Nov 2002).,OADS,/arxiv_data1/oa_pdf/73/e5/bmjopen-2014-005629.PMC4166414.pdf
Secondary global database on body mass index 2014. http://apps.who.int/bmi/index.jsp 22.,OADS,/arxiv_data1/oa_pdf/73/e5/bmjopen-2014-005629.PMC4166414.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005351).,Non-OADS,/arxiv_data1/oa_pdf/4c/59/bmjopen-2014-005351.PMC4166416.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/59/bmjopen-2014-005351.PMC4166416.pdf
Retrieved from http://health.sina.com.cn/news/2013-11-29/0921114941.shtml (accessed 31 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/59/bmjopen-2014-005351.PMC4166416.pdf
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jcte.2014.07.008Journal of Clinical & Translational Endocrinology 1 (2014) 140 e144 Open access under CC BY-NC-ND license.Open access under CC BY-NC-ND license.,OADS,/arxiv_data1/oa_pdf/f7/96/main.PMC4166486.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/f7/main.PMC4166584.pdf
Determination  of  these  pathways  could  provide novel therapeutic  options  and  potentially  decrease  the http://dx.doi.org/10.1016/j.toxrep.2014.08.005 2214-7500/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/f7/main.PMC4166584.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/f7/main.PMC4166584.pdf
He was in his usual stateFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Neurological examination demonstrates mild dysdiadochokinesia and moderately impaired tandem gait.Mittal SO, Machado DG Hypocupremia: A Possible Association with LCCA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"The patient has worsening neurological features with severely impaired tandem gait and severe difficulty in balancing on one foot such that he nearly falls.Hypocupremia: A Possible Association with LCCA Mittal SO, Machado DG Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Parenchymatous atrophy of the cerebellum: A contribu- tion to the symptomatology of intrinsic cerebellar disease J Nerv Ment Dis 1918;48: 273–312, doi: http://dx.doi.org/10.1097/00005053-191810000-00001.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Neuropathology 2008;28:43–50, doi: http://dx.doi.org/10.1111/j.1440-1789.2007.00845.x.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"No white matter changes in the cerebellar peduncleMittal SO, Machado DG Hypocupremia: A Possible Association with LCCA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Metallomics 2013;5:43–51, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Mayo Clin Proc2006;81:1371–1384, doi: http://dx.doi.org/10.4065/81.10.1371.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Acta Neurol Scand Suppl 1994;153:1–22, doi: http://dx.doi.org/10.1111/j.1600-0404.",OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Brain 1986;109:159–180, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Curr Drug Metab 2012;13:237–250, doi: http://dx.doi.org/10.2174/138920012799320455.15.Walshe JM.",OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Mov Disord 2005;20:1658–1661, doi: http://dx.doi.org/10.1002/mds.20628.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Pediatr Res 1981;15:284–289, doi: http://dx.doi.org/10.1203/00006450-198103000-00017.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Nutr Res 1984;3:923–928, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"Biol Trace Elem Res 2011;144:77–85, doi: http://dx.doi.org/ 10.1007/s12011-011-9034-9.",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
"doi.org/10.1007/s12311-009-0136-2.Hypocupremia: A Possible Association with LCCA Mittal SO, Machado DG Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/16/c2/tre-04-202-6022-1.PMC4166672.pdf
Implementation The meta-analysis pipelines described above were implementedusing: R 2.12.1 (available at: http://www.cran.,Non-OADS,/arxiv_data1/oa_pdf/d1/f7/ijc0134-2359.PMC4166677.pdf
r-project.org) 29; the Bioconductor package (available at: http://www.bioconduc- tor.org)30; MySQL 5.0.77 (available at: http://www.mysql.com) and Perl 5.8.8 (available at: http://www.perl.org).,OADS,/arxiv_data1/oa_pdf/d1/f7/ijc0134-2359.PMC4166677.pdf
2Human genes with germline GO terms are associated with these genes using AmiGO (http://amigo.geneontology.org/cgi-bin/amigo/go.cgi); noGO designations were identiﬁed by DAVID at the time of analysis (see Supporting Information Table S2).,Non-OADS,/arxiv_data1/oa_pdf/d1/f7/ijc0134-2359.PMC4166677.pdf
"Therefore, we ﬁrst designed an easily queried website front (the 293 Variant Viewer, http://www.hek293genome.org/index.",OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
The raw data were analysed with version 1.11 of the company’s analysis software and processed withCGAtools v1.5 (http://cgatools.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
The CG raw data and initial analysis results were processed by CGAtools v1.5 (http://cgatools.sourceforge.net/) with scriptsfrom the CG user community tool repository and our in-house scripts (see Supplementary Note 2).,OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
"To enable independent analysis of the data, we mapped the sequencing reads to the human reference genome, build hg18, using RTG Investigator from Real Time Genomics (http://www.realtimegenomics.com/) with default setting (maximum mate-pair insert size: 1,000, minimum insert size 0 and report the maximum best ﬁve matches).",OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
We used GenomeComb (http://genomecomb.sourceforge.net/) to reformat the SNV calling results from CG for the six cell lines49.,OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
at http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3750t1_01.pdf (2001).,Non-OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lin, Y.-C. et al.",Non-OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5767 12 NATURE COMMUNICATIONS | 5:4767 | DOI: 10.1038/ncomms5767 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/40/fd/ncomms5767.PMC4166678.pdf
A detailed explanation of the method used to compute parameters is available online (http://www.nature.com/clpt/journal/v84/n2/extref/clpt200821x1.doc)as supporting information of our previous publication [20].,OADS,/arxiv_data1/oa_pdf/be/b8/jvh0021-0458.PMC4166695.pdf
Type of breed refers to the nomenclature of the international kennel organization F /C19ed/C19eration Cynologique Internationale (FCI; http://www.fci.be/nomenclatur.aspx).,Non-OADS,/arxiv_data1/oa_pdf/27/6c/jbg0131-0153.PMC4166703.pdf
http://www.vortex9.org/PMx.html.,Non-OADS,/arxiv_data1/oa_pdf/27/6c/jbg0131-0153.PMC4166703.pdf
(http://www.fao.org).,Non-OADS,/arxiv_data1/oa_pdf/27/6c/jbg0131-0153.PMC4166703.pdf
"URL http://www.R-project.org/.Ruiz-L /C19opez M.J., Rold /C19an E.R.S., Expeso G., Gomendio M. (2009) Pedigrees and microsatellites among endangeredungulates: what do they tell us?",Non-OADS,/arxiv_data1/oa_pdf/27/6c/jbg0131-0153.PMC4166703.pdf
"Affymetrixand Illumina) commonly used in GWA studies (http://ncbi.nlm.nih.gov/SNP), which is probably why they have not been identified previously.",Non-OADS,/arxiv_data1/oa_pdf/4f/f7/srep06412.PMC4166707.pdf
"However, no such tagSNPs exist (http://www.ensembl.org/Homo_sapiens/Variation).",Non-OADS,/arxiv_data1/oa_pdf/4f/f7/srep06412.PMC4166707.pdf
"The HapMap project indi- cates that FSHR -29A is more prevalent among Chinese (CHB, minor allele frequency 51%) and Japanese (JPT, 47%), and less prevalent among Sub-Saharan Africans (YRI, 24%) compared with Western European (CEU, 30%) (http://hapmap.ncbi.nlm.nih.gov).",Non-OADS,/arxiv_data1/oa_pdf/4f/f7/srep06412.PMC4166707.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6412 | DOI: 10.1038/srep06412 6",Non-OADS,/arxiv_data1/oa_pdf/4f/f7/srep06412.PMC4166707.pdf
"Finally, intestinal eukaryotes were identified by comparing the resulting sequences with those that were deposited in GenBank using the basic local alignment search tool (BLAST), which is available at the NationalCenter for Biotechnology Information (http://blast.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/22/e3/srep06417.PMC4166708.pdf
"The specificity of each primer was tested using the basic local alignment search tool (BLAST), which is available at the National Center for Biotechnology Information (http://blast.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/22/e3/srep06417.PMC4166708.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/22/e3/srep06417.PMC4166708.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6417 | DOI: 10.1038/srep06417 9",Non-OADS,/arxiv_data1/oa_pdf/22/e3/srep06417.PMC4166708.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/d7/srep06409.PMC4166709.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6409 | DOI: 10.1038/srep06409 8",Non-OADS,/arxiv_data1/oa_pdf/dd/d7/srep06409.PMC4166709.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e0/c1/srep06414.PMC4166710.pdf
"To date, more than 600 different EXT1 and 345 EXT2 mutations have been found worldwide and an update on all reported mutations is depos- ited at http://medgen.ua.ac.be/LOVD)20.",Non-OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"The Protein HomologyFold Recognition Engine Phyre2, (http://www.sbg.bio.ic.ac.uk/ phyre2/html, last accessed March 2014) was used to predict the effect of missense mutations on 3D structure and the missense mutationp.Arg346Thr removes two fragments of alpha helix between aa 345 and 347, and from aa 635 to 639, and a beta sheet from aa 361 to 368 in EXT1 protein.",OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"A) predicted the use of cryptic donor splice sites: Human Splice Finder (http://www.umd.be/HSF/, last accessed March 2014), con- sidered the use of a cryptic donor splice site (score: 91.85%) located74 nucleotides downstream from the wild-type sequence, while NetGene2 (http://www.cbs.dtu.dk/cgi-bin/webface?jobid 5netgene2/ last accessed March 2014) predicted the use of a cryptic donor splic-ing site (score: 0.76) 201 nucleotides downstream from the wild-type(score:0.83).",Non-OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"Although some mutation hotspots have been reported20(http://medgen.ua.ac.be/LOVDv.2.0/), we did not observe recurrentEXT1 orEXT2 mutations in patients in this study.",Non-OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"Assessment of functionality of missense mutations .In order to assess the possible pathogenic effect of the new missense mutations, the changes were analyzed using three in-silico online tools: PolyPhen-2 (Polymorphism Phenotyping v2; http:// genetics.bwh.harvard.edu/pph2/, last accessed March 2014), Mutation Taster (http:// www.mutationtaster.org/, last accessed March 2014, and ESE Finder 3.0 (ESE: Exonic Splicing Enhancer; http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process 5home, last accessed March 2014).",OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"Protein Homology Fold Recognition Engine (http://www.sbg.bio.ic.ac.uk/phyre2/html, last accessed March 2014) was used to predict the implications of missense mutations for EXT1 3D structure HumanSplice Finder (http://www.umd.be/HSF/, last accessed March 2014) and NetGene2 (http://www.cbs.dtu.dk/cgi-bin/webface?jobid 5netgene2, last accessed March 2014) online tools were used to assess the possible effect of novel intronic mutations on splicing.Ethics statement .The methods were carried out in accordance with the approved guidelines and in accordance with the Helsinki Declaration as revised in 2000.",OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6407 | DOI: 10.1038/srep06407 7",Non-OADS,/arxiv_data1/oa_pdf/2a/05/srep06407.PMC4166712.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6377 | DOI: 10.1038/srep06377 7",Non-OADS,/arxiv_data1/oa_pdf/7f/86/srep06377.PMC4166713.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6337 | DOI: 10.1038/srep06337 8",Non-OADS,/arxiv_data1/oa_pdf/7a/9e/srep06337.PMC4166714.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/b2/TOAIDJ-8-21.PMC4166788.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/42/TOORTHJ-8-268.PMC4166789.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/6c/TODENTJ-8-129.PMC4166790.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/7a/TORJ-8-20.PMC4166791.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and repr oduction in any medium, provided the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/63/TODENTJ-8-136.PMC4166792.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/92/TORJ-8-24.PMC4166793.pdf
Available from: http://www.jyi.org/issue/a-review-of-   quercetin-chemistry-antioxidant -properties-and-bioavailability/   [Last accessed on 2014 Jan 18].,Non-OADS,/arxiv_data1/oa_pdf/35/53/PR-6-285.PMC4166815.pdf
Available from: http://www.atsdr.cdc.gov/COM/cancer.,Non-OADS,/arxiv_data1/oa_pdf/cf/ee/PR-6-350.PMC4166826.pdf
11       http://www.medsci.org  1161  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(11):  1161 -1171.  doi: 10.7150/ijms.,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
11     http://www.medsci.org  1162  reports demonstrated angiographically that CAS was  indeed associated with variant angina [6 -8].,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
"11     http://www.medsci.org  1163  completely occluded, or when a small artery is co m- pletely occluded [30].",Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
11     http://www.medsci.org  1164    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
"11     http://www.medsci.org  1165  [58], sy mpathomimetic agents (epinep hrine, norep i- nephrine, etc.",Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
11       http://www.medsci.org  1166  Autonomic nervous system   It is known that the activity of the parasymp a- thetic nervous system is enhanced at rest and is su p- pressed by physical activity [63].,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
"11     http://www.medsci.org  1167  by antioxidants, such as vitamin C [97 -100], suggest- ing NO could be degraded by oxygen free radicals.",Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
"11     http://www.medsci.org  1168  provocation tests have been proposed, such as hist a- mine, epinephrine, dopamine, dobutamine [27], the  cold pressor test [71], atrial pacing [7], and exercise [129], the intracoronary administration of methyle r- gonovine is the most sensitive and specific method,  and remains safe for CAS diagnosis, as long as pro- cedural safeguards are adhered to.",Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
11     http://www.medsci.org  1169  ing [148].,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
11     http://www.medsci.org  1170  incidence and clinical and coronary arteriographic findings in 138 patients.,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
11     http://www.medsci.org  1171  89.,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
http://www.uptodate.com/contents/variant -angina?source=search_result&search =variant+angina&selectedTitle=1%7E103.,Non-OADS,/arxiv_data1/oa_pdf/b2/e5/ijmsv11p1161.PMC4166862.pdf
"11       http://www.medsci.org  1172  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(11):  1172 -1184.  doi: 10.7150/ ijms.9056  Research Paper   Chlorophytum borivilianum  Root Extract Maintains near  Normal Blood Glucose, Insulin a nd Lipid Profile Levels  and Prevents Oxidative Stress i n the Pancreas o f  Streptozotocin -Induced Adult Male Diabetic Rats   Nelli Giribabu1, Kilari Eswar Kumar2, Somesula Swapna  Rekha3, Sekaran Muniandy4, Naguib Salleh1  1.",Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1173  glyco sylation and accumulation  of advanced gl y- cation end products (AGEs)  [8].,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
"11     http://www.medsci.org  1174  activity, convulsion, gait, bleeding orifices,  touch/pain response)  and autonomic (defecation,  micturition) profiles.",Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1175  Homeostatic Model Assessment (HOMA)   Insulin resistance index ( HOMA -IR) and β-cell  function  index  (HOMA -β cell function) were calc u- lated according to the following formulas [25].,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1176  Statistical Analyses   Statistical differences were evaluated by analysi s  of variance (ANOVA) followed by Duncan's new  multiple ‐range and Student's t ‐tests .,OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11       http://www.medsci.org  1177    Figure 3: A) Effect of C. borivilianum root aqueous extract treatment on HbA1c level in different experimental groups.,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
"11     http://www.medsci.org  1178  Table 1: Effect of C. borivilianum root aqueous extract treatment on serum levels of total cholesterol, triglycerides, HDL, LDL and VLDL  in different experimental groups.",Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11       http://www.medsci.org  1179    Figure 5: Representative high magnification image of pancreas in different experimental groups .,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1180  functioning index (192.33% and 259.74% respectively)  as compa red to non- treated diabetic rats.,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11       http://www.medsci.org  1181  Pancreas CAT Activity Levels   Figure 6C shows the effect of C. borivilianum  root  extract or glibenclamide on pancreas CAT activity  level s in diabetic rats.,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1182  role in preventing pancreas destruction and mai n- tainin g pancreatic  funct ion in diabetes .,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1183  restore body  weight  via stimulating  protein [63] and  lipid syntheses [64] as well as  glycogen storage [65] in  the skeletal muscles.,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
11     http://www.medsci.org  1184  metabolic syndrome among Chinese children and teenagers.,Non-OADS,/arxiv_data1/oa_pdf/ba/ed/ijmsv11p1172.PMC4166863.pdf
"1 1      http://www.medsci.org  1185  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(11):  1185 -1200.  doi: 10.7150/ ijms.10001  Review  Risk F actors Contributing to T ype 2 Diabetes and  Recent A dvance s in the Treatment and Prevention  Yanling Wu1,2, Yanping Ding1,2, Yoshimasa  Tanaka3 and Wen Zhang2  1.",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"11     http://www.medsci.org  1186  when blood glucose levels are not well cont rolled  with diet alone or with oral hypoglycemic drug s. In  addition, people with T2DM are often accompan ied  by complications , such as  cardiovascular diseases,  diabetic neuropathy , nephropathy , and r etinopathy .",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"11     http://www.medsci.org  1187  also therapeutic target s for the extensively used  pharmaceuticals  of T2DM, for example, KCNJ11 and  PPARG2  are targets  of sulphonylurea  and t hiazol i- dinedione  class es of drugs  widely  used for the treat- ment of T2DM, respectively [36, 37].",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"11     http://www.medsci.org  1188  (VDR) activation or indirectly via calcemic hormones  and also via inflammation [ 63, 64 ].",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1189    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1190  tumors i n vitro  and in experimental animals [ 87].,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"11     http://www.medsci.org  1191  Furthermore , it may also have positive effects  on in- flammation, sleep, cardiovascular and hepatic health,  and central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"11     http://www.medsci.org  1192  diabetic agents and insulin are currently used for the  treatment of T2DM and have brought  about promi s- ing outcomes, problems still exist such as inadequate  efficacy and adverse effects .",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1193  cause early onset of hypertension; (3) increase inci- dence of diabetes ; (4) induce kidney dysfunction ; and  (5) produce hypothyroidism [146] .,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"1 1      http://www.medsci.org  1194  Risk assessment   Statisticall y, about 50% of people  with diabetes  remain  undiagnosed  and approximately  20-30% p a- tients usually  have  already developed  complications   before being diagnosed  [157] .",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1195  should be encouraged.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"11     http://www.medsci.org  1196  develop new  therapeutic strategies  in the treatment of  T2DM, with safety and high therapeutic efficacy.",Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1197  53.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1198  118.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1199  glucose tolerance a randomized controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
11     http://www.medsci.org  1200   Dr. Wen Zhang  is a full professor  with 25 years of research and teaching experience in  Bioorganic Chemistry and Chemical Biology.,Non-OADS,/arxiv_data1/oa_pdf/15/c0/ijmsv11p1185.PMC4166864.pdf
"1 1      http://www.medsci.org  1201  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(11):  1201 -1207.  doi: 10.7150/ ijms.8356   Short Research Communication   Oxidative Stress- Induced Premature Senescence in  Wharton’s Jelly -Derived Mesenchymal Stem Cells  Kong Bung Choo1,2, Lihui Tai1, K.Shri Hymavathee1, Chee Yin Wong3, Phan Nguyen Nhi  Nguyen1,Chiu -Jung Huang4, Soon Keng Cheong1,5 and Tunku Kamarul6  1.",Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
"11     http://www.medsci.org  1202  affecting  characteristics of MSC and, hence, curative  effects in clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
"Bhd,  Selangor, Malaysia (http://www.cryocord.com.my).",Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
11     http://www.medsci.org  1203  assay was performed in sub -confluent cultures dis- playing comparable cell density.,OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
11     http://www.medsci.org  1204  shape (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
11     http://www.medsci.org  1205    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
"11     http://www.medsci.org  1206  regenerative applications of BM -MSCs, including r e- pair of cardiovascular muscles, bone and cartilage as  well as in treatment of lung fibrosis and coronary a r- tery disease [ 36-38].",Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
11     http://www.medsci.org  1207  31.,Non-OADS,/arxiv_data1/oa_pdf/c4/8b/ijmsv11p1201.PMC4166865.pdf
Available from http://www.transfusionguidelines.org.,Non-OADS,/arxiv_data1/oa_pdf/7d/cb/aeu086.PMC4166889.pdf
"Available from http://www.aabb.org/resources/bct/Documents/coi0809r.pdf (accessed July 2013) 16 Armand R, Hess JR.",Non-OADS,/arxiv_data1/oa_pdf/7d/cb/aeu086.PMC4166889.pdf
"Available from http://www.transfusionmedicine.ca/sites/transfusionmedicine/ ﬁles/CBS-CGT-BM.pdf (accessed January 2013) 19 Elzik ME, Dirschl DR, Dahners LE.",Non-OADS,/arxiv_data1/oa_pdf/7d/cb/aeu086.PMC4166889.pdf
"Available from http://onlinelibrary.wiley.com/doi/10.1002/9781444323870 .app2/pdf (accessed May 2013) 27 Rahe-Meyer N, Solomon C, Hanke A, et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/cb/aeu086.PMC4166889.pdf
Available from: http://www.asahq.org/For-Members/Standards-Guidelines-and-Statements.aspx (accessed July 2013)BJA Collins et al .,Non-OADS,/arxiv_data1/oa_pdf/7d/cb/aeu086.PMC4166889.pdf
The P. gaboni assembly is available from: ftp://ftp.sanger.ac.uk/pub/pathogens/ Plasmodium/gaboni/Assembly/Version1/.,Non-OADS,/arxiv_data1/oa_pdf/90/04/ncomms5754.PMC4166903.pdf
"The annotated assemblies for the four laboratory clones can be found at the following FTP sites:ftp://ftp.sanger.ac.uk/pub/pathogens/Plasmodium/falciparum/IT_strain/ version_2/June_2012/, ftp://ftp.sanger.ac.uk/pub/pathogens/Plasmodium/ falciparum/DD2/Assembly/V1_morphed, ftp://ftp.sanger.ac.uk/pub/pathogens/Plasmodium/falciparum/7G8/Assembly/V1_morphed, ftp://ftp.sanger.ac.uk/pub/ pathogens/Plasmodium/falciparum/HB3/Assembly/V1_morphed.",Non-OADS,/arxiv_data1/oa_pdf/90/04/ncomms5754.PMC4166903.pdf
"For colouring, we used a PERL script and FigTree (http://tree.bio.ed.ac.uk/software/ﬁgtree/).",OADS,/arxiv_data1/oa_pdf/90/04/ncomms5754.PMC4166903.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/04/ncomms5754.PMC4166903.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Otto, T. D. et al.",Non-OADS,/arxiv_data1/oa_pdf/90/04/ncomms5754.PMC4166903.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5754 ARTICLE NATURE COMMUNICATIONS | 5:4754 | DOI: 10.1038/ncomms5754 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/90/04/ncomms5754.PMC4166903.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/2c/dddt-8-1299.PMC4166905.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1299–1305Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1299Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6790 8Efficacy and safety of immunosuppressive therapy  in the treatment of seronegative hepatitis  associated aplastic anemia  hai-Fei chen* Bin-Xian Xu hong-shi shen* Zheng-Yang li ling-Juan Jin Jie-Qing Tang Jing Wang Jing-Jing Zhu long-Mei Qin Qing-Ya cui Y ong-Ya ren Tian-Qin Wu Department of hematology, 100th  hospital of People’s liberation  army, suzhou, Jiangsu province,  The People’s republic of china *These authors have contributed  equally to this paper correspondence: Tian-Qin Wu Department of hematology, 100th  hospital of People’s liberation  army, Wuqueqiao road 53#, suzhou  city, Jiangsu Province, The People’s  republic of china  Tel +86 0512 6506 3541 email chhf1224@163.co m Journal name: Drug Design, Development and Therapy Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Chen et al Running head recto: Immunosuppressive therapy in the treatment of seronegative hepatitis DOI: http://dx.doi.org/10.2147/DDDT.S67908 Objective:  To investigate the clinical characteristics of seronegative hepatitis-associated aplastic  anemia (AA) (SNHAA) and hepatitis B virus (HBV) infection complicating AA (HBVAA),  and thereby compare the efficacy of immunosuppressive therapy (IST).",Non-OADS,/arxiv_data1/oa_pdf/31/2c/dddt-8-1299.PMC4166905.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDove pres s Drug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/31/2c/dddt-8-1299.PMC4166905.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/2c/dddt-8-1299.PMC4166905.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/7c/dddt-8-1307.PMC4166906.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1307–1314Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1307Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6854 2Superior rejection profile during the first  24 months after heart transplantation under  tacrolimus as baseline immunosuppressive regimen Matthias helmschrott1 Jan Beckendorf1 ceylan akyol1 arjang ruhparwar2 Bastian schmack2 christian erbel1 christian a gleissner1 Mohammadreza  akhavanpoor1 Philipp ehlermann1 T om Bruckner3 hugo a Katus1 andreas O Doesch1 1Department of cardiology,  angiology, Pneumology, University  of heidelberg, heidelberg, germany;  2Department of cardiac surgery,  University of heidelberg, heidelberg,  germany; 3institute for Medical  Biometry and informatics, University  of heidelberg, heidelberg, germany correspondence: andreas O Doesch Medizinische Klinik iii, Kardiologie,  angiologie, Pulmologie, im neuenheimer  Feld 410, 69120 heidelberg, germany Tel +49 6221 56 39 936 Fax +49 6221 56 4105 email andreas.doesch@med.uni- heidelberg.d eJournal name: Drug Design, Development and Therapy Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Helmschrott et al Running head recto: Superior rejection profile with tacrolimus after heart transplantation DOI: http://dx.doi.org/10.2147/DDDT.S68542 Background:  The use of tacrolimus (TAC) in patients after heart transplantation (HTX) has  increased over the last few years.",Non-OADS,/arxiv_data1/oa_pdf/71/7c/dddt-8-1307.PMC4166906.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDove pres s Drug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/71/7c/dddt-8-1307.PMC4166906.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/7c/dddt-8-1307.PMC4166906.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1269–1276Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1269Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5725 8Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
"Or use: http://dvpr.es/WMp28 TUpdate on the clinical utility and practical   use of ropivacaine in Chinese patients Man Li Li wan wei Mei Yuke Tian Department of Anesthesiology, Tongji  Hospital, T ongji Medical College, Huazhong  University of Science and T echnology, wuhan,  People’s Republic of China Correspondence: wei Mei   Department of Anesthesiology,   Tongji Hospital, Tongji Medical   College, Huazhong University of   Science and Technology, Jiefang   Ave 1095, wuhan 430030, People’s Republic  of China   Tel +86 27 8366 3173   Fax +86 27 8373 4643   email wmei@tjh.tjmu.edu.c n Yuke Tian   Department of Anesthesiology,    T ongji Hospital, T ongji Medical College,   Huazhong University of Science and  T echnology, Jiefang   Ave 1095, wuhan 430030,  People’s Republic  of China   T el +86 27 8366 2853   Fax +86 27 8373 4643   email yktian@tjh.tjmu.edu.c nAbstract:  We reviewed the Chinese and English literature for efficacy and tolerability data as  well as pharmacological properties of ropivacaine in Chinese patients.",Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
"Available from: http://www.imshealth.com/ portal/site/imshealt h. Accessed August 13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
Available from:  http://www.astrazeneca.,Non-OADS,/arxiv_data1/oa_pdf/64/13/dddt-8-1269.PMC4166907.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/19/dddt-8-1315.PMC4166908.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1315–1329Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6851 7novel swellable polymer of orchidaceae family  for gastroretentive drug delivery of famotidine Mahboubeh razavi1 shaik nyamathulla1,2 hamed Karimian1 Mohamed ibrahim  noordin1,2 1Department of Pharmacy, Faculty  of Medicine, 2center for natural  Products and Drug Discovery,  Department of chemistry, Faculty  of science, University of Malaya,  Kuala lumpur, Malaysia correspondence: Mahboubeh razavi Department of Pharmacy, Faculty of  Medicine, University of Malaya, Kuala  lumpur 50603, Malaysia Tel +60 3 7967 3194 Fax +60 3 7967 4964 email mahbobehrazavi @gmail.co m Journal name: Drug Design, Development and Therapy Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Razavi et al Running head recto: Polymer of orchidaceae family for gastroretentive delivery of famotidine DOI: http://dx.doi.org/10.2147/DDDT.S68517 Abstract:  This study aimed to develop hydrophilic, gastroretentive matrix tablets of famotidine  with good floating and swelling properties.",Non-OADS,/arxiv_data1/oa_pdf/88/19/dddt-8-1315.PMC4166908.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDove pres s Drug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/88/19/dddt-8-1315.PMC4166908.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/19/dddt-8-1315.PMC4166908.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/97/dddt-8-1277.PMC4166909.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1277–1286Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1277Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6657 3Hydrogen sulfide, a potential novel drug,  attenuates concanavalin a-induced hepatitis Ping cheng* Kan chen* Yujing Xia Weiqi Dai Fan Wang Miao shen chengfen Wang Jing Yang rong Zhu huawei Zhang Jingjing li Yuanyuan Zheng Junshan Wang Yan Zhang Jie lu Yingqun Zhou chuanyong guo Department of gastroenterology,   shanghai T enth People’s hospital,   T ongji University of Medicine,   shanghai, People’s republic of china *These authors contributed equally   to this work correspondence: Yingqun Zhou;  chuanyong guo   Department of gastroenterology,   shanghai Tenth People’s hospital,   Tongji University of Medicine,   shanghai, People’s republic of china   Tel +86 21 6630 2535  Fax +86 21 6630 3983  email guochuanyong@hotmail.co m;  yqzh02@163.co mBackground:  Hydrogen sulfide (H2S) is known to exert anti-inflammatory properties.",Non-OADS,/arxiv_data1/oa_pdf/2d/97/dddt-8-1277.PMC4166909.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2d/97/dddt-8-1277.PMC4166909.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/97/dddt-8-1277.PMC4166909.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/dddt-8-1221.PMC4166910.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1221–1230Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1221Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6734 9Microencapsulation as a novel delivery method  for the potential antidiabetic drug, Probucol armin Mooranian1 rebecca negrulj1 nigel chen-Tan2 hesham s al-sallami3 Zhongxiang Fang4 TK Mukkur5 Momir Mikov6,7 svetlana golocorbin-Kon6,7 Marc Fakhoury8 gerald F Watts9 Vance Matthews10 Frank arfuso5 hani al-salami1 1Biotechnology and Drug Development research  laboratory school of Pharmacy, curtin health  innovation research institute, Biosciences  research Precinct, curtin University, Perth,  Western australia, australia;  2Faculty of science  and engineering, curtin University, Perth,  Western australia, australia;  3school of Pharmacy,  University of Otago, Dunedin, new Zealand;   4school of Public health, curtin University, Perth,  Western australia, australia;  5curtin health  innovation research institute, Biosciences  research Precinct, school of Biomedical science,  curtin University, Perth, Western australia,  australia;  6Department of Pharmacology,  Toxicology and clinical Pharmacology, Faculty  of Medicine, University of novi sad, serbia;   7Department of Pharmacy, Faculty of Medicine,  University of novi sad, serbia;  8Faculty of  Medicine, University of Montreal, Montreal,  Quebec, canada;  9school of Medicine and  Pharmacology, royal Perth hospital, University  of Western australia;  10laboratory for Metabolic  Dysfunction, UW a centre for Medical research,  harry Perkins institute of Medical research,  Perth, Western australia, australia correspondence: hani al-salami   Biotechnology and Drug Development  research laboratory, curtin health innovation  research institute, Biosciences research  Precinct, curtin University, Kent street,  Bentley Wa 6102, Perth,   Western australia, australia   Tel +61 8 9266 9816  Fax +61 8 9266 2769  email hani.al-salami@curtin.edu.a uIntroduction:  In previous studies, we successfully designed complex multicompartmental  microcapsules as a platform for the oral targeted delivery of lipophilic drugs in type  2 diabetes  (T2D).",Non-OADS,/arxiv_data1/oa_pdf/70/1e/dddt-8-1221.PMC4166910.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/70/1e/dddt-8-1221.PMC4166910.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/1e/dddt-8-1221.PMC4166910.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/f6/dddt-8-1287.PMC4166911.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1287–1297Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1287Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6569 6synthesis and characterization of a glycine-   modified heptamethine indocyanine dye for   in vivo cancer-targeted near-infrared imaging Tao liu1 shenglin luo1 Yang Wang1 Xu Tan1 Qingrong Qi2 chunmeng shi1 1institute of combined injury, state  Key laboratory of Trauma, Burns  and combined injury, chongqing  engineering research center for  nanomedicine, college of Preventive  Medicine, Third Military Medical  University, chongqing, People’s  republic of china; 2Key laboratory  of Drug-Targeting and Drug-Delivery  systems of the Ministry of education,   Department of Medicinal chemistry,   West china school of Pharmacy,   sichuan University, chengdu, People’s  republic of china correspondence: chunmeng shi   institute of combined injury,   Third Military Medical University,   30 gaotanyan road, chongqing 400038,   People’s republic of china   email shicm@sina.co mAbstract:  Near-infrared (NIR) fluorescent sensors have emerged as promising molecular tools  for cancer imaging and detection in living systems.",Non-OADS,/arxiv_data1/oa_pdf/a4/f6/dddt-8-1287.PMC4166911.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a4/f6/dddt-8-1287.PMC4166911.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/f6/dddt-8-1287.PMC4166911.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/e8/dddt-8-1257.PMC4166912.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1257–1267Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1257Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6316 3N-n-butyl haloperidol iodide inhibits h2O2-  induced na+/ca2+-exchanger activation via the   na+/h+ exchanger in rat ventricular myocytes Y ong-Pan huang1,* Fen-Fei gao1,* Bin Wang1 Fu-chun Zheng2 Yan-Mei Zhang1 Yi-cun chen1 Zhan-Qin huang1 Yan-shan Zheng1 shu-Ping Zhong3 gang-gang shi1,4 1Department of Pharmacology,   2Department of Pharmacy, First  affiliated hospital, shantou  University Medical college, shantou,   guangdong, People’s republic of  china;  3Department of Biochemistry  and Molecular Biology, University of  southern california, los angeles, ca,   Usa;  4Department of cardiovascular  Diseases, First affiliated hospital,   shantou University Medical college,   shantou, guangdong, People’s  republic of china *These authors contributed equally   to this work correspondence: gang-gang shi   Department of Pharmacology,   shantou University Medical college,   22 Xinling road, shantou,   guangdong  515041, china   Tel +86 754 8890 0301  Fax +86 754 8855 7562  email ggshi@stu.edu.c nAbstract:  N-n-butyl haloperidol iodide (F2), a novel compound, has shown palliative effects in  myocardial ischemia/reperfusion (I/R) injury.",Non-OADS,/arxiv_data1/oa_pdf/04/e8/dddt-8-1257.PMC4166912.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/04/e8/dddt-8-1257.PMC4166912.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/e8/dddt-8-1257.PMC4166912.pdf
"For lineages not represented in the NCBI collection, the rbcL gene sequence from a closely related genus was used as the query sequence to BLASTn against the expressed seque nce tags (ESTs) in PlantGDB (http://www.plantgdb.org/ , last accessed April 28, 2014; supplementary table S1 ,Supplementary Material online).",OADS,/arxiv_data1/oa_pdf/3a/79/msu207.PMC4166922.pdf
Supplementary Material Supplementary ﬁgures S1–S8 and tables S1–S4 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/3a/79/msu207.PMC4166922.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/dc/msu209.PMC4166923.pdf
"Source code and bina ries (Windows, OSX, and Linux) are available at https://github.com/ szpiech/selscan .",OADS,/arxiv_data1/oa_pdf/1c/b4/msu211.PMC4166924.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/b4/msu211.PMC4166924.pdf
"In addition, wecompare performance on these statistics with the programs rehh (Gautier and Vitalis 2012 ,http://cran.r-project.org/ package ¼rehh , last accessed July 16, 2014), ihs (Voight et al.2006 ), and xpehh (Pickrell et al .2009 ).",OADS,/arxiv_data1/oa_pdf/1c/b4/msu211.PMC4166924.pdf
Both ihs and xpehh are available for download at http://hgdp.uchicago.,Non-OADS,/arxiv_data1/oa_pdf/1c/b4/msu211.PMC4166924.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/msu223.PMC4166929.pdf
Available from: http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/fb/b2/msu223.PMC4166929.pdf
"Recent advances inourunderstanding ofStreptococcus pneumoniae infection Charles Feldman1*andRonald Anderson2 Addresses:1Division ofPulmonology, Department ofInternal Medicine, Charlotte Maxeke Johannesburg Academic Hospital andFaculty of Health Sciences, University oftheWitwatersrand, 7York Road, Parktown, 2193, Johannesburg, South Africa;2Department ofImmunology, Faculty ofHealth Sciences, University ofPretoria, 5Bophela Road, Arcadia, Pretoria, 0083, South Africa *Corresponding author: Charles Feldman (charles.feldman@wits.ac.za) F1000Prime Reports 2014, 6:82(doi:10.12703/P6-82) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/82 Abstract Anumber ofsignificant challenges remain with regard tothediagnosis, treatment, andprevention of infections with Streptococcus pneumoniae (pneumococcus), which remains themost common bacterial cause ofcommunity-acquired pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Major pneumococcal virulence factors Factor Activity Polysaccharide capsule Attachment to respiratory epithelial cells (pro-adhesive), evasion of hostdefenses Hydrogen peroxide Pro-invasive, evasion of host defenses Pneumolysin Pro-invasive, evasion of host defenses Pneumococcal surface adhesin C Pro-adhesive, pro-invasive, evasion of host defenses Pneumococcal surface protein A Evasion of host defensesPneumococcal surface protein C Pro-adhesive, pro-invasive, evasion of host defenses Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"If inappropriately activated, however, these same Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Somewhat disappointingly, however, the promiseof this adjunctive strategy has not been confirmed in onelarge, randomized, double-blinded, placebo-controlled trial in adults with severe CAP [64] or in another large Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Although thisappears to have been an issue with first-generation PCVs,specifically PCV7 [78], it is likely to be less so with the Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Li M, Zhong X, He Z, Wen M, Li J, Peng X, Liu G, Deng J, Zhang J, Bai J: Effect of erythromycin on cigarette-induced histone deacetylase protein expression and nuclear factor- kB activity Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
[http://www.pfizer.com/news/press- release-detail/pfizer] 78.,Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:82 http://f1000.com/prime/reports/m/6/82",Non-OADS,/arxiv_data1/oa_pdf/61/aa/medrep-06-82.PMC4166932.pdf
"Leptin signaling Hyeong-Kyu Park1and Rexford S.Ahima2* Addresses:1Department ofInternal Medicine, Soonchunhyang University College ofMedicine, 22,Daesagwan-gil (657 Hannam-dong), Yongsan-gu, Seoul, Korea;2Division ofEndocrinology, Diabetes andMetabolism, andtheInstitute forDiabetes, Obesity andMetabolism, Department ofMedicine, Perelman School ofMedicine attheUniversity ofPennsylvania, 12-104 Smilow Center forTranslational Research, 3400 Civic Center Boulevard, Building 421, Philadelphia, Pennsylvania 19104, USA *Corresponding author: Rexford S.Ahima (ahima@mail.med.upenn.edu) F1000Prime Reports 2014, 6:73(doi:10.12703/P6-73) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/73 Abstract Leptin issecreted byadipose tissue andregulates energy homeostasis, glucose andlipid metabolism, immune function, andother systems.",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Together, these data Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:73 http://f1000.com/prime/reports/b/6/73",Non-OADS,/arxiv_data1/oa_pdf/3d/6f/biolrep-06-73.PMC4166933.pdf
"Recent advances intheunderstanding ofacute kidney injury Florian Tögel1andChristof Westenfelder2,3* Addresses:1Division ofRenal (Kidney) Medicine, Brigham andWomen ‘sHospital, 45Francis Street, Boston, MA02115, USA;2Department of Medicine, Division ofNephrology, Department ofPhysiology, University ofUtah, SaltLake City, UT,USA;3George E.Wahlen VAHSC Medical Center, 500Foothill Boulevard, SaltLake City, UT84148, USA *Corresponding author: Christof Westenfelder (christof.westenfelder@hsc.utah.edu) F1000Prime Reports 2014, 6:83(doi:10.12703/P6-83) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/m/6/83 Abstract Acute kidney injury (AKI) isacommon clinical entity associated with high morbidity andmortality andclinical costs.,Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"Thefewdata available Page 2of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:83 http://f1000.com/prime/reports/m/6/83",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:83 http://f1000.com/prime/reports/m/6/83",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"These defects contribute to continuous tissue damage by hypoxia as a result of micro-vessel Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:83 http://f1000.com/prime/reports/m/6/83",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"National Institute for Health and Care Excellence (NICE): Acute kidney injury: prevention, detection and management of acute kidney injury up to the point of renal replacement therapy; 2013, [http://www.nice.org.uk/guidance/cg169/resources/ cg169-acute-kidney-injury-costing-statement2] 3.",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:83 http://f1000.com/prime/reports/m/6/83",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:83 http://f1000.com/prime/reports/m/6/83",Non-OADS,/arxiv_data1/oa_pdf/15/f5/medrep-06-83.PMC4166934.pdf
"Advances inmanaging ankylosing spondylitis David I.Daikh1,2*andPatty P.Chen1 Addresses:1Division ofRheumatology, University ofCalifornia, SanFrancisco, 400 Parnassus Avenue, SanFrancisco, CA94143, USA; 2SanFrancisco VAMedical Center, 4150 Clement Street, SanFrancisco, CA94121, USA *Corresponding author: David I.Daikh (david.daikh@ucsf.edu) F1000Prime Reports 2014, 6:78(doi:10.12703/P6-78) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/78 Abstract Ankylosing spondylitis (AS) isachronic inflammatory disease with prominent involvement ofthe spine andsacroiliac joints which frequently leads tosignificant spine deformity anddisability.,Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Patient education and counselingabout abstinence and smoking cessation are also key non-pharmacologic interventions for AS because cigarette Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"In the TNF- ainhibitor-naïve group, 50% achieved ASAS20 response (at least 20% improvementin the ASAS response criteria), 40% achieved ASAS40response (at least 40% improvement in the ASAS response criteria), 30% achieved partial remission based on ASAS Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Ongoing studies Several current studies could help identify new targetsand novel indications for established treatments in AS.Tofacitinib is an orally bioavailable small-molecule JAK Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Poddubnyy D,Haibel H,Listing J,Märker-Hermann E,Zeidler H, Braun J,Sieper J,Rudwaleit M:Baseline radiographic damage, elevated acute-phase reactant levels, andcigarette smoking Page 6of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Haibel H, Rudwaleit M, Listing J, Heldmann F, Wong RL, Kupper H, Braun J, Sieper J: Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:78 http://f1000.com/prime/reports/m/6/78",Non-OADS,/arxiv_data1/oa_pdf/05/5f/medrep-06-78.PMC4166936.pdf
"Carbapenemase-producing Klebsiella pneumoniae Elizabeth Robilotti* andStan Deresinski Address: Department ofMedicine, Division ofInfectious Diseases, Stanford University School ofMedicine, 300 Pasteur Drive, Stanford, CA94305, USA *Corresponding author: Elizabeth Robilotti (robilotti@stanford.edu) F1000Prime Reports 2014, 6:80(doi:10.12703/P6-80) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/80 Abstract The continuing emergence ofinfections duetomultidrug resistant bacteria isaserious public health problem.,Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Change in the Clinical and Laboratory Standards Institute interpretive carbapenem breakpoints Carbapenem Previous Breakpoints (M100-S19) MIC ( mg/ml)Current Breakpoints (M100-S22) MIC ( mg/ml) Susceptible Intermediate Resistant Susceptible Intermediate Resistant Doripenem - - - ≤12 ≥4 Ertapenem ≤24 ≥8 ≤0.5 1 ≥2 Imipenem ≤48 ≥16 ≤12 ≥4 Meropenem ≤48 ≥16 ≤12 ≥4 Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Of205 patients with CR-KP bloodstream infection seen at Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"One proposed mechanism ofaction is as follows: the least potent carbapenem against Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
[http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf] 3.,Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
[http://www.cdc.gov/hai/pdfs/cre/cre-guidance-508.pdf] 12.,Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
[http://www.cdc.gov/HAI/settings/lab/kpc-ndm1-lab- protocol.html] 14.,OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG: Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
[http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html] 30.,Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Oliva A, D ’Abramo A, D ’Agostino C, Iannetta M, Mascellino MT, Gallinelli C, Mastroianni CM, Vullo V: Synergistic activity and effectiveness of a doubl e-carbapenem regimen in Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:80 http://f1000.com/prime/reports/m/6/80",Non-OADS,/arxiv_data1/oa_pdf/ef/c4/medrep-06-80.PMC4166937.pdf
"Prevention andmanagement ofpelvic organ prolapse Ilias Giarenis andDudley Robinson* Address: Department ofUrogynaecology, King ’sCollege Hospital, Denmark Hill, London, SE59RS, UK *Corresponding author: Dudley Robinson (dudley.robinson@nhs.net) F1000Prime Reports 2014, 6:77(doi:10.12703/P6-77) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/77 Abstract Pelvic organ prolapse isahighly prevalent condition inthefemale population, which impairs the health-related quality oflifeofaffected individuals.",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"Risk factors and pelvic organ prolapse Demographics Age Postmenopausal status Obstetric factors Parity Vaginal deliveryInstrumental vaginal delivery Pelvic surgery Hysterectomy Pelvic organ prolapse surgery Colposuspension Rectopexy Bowel dysfunction Chronic constipation Defecatory straining Connective tissue disorders Ehlers-Danlos/Benign joint hypermobility syndromeMarfan syndrome Lifestyle factors Obesity Smoking : Chronic ObstructivePulmonary DiseaseHigh-impact exercisePhysically strenuous (manual)occupation Genetics Family history White Caucasian, Asian race Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"A decision-analytic Markov model, examining thecost-utility of anterior repair augmented with syntheticmesh, compared with non-mesh repair, suggests that the Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"It is associated with similar anatomic and functional outcomes, but with a longer Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"Barber MD, Brubaker L,Burgio KL, Richter HE, Nygaard I, Weidner AC, Menefee SA, Lukacz ES, Norton P,Schaffer J, Nguyen JN, Borello-France D,Goode PS, Jakus-Waldman S, Spino C,Warren LK, Gantz MG, Meikle SF:Comparison of2 transvaginal surgical approaches and perioperative Page 6of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"Halaska M, Maxova K, Sottner O, Svabik K, Mlcoch M, Kolarik D, Mala I, Krofta L, Halaska MJ: A multicenter, randomized, prospective, controlled study comparing sacrospinous Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:77 http://f1000.com/prime/reports/m/6/77",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/medrep-06-77.PMC4166938.pdf
"5, 40225 Düsseldorf, Germany *Corresponding author: Hans Werner Müller (hanswerner.mueller@uni-duesseldorf.de) F1000Prime Reports 2014, 6:84(doi:10.12703/P6-84) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/84 Abstract Inthelastcentury, research inthefield ofspinal cord trauma hasbrought insightful knowledge which hasledtoadetailed understanding ofmechanisms that areinvolved ininjury- andrecovery-related processes.",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"Questions of age and timing Regeneration studies are generally performed in youngadult animals, whereas the SCI epidemiology shows that there is an increased incidence at older ages [62] in Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:84 http://f1000.com/prime/reports/m/6/84",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"different injury models Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:84 http://f1000.com/prime/reports/m/6/84",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"Page 4of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:84 http://f1000.com/prime/reports/m/6/84",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:84 http://f1000.com/prime/reports/m/6/84",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:84 http://f1000.com/prime/reports/m/6/84",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
[http://www.cnr.de]94.,Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
[http://www.proneuron.com] 98.,Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:84 http://f1000.com/prime/reports/m/6/84",Non-OADS,/arxiv_data1/oa_pdf/37/98/medrep-06-84.PMC4166939.pdf
"Histone modifications andachoice ofvariant: alanguage that helps thegenome express itself Zachary A.Gurard-Levin1,2,3,4,5*andGeneviève Almouzni1,2,3,4,5* Addresses:1Institut Curie, Centre deRecherche, Paris, F-75248, France;2CNRS, UMR3664, Paris, F-75248, France;3Équipe Labellisée Ligue contre leCancer, UMR3664, Paris, F-75248, France;4UPMC, UMR3664, Paris, F-75248, France;5Sorbonne University, PSL, Paris, France *Corresponding authors: Zachary A.Gurard-Levin (zachary.gurard-levin@curie.fr); Geneviève Almouzni (genevieve.almouzni@curie.fr) F1000Prime Reports 2014, 6:76(doi:10.12703/P6-76) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/b/6/76 Abstract Covalent post-translational modifications onhistones impact chromatin structure andfunction.,Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
A useful systematic analysis of nearly 200 antibodies using a standardized method employed by the ENCODE consortium is available online [43] (see http://compbio.med.harvard.edu/antibodies/).,OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Exploiting epitope-tagged histone var-iants in order to purify soluble histone complexes [65]revealed that different pools of non-nucleosomal Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Notably, it is important to considerinstances where histones do not have the capacity to bearthe same modifications either due to mutations [88-91] orthe presence of variants, such as the centromeric H3 variant Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Page 5of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Brownell JE,Zhou J,Ranalli T,Kobayashi R,Edmondson DG, Roth SY, Allis CD: Tetrahymena histone acetyltransferase A: Page 6of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Neumann H, Hancock SM, Buning R, Routh A, Chapman L, Somers J, Owen-Hughes T, van Noort J, Rhodes D, Chin JW: A method for genetically installing site-specific acetylation in recombinant Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y: Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:76 http://f1000.com/prime/reports/b/6/76",Non-OADS,/arxiv_data1/oa_pdf/1f/58/biolrep-06-76.PMC4166940.pdf
"Known unknowns forallele-specific expression andgenomic imprinting effects Christopher Gregg1,2 Addresses:1Department ofNeurobiology &Anatomy andHuman Genetics, University ofUtah School ofMedicine, 323Wintrobe Bldg 530, University ofUtah, School ofMedicine, 20North 1900 East, SaltLake City, UT84132-3401 USA;2TheNew York Stem Cell Foundation, 178Columbus Avenue #237064, New York, NY10023, USA Email: chris.gregg@neuro.utah.edu F1000Prime Reports 2014, 6:75(doi:10.12703/P6-75) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/75 Abstract Recent studies have provided evidence fornon-canonical imprinting effects that areassociated with allele-specific expression biases atthetissue level inmice.,Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"These pioneering studies have fundamentally changed ourunderstanding ofgene Page 4of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Importantly, all of the genes thatexhibit the canonical imprinting effects I have detailedhere have been identified in the mouse genome.However, although canonical imprinted genes exhibit allele silencing, a growing list of genes in the genome Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"For example, Dlk1 is imprinted in most cells that express the gene in the Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Blagitko N, Mergenthaler S, Schulz U, Wollmann HA, Craigen W, Eggermann T, Ropers HH, Kalscheuer VM: Human GRB10 is Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:75 http://f1000.com/prime/reports/b/6/75",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/biolrep-06-75.PMC4166941.pdf
"Membrane tethering PeiZhiCheryl Chia1andPaul A.Gleeson2* Addresses:1National Institute ofDental andCraniofacial Research, National Institutes ofHealth, 30Convent Drive, Bethesda, MD20892-4340, USA;2TheDepartment ofBiochemistry andMolecular Biology andBio21 Molecular Science andBiotechnology Institute, 30Flemington Road, TheUniversity ofMelbourne, Victoria 3010, Australia *Corresponding author: Paul A.Gleeson (pgleeson@unimelb.edu.au) F1000Prime Reports 2014, 6:74(doi:10.12703/P6-74) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/74 Abstract Membrane trafficking depends ontransport vesicles andcarriers docking andfusing with thetarget organelle forthedelivery ofcargo.,OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 2 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 3 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 4 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"The mammalian TRAPPII complexis associated with COPI-coated vesicular structures andbinds to the COP coat adaptor subunit g1COP [71,75], and as expected from the characteristics of the yeastTRAPP complexes, the mammalian TRAPPII complex has GEF activity for the mammalian Ypt1 homologue, Page 5 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 6 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"The emerging view isthat HOPS tethers bybinding Ytp7p/Rab7 ononemembrane and Page 7of14 (page number notforcitation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 8 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Grabski R, Balklava Z, Wyrozumska P, Szul T, Brandon E, Alvarez C, Holloway ZG, Sztul E: Identification of a functional domain within the p115 tethering factor that is required for Golgi Page 9 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Sacher M, Jiang Y, Barrowman J, Scarpa A, Burston J, Zhang L, Schieltz D, Yates JR, Abeliovich H, Ferro-Novick S: TRAPP, a highly Page 10 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 11 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 12 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Sivaram, Mylavarapu V S, Furgason, Melonnie L M, Brewer DN, Munson M: The structure of the exocyst subunit Sec6p defines Page 13 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Page 14 of 14 (page number not for citation purposes)F1000Prime Reports 2014, 6:74 http://f1000.com/prime/reports/b/6/74",Non-OADS,/arxiv_data1/oa_pdf/92/81/biolrep-06-74.PMC4166942.pdf
"Epidemiology ofinvasive fungal diseases onthebasis of autopsy reports María Cecilia Dignani1-3 Addresses:1Registro deMicosis Invasoras REMIIN (Invasive Mycoses ’Registry), Yerbal 315App 2B,1405, Buenos Aires, Argentina;2Argentinean Society ofInfectious Diseases, Av.DeMayo 1370, Floor 11th,Of.300, 1085, Buenos Aires, Argentina;3Italian Hospital ofMendoza, East Access 1070, SanJosé, 5519, Mendoza, Argentina Email: mcdignani@remiin.com F1000Prime Reports 2014, 6:81(doi:10.12703/P6-81) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/81 Abstract Invasive fungal diseases (IFDs) areamajor cause ofmorbidity andmortality among immunocompromised patients andcost tohealth services.,Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
"(28 –37 %), while the third and fourth places belong to Cryptococcus Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:81 http://f1000.com/prime/reports/m/6/81",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:81 http://f1000.com/prime/reports/m/6/81",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:81 http://f1000.com/prime/reports/m/6/81",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:81 http://f1000.com/prime/reports/m/6/81",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:81 http://f1000.com/prime/reports/m/6/81",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:81 http://f1000.com/prime/reports/m/6/81",Non-OADS,/arxiv_data1/oa_pdf/fb/2f/medrep-06-81.PMC4166943.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/17/srep06415.PMC4166945.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : Yes, there is potential Competing Interest.",Non-OADS,/arxiv_data1/oa_pdf/0d/a9/srep06406.PMC4166948.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6406 | DOI: 10.1038/srep06406 11",Non-OADS,/arxiv_data1/oa_pdf/0d/a9/srep06406.PMC4166948.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cb/6f/srep06376.PMC4166949.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6376 | DOI: 10.1038/srep06376 7",Non-OADS,/arxiv_data1/oa_pdf/cb/6f/srep06376.PMC4166949.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 963–974International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  963OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S6728 3Chronic respiratory diseases and risk factors   in 12 regions of the russian Federation alexander g Chuchalin1 nikolai Khaltaev2 nikolay s antonov1 Dmitry V galkin3 leonid g Manakov4 Paola antonini5 Michael Murphy5 alexander g solodovnikov6 Jean Bousquet7  Marcelo hs Pereira8 Irina V Demko9 1Institute of Pulmonology, Federal  Medical and Biological agency,  Moscow, russia; 2global alliance  against Chronic respiratory Diseases  (garD), genève, switzerland;  3glaxo smithKline, Moscow, russia;  4Far eastern scientific Center  of Physiology and Pathology of  respiration ras (russian academy  of sciences), Blagoveshchensk, russia;  5Worldwide Clinical Trials, King  of Prussia, P a, Usa; 6Worldwide  Clinical Trials, ekaterinburg, russia;  7Institut national de la santé et de  la recherche Médicale, Montpellier,  France; 8research and Development  Chief Medical Office, International  Medical, glaxo smithKline, london,  United Kingdom; 9Krasnoyarsk state  Medical University, Krasnoyarsk,  russia Correspondence: alexander g Chuchalin   Institute of Pulmonology, Federal   Medical and Biological agency,   11th Parkovaya, 32, 105077,   Moscow, russia   T el +7 495 465 5264   Fax +7 495 465 5264   email chuchalin@inbox.r uBackground:  Estimation suggests that at least 4 million people die, annually, as a result of  chronic respiratory disease (CRD).",Non-OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
"Available from: http://www.whiar.org/docs/ARIA_PG_08_View_ WM.pd f. Accessed July 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report2014_Feb07.pd f. Accessed July 17, 2014.",OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
Available from:  http://www.ginasthma.org/local/uploads/files/GINA_Report_March13.,OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/3f/copd-9-963.PMC4166963.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/d8/imcrj-7-123.PMC4166964.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 123–125International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  123Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/ 10.2147/IMCRJ.S6210 0Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/5a/d8/imcrj-7-123.PMC4166964.pdf
"Or use: http://dvpr.es/1sR7i9 BWarfarin-induced deep vein thrombosis Khalid a Binymin1 Magda Nasher2 Dipti patel2 1Liverpool University, Medical  school, england, UK; 2southport and  ormskirk NH s trust, southport  District General Hospital, Kew, UK Correspondence: Khalid Binymin   Liverpool University, southport Hospital,  Kew, southport, pR8 6pN england, UK   tel +44 017 045 574 71   email kbinymin@nhs.ne tAbstract:  We are presenting a 72-year-old female who was admitted to hospital with deep  vein thrombosis (DVT).",Non-OADS,/arxiv_data1/oa_pdf/5a/d8/imcrj-7-123.PMC4166964.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/5a/d8/imcrj-7-123.PMC4166964.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/d8/imcrj-7-123.PMC4166964.pdf
"This is an Open Access article distributed under the termsof the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/ac/ciu450.PMC4166980.pdf
Available at: http://www.cdc.gov/std/stats11/msm.htm .A c - cessed 14 April 2014.,OADS,/arxiv_data1/oa_pdf/f9/ac/ciu450.PMC4166980.pdf
Available at: http://www.gilead.com/approximately/media/Files/pdfs/medicines/hiv/truvada/truvada_pi.PDF .,Non-OADS,/arxiv_data1/oa_pdf/f9/ac/ciu450.PMC4166980.pdf
"This is an Open Access article distributed under the termsof the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/54/ciu477.PMC4166983.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 371–380Journal of Multidisciplinary Healthcare Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
Or use: http://dvpr.es/1oEiO4 VDove press submit your manuscript | www.dovepress.co m Dove press  371ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S6669 3Implementation of an electronic surgical referral  service.,Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
Data from the  national waiting list register was extracted ( http://www.fritt - sykehusvalg.no/start /) to perform this analysis.,OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
Available from: http://www.cadth.ca/ en/publication/296 2.,Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
"http://www.dnb.no/en/currencylist?la=EN&site=DNB_N O; apersonal communication (September 1, 2010) North  Norwegian Health Administration (JN):  828 NOK per travel =88 £ per travel; blocal data: Based on a mean salary of  102 £ (965 NOK)/hour for a hospital physician, and a mean  salary for administrative personnel of  40 £.",OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
Reimbursement and DRG weighting in Norwegian Hospitals   2012: http://www.helsedirektoratet.no/publikasjoner/regelverk-innsatsstyrt-finansiering-2012/Sider/default.asp x.,OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
"1 DRG weight:  38,209 NOK; Outpatient consultation (day and  night-time): DRG  923, weight  0.017; Cost of hernia surgery: DRG  1,62O, weight  0.275: 1,119 £; Cost of cholecystectomy: DRG  4,94O, weight  0,482: 1,961 £; Cost of sinus  pilonidalis: DRG  1,58O, weight  0,201: 817 £; iEstimated from a median income of  276,000 NOK/year/patient as reported by Statistics in Norway: http://www.ssb.no/english /.",Non-OADS,/arxiv_data1/oa_pdf/5c/b7/jmdh-7-371.PMC4167028.pdf
http://dx.doi.org/10.1016/j.rinphs.2012.10.001,OADS,/arxiv_data1/oa_pdf/af/90/main.PMC4167178.pdf
http://dx.doi.org/10.1016/j.rinphs.2012.09.001,Non-OADS,/arxiv_data1/oa_pdf/de/47/main.PMC4167179.pdf
http://dx.doi.org/10.1016/j.rinphs.2012.09.002,Non-OADS,/arxiv_data1/oa_pdf/0b/ff/main.PMC4167180.pdf
"Communicative & Integrative Biology 2014;  7:e27984; http://dx.doi.org/10.4161/cib.27984 Addendum to: Chaumont S, Andre C, Perrais  D, Boue-Grabot E, Taly A, Garret M. Agonist- dependent endocytosis of gamma-aminobu - tyric acid type A (GABAA) receptors revealed  by a gamma2(R43Q) epilepsy mutation.",Non-OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Neuron  2013; 80:691-703;  PMID:24183020 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Neuron 2011; 70:385-409;  PMID:21555068 ;  http://dx.doi.org/10.1016/j.neuron.2011.03.024 3.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Curr Opin  Neurobiol 2010; 20:550-6;  PMID:20650630 ;  http://dx.doi.org/10.1016/j.conb.2010.06.001 4.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Nat Rev Neurosci 2008; 9:331- 43; PMID:18382465 ; http://dx.doi.org/10.1038/ nrn2370 7.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Proc Natl Acad Sci U S A 2004; 101:12736-41;   PMID :15310851 ; http://dx.doi.org/10.1073/ pnas.0401860101 8.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Results Probl  Cell Differ 2008; 44:1-28;  PMID:17549438 ;  http://dx.doi.org/10.1007/400_2007_039 9.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
J Neurosci 2012; 32:2485- 98; PMID:22396422 ; http://dx.doi.org/10.1523/ JNEUROSCI.1622-11.201110.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Nat Neurosci  2001; 4:794-802;  PMID:11477425 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Proc Natl Acad Sci U S A 2007; 104:17536- 41; PMID:17947380 ; http://dx.doi.org/10.1073/ pnas.0708440104 14.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Nat Genet 2001; 28:49- 52; PMID:11326275 ; http://dx.doi.org/10.1038/ ng0501-49 15.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Annu  Rev Neurosci 2003; 26:599-625;  PMID:14527270 ;  http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
J Biol  Chem 2013; 288:28254-65;  PMID:23935098 ;  http://dx.doi.org/10.1074/jbc.M113.470807 17.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Nature  1999; 397:69-72;  PMID:9892355 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Trends Mol Med  2008; 14:93-102;  PMID:18262468 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Nature 2006;  440:448-55;  PMID:16554804 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
J Biol Chem 2004; 279:47034-9;   PMID:15342642 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Proc Natl Acad Sci U S A 2006; 103:16965-70;   PMID:17077146 ; http://dx.doi.org/10.1073/ pnas.0607477103 24.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Trends Pharmacol Sci  2010; 31:161-74;  PMID:20096941 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
J Physiol 2010; 588:587- 96; PMID:19933751 ; http://dx.doi.org/10.1113/ jphysiol.2009.183137 27.,Non-OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
Biochim  Biophys Acta 2011; 1808:667-73;  PMID:21126507 ;  http://dx.doi.org/10.1016/j.bbamem.2010.11.022,OADS,/arxiv_data1/oa_pdf/10/dd/cib-7-e27984.PMC4167410.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/ac/btt-8-221.PMC4167485.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2014:8 221–226Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  221Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5095 1New product development with the innovative  biomolecular sublingual immunotherapy  formulations for the management of allergic rhinitis Franco Frati1 Lorenzo Cecchi2,3 enrico Scala4 erminia Ridolo5 ilaria Dell’Albani1 eleni Makrì6 Giovanni Pajno7 Cristoforo incorvaia6 1Medical and Scientific Department,   Stallergenes, Milan, italy;  2interdepartmental Centre of  Bioclimatology, University of Florence,   Florence, italy; 3Allergy and Clinical  immunology Section, Azienda Sanitaria  di Prato, Prato, italy; 4experimental  Allergy Unit, iDi-iRCCS, Rome,   italy; 5Department of Clinical and  experimental Medicine, University  of Parma, Parma, italy; 6Allergy/ Pulmonary Rehabilitation, iCP  Hospital, Milan, italy; 7Department of  Pediatrics, Allergy Unit, University of  Messina, Messina, italy Correspondence: Franco Frati   Medical and Scientific Department,  Stallergenes, via Tibullo  2, 20151,   Milan, italy   Tel +39 023 345 4327  Fax +39 027 005 8778  email ffrati@stallergenes.i tAbstract:  The molecular allergy technique, currently defined as component-resolved diagnosis,  significantly improved the diagnosis of allergy, allowing for differentiation between molecules  actually responsible for clinical symptoms (genuine sensitizers) and those simply cross-reacting  or shared by several sources (panallergens), thus influencing the appropriate management of a  patient’ s allergy.",Non-OADS,/arxiv_data1/oa_pdf/2d/ac/btt-8-221.PMC4167485.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/2d/ac/btt-8-221.PMC4167485.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2d/ac/btt-8-221.PMC4167485.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/7e/nihms627201.PMC4167819.pdf
© 2012 The Authors This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License (CC-BY-NC-ND; http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode ).,Non-OADS,/arxiv_data1/oa_pdf/e4/e1/nihms-409838.PMC4167904.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Extended Results, Extended Experimental Procedures, six figures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2012.08.042 .",OADS,/arxiv_data1/oa_pdf/e4/e1/nihms-409838.PMC4167904.pdf
Architecture of the κB Sites in NF- κBB Target Gene Promoters We next investigated the promoters of NF- κB target genes from published literature and a database ( http://bioinfo.lifl.fr/NF-KB/ ) that has compiled promoters for over 100 mouse/ human NF- κB target genes.,OADS,/arxiv_data1/oa_pdf/e4/e1/nihms-409838.PMC4167904.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium,provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
"Available at: https://secure.cihi.ca/estore/productFamily.htm?locale=fr&pf=PFC105&lang=fr&media=0.2 Chevreul K, Durand-Zaleski I, Bahrami S, et al.",OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
Available at: http://www.drees.,Non-OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
Available at: http://www.insee.fr/.,Non-OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
Available at: http://www.sante.gouv.fr/IMG/pdf/Prevention_bu cco-dentaire_chez_les_personnes_agees.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
2000 (cited 2012).Available at: http://www.bsdh.org.uk/guidelines/domicil.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/eurpub/ckt199 Advance Access published on 14 February 2014 .................. ................... ................... .................. ................ ............... Association of physical activity with future mental health in older, mid-life and younger women Amanda Griffiths1, Anne Kouvonen2,3, Jaana Pentti4, Tuula Oksanen4, Marianna Virtanen4, Paula Salo4,5, Ari Va ¨a¨na¨nen4, Mika Kivima ¨ki4,6,7, Jussi Vahtera4,8 1 Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, UK 2 School of Sociology, Social Policy & Social Work, Queen’s University Belfast, Belfast, UK3 UKCRC Centre of Excellence for Public Health (NI), Queen’s University Belfast, Belfast, UK4 Finnish Institute of Occupational Health, Helsinki and Turku, Finland5 Department of Psychology, University of Turku, Turku, Finland6 Department of Epidemiology and Public Health, University College London, London, UK 7 Institute of Behavioral Sciences, University of Helsinki, Helsinki, Finland 8 Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland Correspondence: Amanda Griffiths, Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, YANG Fujia Building, Jubilee Campus, Wollaton Road, Nottingham NG8 1BB, UK, Tel: +44 115 846 6637,Fax: +44 115 846 6625, e-mail: amanda.griffiths@nottingham.ac.uk Background: Mental ill-health, particularly depression and anxiety, is a leading and increasing cause of disability worldwide, especially for women.",Non-OADS,/arxiv_data1/oa_pdf/a4/43/ckt179.PMC4168041.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.qualityindicators.ahrq.gov/modules/pqi_overview.aspx.,Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb36.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at:http://www.hcup-us.ahrq.gov/reports/statbriefs/sb83.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
"Potentially avoidable hospitalizations in Tennesse Available at: http://www.memphis.edu/mlche/pdfs/hospitalizations/issuebriefpah- sinshelbytn2009may042012.pdf, 2009.",Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb61.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb99.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
2005.Available at: http://www.ct.gov/dph/lib/dph/ohca/publications/acsc_databook00-04.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.dshs.state.tx.us/ THCIC/Publications/Hospitals/PQIReport2008/PreventableHospitalizations2008.shtm.,Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.salute.gov.it/ricoveriOspedalieri/newsRicoveriOspedalieri.jsp?id=1428&menu=inevidenza&lingua=italiano.,Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.salute.gov.it/ricoveriOspedalieri/ricoveriOspedalieri.jsp.,Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at:http://www.qualityindicators.ahrq.gov/Downloads/Modules/PQI/V43/Composite_User_Technical_Specification_PQI_4.3.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://arxiv.org/pdf/1205.3519.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://www.ahrq.gov/research/findings/nhqrdr/nhqr11/nhqr11.pdf.,OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
Available at: http://dx.doi.org/10.1787/health_glance-2011-en.,Non-OADS,/arxiv_data1/oa_pdf/5b/0f/ckt203.PMC4168043.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium,provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/13/cku026.PMC4168044.pdf
"Available at: http://www.carersuk.org/media/k2/attachments/Valuing_carers_2011___Carers_UK.pdf (13 January 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/79/13/cku026.PMC4168044.pdf
"Available at: http://www.nia.nih.gov/health/publication/why-population-aging-matters-global-perspective/trend-3-rising-numbers-oldest-old (13 January2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/79/13/cku026.PMC4168044.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium,provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/c4/cku089.PMC4168045.pdf
"Available at: http://www.unrwa.org/Accessed (21 November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e1/c4/cku089.PMC4168045.pdf
"Availableat: http://www.childinfo.org/files/MICS4_Lebanon-Palestinians_FinalReport_2011_ Ar.pdf (21 October 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e1/c4/cku089.PMC4168045.pdf
"Available at: http://www.anera.org/refugeereport/ (12 December 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e1/c4/cku089.PMC4168045.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ The Supplementary Information that accompanies this paper is available on the Immunology and Cell Biology website (http://www.nature.com/icb)Identiﬁcation of fungus-speciﬁc Tr1 cells in humans and mice TB e d k e et al 670 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/8e/e6/icb201434a.PMC4168117.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Preparedness for Prevention of Ebola Virus Disease Eung Soo Hwang Department of Microbiology and Immunology, Seoul National University College of Medicine, and Institute of Endemic Diseases, Seoul National University Medical  Research Center, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.9.1185  • J Korean Med Sci 2014; 29: 1185 Ebola virus (EBOV) is the causative agent of Ebola virus disease  (EVD; formerly known as Ebola hemorrhagic fever).",Non-OADS,/arxiv_data1/oa_pdf/54/ef/jkms-29-1185.PMC4168168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Implications of Social Rejection and Peer Victimization:  Beyond Social Phenomenon Hee Jeong Yoo Department of Psychiatry, Seoul National University College of Medicine, Seongnam, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.9.1186  • J Korean Med Sci 2014; 29: 1186-1187 Recently, suicides of victims of peer rejection (“ wang-tta ”) have  received public attention and exposed the phenomenon as a  serious social/educational problem.",Non-OADS,/arxiv_data1/oa_pdf/4b/c4/jkms-29-1186.PMC4168169.pdf
"Yoo HJ • Social Rejection and Peer Victimization http://jkms.org   1187 http://dx.doi.org/10.3346/jkms.2014.29.9.1186fluence the formation of the nature of wang-tta , similar to Ijime   in Japan (5).",Non-OADS,/arxiv_data1/oa_pdf/4b/c4/jkms-29-1186.PMC4168169.pdf
ORCID Hee Jeong Yoo http://orcid.org/0000-0003-0521-2718  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/c4/jkms-29-1186.PMC4168169.pdf
Available at http://news.kukinews.com/article/view.asp?page=1& gCode=kmi&arcid=0007097559&cp=nv [accessed on 24 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/4b/c4/jkms-29-1186.PMC4168169.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-63572,3,7,8-Tetrachlorodibenzo-P-Dioxin Induced Cell-Specific Drug  Transporters With Acquired Cisplatin Resistance in Cisplatin  Sensitive Cancer Cells 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can induce drug transporter genes such as the  ATP-binding cassette G member 2 ( ABCG2 ), which contributes to multidrug resistance.",Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
"Keywords:  TCDD; ABCG2 ; AhR; Acquired Cisplatin Resistance; Drug TransportersTuvshinjargal Gotovdorj,1,2   Eunil Lee,1,2,3,4 Yongchul Lim,2   Eun Jeong Cha,2 Daeho Kwon,5   Eunyoung Hong,3 YunJeong Kim,4   and Min-Yeong Oh4 1Molecular, Cellular and Developmental Biology,  Division of Biomedical Science, Graduate School,  Korea University, Seoul; 2Department of Preventive  Medicine, College of Medicine, Korea University,  Seoul; 3Department of Public Health, Graduate  School, Korea University, Seoul; 4Graduate School of  Public Health, Korea University, Seoul; 5Department  of Microbiology, College of Medicine, Kwandong  University, Gangneung, Korea  Received: 10 May 2014 Accepted: 5 June 2014 Address for Correspondence: Eunil Lee, MD Department of Preventive Medicine, College of Medicine, Korea  University, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, Korea Tel: +82.2-920-6170, Fax: +82.2-927-7220 E-mail: eunil@korea.ac.kr  Funding:  This work was supported by the National Research  Foundation of Korea (NRF) grant funded by the Korea government  (MEST) (20090091416, Environmental Toxico-Genomics and  Proteomics Center project).http://dx.doi.org/10.3346/jkms.2014.29.9.1188  • J Korean Med Sci 2014; 29: 1188-1198 INTRODUCTION The environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-di - oxin (TCDD) is one of the most potent toxins.",Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org   1189 http://dx.doi.org/10.3346/jkms.2014.29.9.1188side (12).,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
"• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells 1190  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188non-small cell lung carcinoma (A549, H460), and lymphoma  (Jurkat) cell lines were grown in RPMI 1640; breast (MCF7), glio - blastoma (U373-MG, U87-MG), and Hep3B liver cancer cells  were cultured in DMEM; HepG2 liver and colon (LS180, Caco- 2) cancer cell lines were grown in EMEM, and leukemia cell  lines (HL60, K562) were cultured in IMDM.",Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org   1191 http://dx.doi.org/10.3346/jkms.2014.29.9.1188Western blotting  Cell lysates containing 40 µg of protein were boiled at 95°C for 5  min and subjected to SDS-PAGE using 8% gels.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
"• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells 1192  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188nificantly upregulated (4.6-, 4.6- and 2.6-fold, respectively) by  combined treatment with TCDD and cisplatin (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org   1193 http://dx.doi.org/10.3346/jkms.2014.29.9.1188Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells 1194  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org   1195 http://dx.doi.org/10.3346/jkms.2014.29.9.1188Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells 1196  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
"• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org   1197 http://dx.doi.org/10.3346/jkms.2014.29.9.1188pends on the activation of the AhR signaling pathway (19, 31).",Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
ORCID Tuvshinjargal Gotovdorj http://orcid.org/0000-0001-6174-2022 Eunil Lee http://orcid.org/0000-0003-1524-5046 Yongchul Lim http://orcid.org/0000-0001-9195-0623 Eun Jeong Cha http://orcid.org/0000-0003-1080-0506 Daeho Kwon http://orcid.org/0000-0003-1314-2587 Eunyoung Hong http://orcid.org/0000-0002-0329-8004 YunJeong Kim http://orcid.org/0000-0003-0870-4320 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells 1198  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.11888.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
• TCDD Induced Drug Transporters in Cisplatin Sensitive Cancer Cells http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1188Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/8d/db/jkms-29-1188.PMC4168170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a  Disease Activity Biomarker in Patients with Rheumatoid Arthritis  Our study aimed to investigate whether serum leucine-rich alpha-2-glycoprotein (LRG)  levels are elevated in patients with rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
"Keywords:  Leucine-Rich Alpha-2-Glycoprotein; Arthritis, Rheumatoid; Disease Activity;  Tumor Necrosis Factor-alphaYou Jung Ha,1 Eun-Jin Kang,2   Sang-Won Lee,3 Soo-Kon Lee,3   Yong-Beom Park,3 Jung-Soo Song,4   and Sang Tae Choi4 1Division of Rheumatology, Department of Internal  Medicine, Seoul National University Bundang  Hospital, Seongnam; 2Division of Rheumatology,  Department of Internal Medicine, Busan Medical  Center, Busan; 3Division of Rheumatology,  Department of Internal Medicine, Yonsei University  College of Medicine, Seoul; 4Division of  Rheumatology, Department of Internal Medicine,  Chung-Ang University College of Medicine, Seoul,  Korea Received: 3 January 2014 Accepted: 28 May 2014 Address for Correspondence: Sang Tae Choi, MD Division of Rheumatology, Department of Internal Medicine,  Chung-Ang University College of Medicine, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755, Korea  Tel: +82.10-2997-1532, Fax: +82.2-6299-2017 E-mail: beconst@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.9.1199  • J Korean Med Sci 2014; 29: 1199-1204 INTRODUCTION Rheumatoid arthritis (RA) is a chronic autoimmune disease  that primarily affects the synovial lining of the diarthrodial joints  (1).",Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
• Serum Leucine-Rich Alpha-2 Glycoprotein in Rheumatoid Arthritis 1200  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1199age- and sex- matched healthy controls.,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
• Serum Leucine-Rich Alpha-2 Glycoprotein in Rheumatoid Arthritis http://jkms.org   1201 http://dx.doi.org/10.3346/jkms.2014.29.9.1199 LRG (ng/mL)  RA Controls60 50 40 30 20P < 0.001 Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
• Serum Leucine-Rich Alpha-2 Glycoprotein in Rheumatoid Arthritis 1202  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1199Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
• Serum Leucine-Rich Alpha-2 Glycoprotein in Rheumatoid Arthritis http://jkms.org   1203 http://dx.doi.org/10.3346/jkms.2014.29.9.1199be regulated in part cytokines other than TNF- α or IL-6 in pa - tients with RA.,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
ORCID You-Jung Ha http://orcid.org/0000-0001-6107-9523 Yong-Beom Park http://orcid.org/0000-0003-4698-8620 Jung-Soo Song http://orcid.org/0000-0001-8651-5125 Sang Tae Choi http://orcid.org/0000-0002-2074-1733 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
• Serum Leucine-Rich Alpha-2 Glycoprotein in Rheumatoid Arthritis 1204  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1199biological disease-modifying antirheumatic drugs.,Non-OADS,/arxiv_data1/oa_pdf/c8/a8/jkms-29-1199.PMC4168171.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Drug Survival Rates of Tumor Necrosis Factor Inhibitors in  Patients with Rheumatoid Arthritis and Ankylosing Spondylitis We investigated the compliance of Korean patients using tumor necrosis factor (TNF)  inhibitors to treat rheumatoid arthritis (RA) and ankylosing spondylitis (AS), and identified  potential predictors associated with treatment discontinuation.",Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
"Keywords:  Arthritis, Rheumatoid; Spondylitis, Ankylosing; TNF Inhibitor; SurvivalJi-Hyoun Kang, Dong-Jin Park,   Jeong-Won Lee, Kyung-Eun Lee,   Lihui Wen, Tae-Jong Kim,   Yong-Wook Park, and Shin-Seok Lee Division of Rheumatology, Department of Internal  Medicine, Chonnam National University Medical  School & Hospital, Gwangju, Korea Received: 26 January 2014 Accepted: 3 June 2014 Address for Correspondence: Shin-Seok Lee, MD Division of Rheumatology, Department of Internal Medicine,  Chonnam National University Medical School & Hospital,   42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82.62-220-6591, Fax: +82.62-225-8578 E-mail: shinseok@chonnam.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.9.1205  • J Korean Med Sci 2014; 29: 1205-1211 INTRODUCTION The introduction of tumor necrosis factor (TNF) inhibitors has  revolutionized the management of chronic inflammatory dis - eases, including rheumatoid arthritis (RA) and ankylosing spon - dylitis (AS) (1).",Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
• Drug Survival Rates of TNF Inhibitors 1206  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1205been diagnosed with RA or AS by a physician.,Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
• Drug Survival Rates of TNF Inhibitors http://jkms.org   1207 http://dx.doi.org/10.3346/jkms.2014.29.9.1205Table 1.,Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
• Drug Survival Rates of TNF Inhibitors 1208  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1205Table 4.,Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
• Drug Survival Rates of TNF Inhibitors http://jkms.org   1209 http://dx.doi.org/10.3346/jkms.2014.29.9.1205ercept group had a lower discontinuation rate than the inflix - imab group in RA patients.,Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
"• Drug Survival Rates of TNF Inhibitors 1210  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1205ly MTX, was associated with better drug survival in the SSAGT  study (9) and a Norwegian study (22), whereas the retention rate  was greater without concomitant DMARDs in a French study  (30).",Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
ORCID Ji-Hyoun Kang http://orcid.org/0000-0003-1113-2001 Dong-Jin Park http://orcid.org/0000-0002-8709-987X Jeong-Won Lee http://orcid.org/0000-0002-6945-0398 Kyung-Eun Lee http://orcid.org/0000-0003-1048-9068 Lihui Wen http://orcid.org/0000-0002-6385-0825 Tae-Jong Kim http://orcid.org/0000-0002-6749-7598 Yong-Wook Park http://orcid.org/0000-0002-6937-7119 Shin-Seok Lee http://orcid.org/0000-0001-6810-7355 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
"• Drug Survival Rates of TNF Inhibitors http://jkms.org   1211 http://dx.doi.org/10.3346/jkms.2014.29.9.1205Kollerup G, Linde L, Lindegaard HM, Poulsen UE, et al.",OADS,/arxiv_data1/oa_pdf/97/1f/jkms-29-1205.PMC4168172.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cancer of the Prostate Risk Assessment (CAPRA) Preoperative  Score Versus Postoperative Score (CAPRA-S): Ability to Predict  Cancer Progression and Decision-Making Regarding Adjuvant  Therapy after Radical Prostatectomy The University of California, San Francisco, announced in 2011 Cancer of the Prostate Risk  Assessment Postsurgical (CAPRA-S) score which included pathologic data, but there were  no results for comparing preoperative predictors with the CAPRA-S score.",Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
"Keywords:  Prostatic Neoplasms; Prostatectomy; Disease Progression; RecurrenceWon Ik Seo, Pil Moon Kang,   Dong Il Kang, Jang Ho Yoon,   Wansuk Kim, and Jae Il Chung  Department of Urology, Busan Paik Hospital, Inje  University, Busan, Korea Received: 7 April 2014 Accepted: 3 June 2014 Address for Correspondence:  Jae Il Chung, MD Department of Urology, Busan Paik Hospital, Inje University  College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 614-735,  Korea Tel: +82.51-890-6384, Fax: +82.51-892-2728 E-mail: prosdoc@hanmail.net Funding:  This study was supported by a grant from INJE  University 2014 research fund, Korea.http://dx.doi.org/10.3346/jkms.2014.29.9.1212  • J Korean Med Sci 2014; 29: 1212-1216 INTRODUCTION A radical prostatectomy is the most common primary treatment  for clinically localized prostate cancer (1).",Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
• Validity of CAPRA-S Score to Predict Progression after Prostatectomy http://jkms.org   1213 http://dx.doi.org/10.3346/jkms.2014.29.9.1212Table 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
"• Validity of CAPRA-S Score to Predict Progression after Prostatectomy 1214  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1212> 6), the 5-yr progression-free probability was 56.9% and its haz - ard ratio was 13.1 ( P= 0.014; Fig.",Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
• Validity of CAPRA-S Score to Predict Progression after Prostatectomy http://jkms.org   1215 http://dx.doi.org/10.3346/jkms.2014.29.9.1212nomogram (20).,Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
ORCID Won Ik Seo http://orcid.org/0000-0002-3004-101X Jae Il Chung http://orcid.org/0000-0002-8114-1125 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
• Validity of CAPRA-S Score to Predict Progression after Prostatectomy 1216  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.12129.,Non-OADS,/arxiv_data1/oa_pdf/0a/c7/jkms-29-1212.PMC4168173.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Benefits of a Continuous Ambulatory Peritoneal Dialysis (CAPD)  Technique with One Icodextrin-Containing and Two Biocompatible  Glucose-Containing Dialysates for Preservation of Residual Renal  Function and Biocompatibility in Incident CAPD Patients In a prospective randomized controlled study, the efficacy and safety of a continuous  ambulatory peritoneal dialysis (CAPD) technique has been evaluated using one icodextrin- containing and two glucose-containing dialysates a day.",Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
"[Clincal Trial Registry,  ISRCTN23727549] Keywords:  Biocompatibility; Peritoneal Dialysis, Continuous Ambulatory; Icodextrin,  Randomized Controlled Trial; Residual Renal Function Hye Eun Yoon, Yoon Kyung Chang,   Seok Joon Shin, Bum Soon Choi,   Byung Soo Kim, Cheol Whee Park,   Ho Cheol Song, Sun Ae Yoon,   Dong Chan Jin, and Yong-Soo Kim Department of Internal Medicine, College of  Medicine, The Catholic University of Korea, Seoul,  Korea Received: 28 February 2014 Accepted: 19 June 2014 Address for Correspondence: Yong-Soo Kim, MD Department of Internal Medicine, College of Medicine, The  Catholic University of Korea, 222 Banpo-daero, Seocho-gu,  Seoul 137-701, Korea Tel: +82.2-2258-6036, Fax: +82.2-599-3589 E-mail: kimcmc@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.9.1217  • J Korean Med Sci 2014; 29: 1217-1225 INTRODUCTION Preservation of residual renal function (RRF) has consistently  been an independent predictor of mortality and cardiovascular  death in peritoneal dialysis (PD) patients (1-8).",Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
"• CAPD with One Icodextrin and Two Glucose-Dialysates 1218  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1217full dose CAPD, adequate solute clearance and volume control  can be achieved by RRF in incident CAPD patients.",Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
• CAPD with One Icodextrin and Two Glucose-Dialysates http://jkms.org   1219 http://dx.doi.org/10.3346/jkms.2014.29.9.1217Statistical analysis There was no patient who crossed over the two groups.,Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
"• CAPD with One Icodextrin and Two Glucose-Dialysates 1220  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1217and gender, there was no statistical difference in renal CrCl be - tween the two groups ( P= 0.060).",OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
• CAPD with One Icodextrin and Two Glucose-Dialysates http://jkms.org   1221 http://dx.doi.org/10.3346/jkms.2014.29.9.1217groups.,Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
• CAPD with One Icodextrin and Two Glucose-Dialysates 1222  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1217group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
"• CAPD with One Icodextrin and Two Glucose-Dialysates http://jkms.org   1223 http://dx.doi.org/10.3346/jkms.2014.29.9.1217preservation of mesothelial cell homeostasis, compared with  the four exchanges CAPD technique using low GDP , glucose  solutions in incident CAPD patients.",Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
"• CAPD with One Icodextrin and Two Glucose-Dialysates 1224  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1217toneal transport might have affected our results, and the thrice  CAPD technique using one icodextrin-containing and two-glu - cose containing dialysates may be a better option for high peri - toneal membrane transporters.",Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
ORCID Hye Eun Yoon http://orcid.org/0000-0002-6347-7282 Yoon Kyung Chang http://orcid.org/0000-0003-4193-2034 Seok Joon Shin http://orcid.org/0000-0001-7642-2849 Bum Soon Choi http://orcid.org/0000-0002-1412-9951   Byung Soo Kim http://orcid.org/0000-0001-5034-9014 Cheol Whee Park http://orcid.org/0000-0002-9912-5393 Ho Cheol Song http://orcid.org/0000-0002-9849-8091 Sun Ae Yoon http://orcid.org/0000-0003-1175-8098 Dong Chan Jin http://orcid.org/0000-0002-6637-8263 Yong-Soo Kim http://orcid.org/0000-0003-2152-1289   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
• CAPD with One Icodextrin and Two Glucose-Dialysates http://jkms.org   1225 http://dx.doi.org/10.3346/jkms.2014.29.9.1217ance targets and measurements.,OADS,/arxiv_data1/oa_pdf/55/ed/jkms-29-1217.PMC4168174.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Risk Factors for Death during Pulmonary Tuberculosis Treatment  in Korea: A Multicenter Retrospective Cohort Study The data regarding risk factors for death during tuberculosis (TB) treatment are  inconsistent, and few studies examined this issue in Korea.",Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
"Keywords:  Tuberculosis, Pulmonary; Therapeutics; Mortality, Korea Yong-Soo Kwon,1 Yee Hyung Kim,2   Jae-Uk Song,3 Kyeongman Jeon,4   Junwhi Song,5 Yon Ju Ryu,6   Jae Chol Choi,7 Ho Cheol Kim,8   and Won-Jung Koh4 1Department of Internal Medicine, Chonnam  National University Hospital, Gwangju; 2Department  of Pulmonary and Critical Care Medicine, Kyung  Hee University Hospital at Gangdong, School of  Medicine, Kyung Hee University, Seoul; 3Division of  Pulmonary and Critical Care Medicine, Department  of Medicine, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine,  Seoul; 4Division of Pulmonary and Critical Care  Medicine, Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of  Medicine, Seoul; 5Division of Pulmonology, Samsung  Changwon Hospital, Changwon; 6Division of  Pulmonary and Critical Care Medicine, Department  of Medicine, Ewha Medical Center and Ewha  Medical Research Institute, Ewha Womans  University School of Medicine, Mokdong Hospital,  Seoul; 7Department of Internal Medicine, Chung-Ang  University School of Medicine, Seoul; 8Department  of Internal Medicine, College of Medicine,  Gyeongsang Institute of Health Sciences,  Gyeongsang National University, Jinju, Korea Received: 16 March 2014 Accepted: 3 June 2014 Address for Correspondence: Won-Jung Koh, MD Division of Pulmonary and Critical Care Medicine, Department  of Medicine, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu,   Seoul 135-710, Korea Tel: +82.2-3410-3429, Fax: +82.2-3410-3849 E-mail: wjkoh@skku.edu  Funding:  This study was supported by a grant of the Korean  Health technology R&D Project, Ministry for Health & Welfare,  Republic of Korea (HI13C0871).http://dx.doi.org/10.3346/jkms.2014.29.9.1226  • J Korean Med Sci 2014; 29: 1226-1231 INTRODUCTION The incidence and mortality of tuberculosis (TB) remain high worldwide, with 8.6 mil - lion incident cases and 1.3 million deaths in 2012 (1).",Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
• Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea http://jkms.org   1227 http://dx.doi.org/10.3346/jkms.2014.29.9.1226defined as a non-infectious chronic pulmonary disease such as  chronic obstructive pulmonary disease and asthma.,Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
"• Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea 1228  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1226yr), and there were 1,417 males (57.1%).",OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
"• Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea http://jkms.org   1229 http://dx.doi.org/10.3346/jkms.2014.29.9.1226of unsuccessful outcomes (34, 35).",Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
"• Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea 1230  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1226 In summary, the mortality rate of pulmonary TB in Korea was  high, at 3.7%.",OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
ORCID Yong-Soo Kwon http://orcid.org/0000-0001-5121-4488 Yee Hyung Kim http://orcid.org/0000-0002-2921-0314 Jae-Uk Song http://orcid.org/0000-0002-0181-0844 Kyeongman Jeon http://orcid.org/0000-0002-4822-1772 Junwhi Song http://orcid.org/0000-0002-8760-7627 Yon Ju Ryu http://orcid.org/0000-0003-4059-9401 Jae Chol Choi http://orcid.org/0000-0002-8761-6494 Ho Cheol Kim http://orcid.org/0000-0002-3262-0672 Won-Jung Koh http://orcid.org/0000-0002-4756-3527 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
Available at http://www.who.int/tb/ publications/global_report/en [accessed on 1 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
Available at http://kosis.kr/ups/ups_01List01.jsp?grp_ no=1005&pubcode=YD&type=F [accessed on 1 March 2014].,OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
Available at http://tbfree.cdc.go.kr/tbfree/ guide.do?page=11&id=4110 [accessed on 1 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
• Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea http://jkms.org   1231 http://dx.doi.org/10.3346/jkms.2014.29.9.122627.,Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
Available at http://www.who.int/tb/publi - cations/tb_treatmentguidelines/en [accessed on 1 March 2014].,Non-OADS,/arxiv_data1/oa_pdf/d1/94/jkms-29-1226.PMC4168175.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Epidemiological Aspects of Pertussis among Adults and  Adolescents in a Korean Outpatient Setting: A Multicenter,   PCR-Based Study Epidemiological data of Bordetella pertussis  infection among adolescents and adults are  limited in Korea.",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.9.1232  • J Korean Med Sci 2014; 29: 1232-1239 INTRODUCTION Pertussis is a highly infectious disease and can cause significant morbidity in infants  and the elderly (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
• Pertussis Incidence among Adults and Adolescents http://jkms.org   1233 http://dx.doi.org/10.3346/jkms.2014.29.9.1232not always readily available and are time-consuming in real- world clinical settings.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
"• Pertussis Incidence among Adults and Adolescents 1234  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1232for pertussis diagnosis, the “repeated-insertion sequence” and  the “pertussis toxin (PT) promoter region” are used most com - monly as target regions (15, 16).",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
• Pertussis Incidence among Adults and Adolescents http://jkms.org   1235 http://dx.doi.org/10.3346/jkms.2014.29.9.1232there were no significant differences among the three hospital  groups (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
"• Pertussis Incidence among Adults and Adolescents 1236  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1232and hospital levels were included, post-tussive vomiting was  significantly associated with pertussis (odds ratio [OR], 2.508;  95% confidence interval [CI], 1.146-5.486), and secondary re - ferral hospitals showed a borderline significance (OR, 3.198;  95% CI, 0.921-11.105; Table 3).",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
• Pertussis Incidence among Adults and Adolescents http://jkms.org   1237 http://dx.doi.org/10.3346/jkms.2014.29.9.1232cough illnesses.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
• Pertussis Incidence among Adults and Adolescents 1238  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1232ORCID Sunghoon Park http://orcid.org/0000­0001­7004­6985  Sun Hwa Lee http://orcid.org/0000­0002­2002­0282 Ki-Hyun Seo http://orcid.org/0000­0002­0608­0676 Kyeong-Cheol Shin http://orcid.org/0000­0003­1972­1847 Kwang Ha Yoo http://orcid.org/0000­0001­9969­2657 Jae Seuk Park http://orcid.org/0000­0001­9307­1155 Jae Hwa Cho http://orcid.org/0000­0002­3432­3997 Yongchun Ko http://orcid.org/0000­0001­5635­8579 Soo-Keol Lee http://orcid.org/0000­0002­5608­9927 Do Il Kim http://orcid.org/0000­0001­9046­3970 Jun Wook Ha http://orcid.org/0000­0003­4967­2302 Jae-Myung Lee http://orcid.org/0000­0002­6241­6349 Ji-Won Suhr http://orcid.org/0000­0002­6649­9962 Ki-Suck Jung http://orcid.org/0000­0002­6878­6543   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
"• Pertussis Incidence among Adults and Adolescents http://jkms.org   1239 http://dx.doi.org/10.3346/jkms.2014.29.9.1232among adolescents and adults, Minnesota, 1995­1996.",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/jkms-29-1232.PMC4168176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clarithromycin-Based Standard Triple Therapy Can Still Be  Effective for Helicobacter pylori  Eradication in Some Parts of the  Korea We evaluated the antibiotic resistance rates and eradication rates of clarithromycin based  triple therapy from 2005 to 2010 retrospectively.",Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
"Keywords:  Helicobacter pylori ; Clarithromycin Resistance; Minimum Inhibitory  ConcentrationKyu-Hyun Yoon, Sung Woon Park,   Sang Wook Lee, Beom Jin Kim,   and Jae Gyu Kim Division of Gastroenterology, Department of Internal  Medicine, Chung-Ang University College of  Medicine, Seoul, Korea Received: 10 January 2014 Accepted: 26 May 2014 Address for Correspondence: Jae Gyu Kim, MD Division of Gastroenterology, Department of Internal Medicine,  Chung-Ang University College of Medicine, 102 Heukseok-ro,  Dongjak-gu, Seoul 156-755, Korea  Tel: +82.2-6299-3147, Fax: +82.2-6299-1137  E-mail: jgkimd@cau.ac.kr http://dx.doi.org/10.3346/jkms.2014.29.9.1240  • J Korean Med Sci 2014; 29: 1240-1246 INTRODUCTION  Helicobacter pylori  is a curved, microaerophilic, Gram-negative  bacterium that was isolated in 1983 from the stomach biopsy  specimens of patients with chronic gastritis (1).",Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
"• Clarithromycin-Based Triple Therapy for Helicobacter pylori  Eradication http://jkms.org   1241 http://dx.doi.org/10.3346/jkms.2014.29.9.1240lori eradication and 3) to detect mutations in 23S rRNA of clar - ithromycin-resistant H. pylori  isolates from Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
• Clarithromycin-Based Triple Therapy for Helicobacter pylori  Eradication 1242  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1240Fig.,Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
• Clarithromycin-Based Triple Therapy for Helicobacter pylori  Eradication http://jkms.org   1243 http://dx.doi.org/10.3346/jkms.2014.29.9.1240Table 3.,Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
• Clarithromycin-Based Triple Therapy for Helicobacter pylori  Eradication 1244  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1240Fig.,Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
"• Clarithromycin-Based Triple Therapy for Helicobacter pylori  Eradication http://jkms.org   1245 http://dx.doi.org/10.3346/jkms.2014.29.9.1240sensus Report recommends treatment with PPI-clarithromy - cin-metronidazole in populations with less than 40% metroni - dazole resistance (14); however, metronidazole may still be less  effective in Korea due to the relatively high resistance rate.",Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
ORCID Kyu-Hyun Yoon http://orcid.org/0000-0002-0252-6386  Sung Woon Park http://orcid.org/0000-0003-0576-9786  Sang Wook Lee http://orcid.org/0000-0001-9762-6998  Beom Jin Kim http://orcid.org/0000-0003-4846-1423  Jae Gyu Kim http://orcid.org/0000-0002-4841-9404  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
• Clarithromycin-Based Triple Therapy for Helicobacter pylori  Eradication 1246  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.12402.,Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
Available at http://www.microbiolab-bg.com/CLSI.,Non-OADS,/arxiv_data1/oa_pdf/69/63/jkms-29-1240.PMC4168177.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Shifting Prevalence of Gallbladder Polyps in Korea Only a few studies have evaluated the population-adjusted prevalence of gallbladder  polyps (GBP).",Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
"Keywords:  Gallbladder Polyps; Prevalence; Risk Factors; KoreaYoo Jin Lee, Kyung Sik Park,   Kwang Bum Cho, Eun Soo Kim,   Byoung Kuk Jang, Woo Jin Chung,   and Jae Seok Hwang Division of Gastroenterology and Hepatology,  Department of Internal Medicine, Keimyung  University School of Medicine, Daegu, Korea Received: 12 March 2014 Accepted: 28 May 2014 Address for Correspondence: Kyung Sik Park, MD Division of Gastroenterology and Hepatology, Department of  Internal Medicine, Keimyung University School of Medicine, 56  Dalseongro, Jung-gu, Daegu 700-712, Korea Tel: +82.53-250-7088, Fax: +82.53-250-7442 E-mail: seenae99@dsmc.or.krhttp://dx.doi.org/10.3346/jkms.2014.29.9.1247  • J Korean Med Sci 2014; 29: 1247-1252 INTRODUCTION Gallbladder polyps (GBP) are defined as lesions protruding from  the gallbladder mucosa that are usually found incidentally by  ultrasonography (USG) (1).",Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
"• Shifting Prevalence of Gallbladder Polyp  1248  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1247Diagnosis of GBP  After fasting for at least 11 hr prior to the examination, radiology  specialists performed USG examinations using an ACUSON  128XP 10 (Acuson, Charleston Road, CA, USA) and Philips-iU22  (Philips, Bothell, WA, USA) equipped with a 3.5/5.0 MHz ultra - sound probe.",Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
"• Shifting Prevalence of Gallbladder Polyp  http://jkms.org   1249 http://dx.doi.org/10.3346/jkms.2014.29.9.1247Prevalence of GBP Among a total of 14,250 subjects, 765 had GBP , and the overall  prevalence through the 11-yr time period was approximately  6.3%.",Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
• Shifting Prevalence of Gallbladder Polyp  1250  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1247 Many studies have reported on the risk factors that predis - pose patients to developing GBP .,Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
• Shifting Prevalence of Gallbladder Polyp  http://jkms.org   1251 http://dx.doi.org/10.3346/jkms.2014.29.9.1247formation of cholesterol polyps (26).,Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
ORCID Yoo Jin Lee http://orcid.org/0000-0003-1799-0146  Kyung Sik Park http://orcid.org/0000-0003-1874-9936 Kwang Bum Cho http://orcid.org/0000-0003-2203-102X Eun Soo Kim http://orcid.org/0000-0003-0806-9136 Byoung Kuk Jang http://orcid.org/0000-0002-8950-0866 Woo Jin Chung http://orcid.org/0000-0002-3736-1067 Jae Seok Hwang http://orcid.org/0000-0002-1510-3534  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
• Shifting Prevalence of Gallbladder Polyp  1252  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1247tures of polypoid lesions of the gallbladder and risk factors of gallbladder  cancer.,Non-OADS,/arxiv_data1/oa_pdf/89/ed/jkms-29-1247.PMC4168178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Sarcopenia as a Useful Predictor for Long-Term Mortality in  Cirrhotic Patients with Ascites This study aimed to assess and compare sarcopenia with other prognostic factors for  predicting long-term mortality in cirrhotic patients with ascites.",Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
"Received: 21 May 2014 Accepted: 2 July 2014 Address for Correspondence: Joo Hyun Sohn, MD Department of Internal Medicine, Hanyang Univesity Guri  Hospital, 153 Gyeongchun-ro, Guri 471-701, Korea Tel: +82.31-560-2225, Fax: +82.31-555-2998 E-mail: sonjh@hanyang.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.9.1253  • J Korean Med Sci 2014; 29: 1253-1259 INTRODUCTION The presence of ascites in cirrhotic patients is known to lower  the long-term survival (1).",Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
• Sarcopenia in Cirrhotic Ascites 1254  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1253cirrhotic patients (16).,Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
"• Sarcopenia in Cirrhotic Ascites http://jkms.org   1255 http://dx.doi.org/10.3346/jkms.2014.29.9.1253CP score, MELD score, MELD-Na, HVPG and PMTH for pre - dicting 1-yr mortality were evaluated by sensitivity, specificity,  and the area under the receiver operating characteristics curve  (AUROC).",OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
• Sarcopenia in Cirrhotic Ascites 1256  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1253rum Na ( r= 0.266.,Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
"• Sarcopenia in Cirrhotic Ascites http://jkms.org   1257 http://dx.doi.org/10.3346/jkms.2014.29.9.1253 In the univariate analysis for death of cirrhotic patients with  ascites, the presence of refractory ascites ( P= 0.010), INR ( P=  0.009), Na ( P= 0.005), CP score ( P= 0.015), MELD score ( P=  0.014), MELD-Na ( P= 0.001) and PMTH ( P= 0.001) were relat - ed with long-term mortality.",Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
"• Sarcopenia in Cirrhotic Ascites 1258  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1253ment of the psoas muscle mass was found very accessible and  highly precise to quantify the skeletal muscle in the body (17,  18).",OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
ORCID Tae Yeob Kim http://orcid.org/0000-0001-7978-5303 Min Yeong Kim http://orcid.org/0000-0002-6228-7313 Joo Hyun Sohn http://orcid.org/0000-0002-8977-4509 Sun Min Kim http://orcid.org/0000-0002-3536-6585 Jeong Ah Ryu http://orcid.org/0000-0002-4474-180X Sanghyeok Lim http://orcid.org/0000-0002-1607-3744 Youngsoo Kim http://orcid.org/0000-0002-1069-0135 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
• Sarcopenia in Cirrhotic Ascites http://jkms.org   1259 http://dx.doi.org/10.3346/jkms.2014.29.9.12532.,Non-OADS,/arxiv_data1/oa_pdf/91/bf/jkms-29-1253.PMC4168179.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Results of Surgical Treatment on Benign Anal Diseases in Korean  HIV-Positive Patients Perianal diseases are the most common reasons for surgery in HIV-positive patients.",Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
"Keywords:  HIV; Acquired Immunodeficiency Syndrome; Anal Operation; Condyloma  Acuminata; Wound HealingHeung-Kwon Oh,1 Sang-Hui Moon,2  Seungbum Ryoo,2 Eun Kyung Choe,2   and Kyu Joo Park2 1Department of Surgery, Seoul National University  Bundang Hospital, Seongnam; 2Department of  Surgery, Seoul National University College of  Medicine, Seoul, Korea Received: 8 June 2014 Accepted: 10 July 2014 Address for Correspondence: Kyu Joo Park, MD Department of Surgery, Seoul National University College of  Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82.2-2072-2901, Fax: +82.2-766-3975 E-mail: kjparkmd@plaza.snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.9.1260  • J Korean Med Sci 2014; 29: 1260-1265 INTRODUCTION The incidence of acquired immunodeficiency syndrome (AIDS),  first reported in 5 patients in June 1981, has increased annually,  and it is estimated that as of 2012, 35 million people worldwide  are living with the human immunodeficiency virus (HIV) (1).",Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
"• Surgical Management of Anal Disease with HIV Infection http://jkms.org   1261 http://dx.doi.org/10.3346/jkms.2014.29.9.1260Statistical analysis The current study evaluated the clinical characteristics of anal  diseases in HIV-positive patients, their surgical management,  wound healing, and recurrence by disease type.",OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
• Surgical Management of Anal Disease with HIV Infection 1262  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1260Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
"• Surgical Management of Anal Disease with HIV Infection http://jkms.org   1263 http://dx.doi.org/10.3346/jkms.2014.29.9.1260wound healing, and recurrence, were not different between these  two groups.",Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
"• Surgical Management of Anal Disease with HIV Infection 1264  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1260with the implementation of highly active antiretroviral therapy  and the development of new medical therapies; concomitantly,  cases of invasive malignancies have increased (5, 16).",Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
ORCID  Heung-Kwon Oh http://orcid.org/0000-0002-8066-2367 Sang-Hui Moon http://orcid.org/0000-0003-1102-8714 Seungbum Ryoo http://orcid.org/0000-0001-6407-0444 Eun Kyung Choe http://orcid.org/0000-0002-7222-1772 Kyu Joo Park http://orcid.org/0000-0002-9134-7426 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
Available at http://www.unaids.org/en/data - analysis/knowyourepidemic [accessed on 15 May 2014].,OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
Available at http://aidsinfo.cdc.go.kr/ aidsinfo/user/jsp/ud/ud04_1ht01i.jsp [accessed on 15 May 2014].,OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
• Surgical Management of Anal Disease with HIV Infection http://jkms.org   1265 http://dx.doi.org/10.3346/jkms.2014.29.9.126019: 1-5.,Non-OADS,/arxiv_data1/oa_pdf/a1/21/jkms-29-1260.PMC4168180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Anti-Müllerian Hormone Levels in the Follicular Fluid of the  Preovulatory Follicle: A Predictor for Oocyte Fertilization and  Quality of Embryo This prospective study investigated the relationship between anti-Müllerian hormone  (AMH) level in the follicular fluid (FF) and the quality of the oocyte and embryo.",Non-OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.9.1266  • J Korean Med Sci 2014; 29: 1266-1270 INTRODUCTION Anti-Müllerian hormone (AMH), also called Müllerian-inhibit - ing substance, has become known as an important regulator of  follicle development (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
• Follicular Fluid Anti-Müllerian Hormone and Embryo Quality http://jkms.org   1267 http://dx.doi.org/10.3346/jkms.2014.29.9.1266MATERIALS AND METHODS Subjects A total of 65 FF samples from 54 women were collected.,OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
• Follicular Fluid Anti-Müllerian Hormone and Embryo Quality 1268  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1266RESULTS Clinical characteristics of the study subjects and outcomes  of COS Clinical characteristics of the study subjects and COS outcomes  are presented in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
• Follicular Fluid Anti-Müllerian Hormone and Embryo Quality http://jkms.org   1269 http://dx.doi.org/10.3346/jkms.2014.29.9.1266any significant difference in the quality of oocytes and embryos  originating from high- or low- AMH -producing follicles.,Non-OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
ORCID Jee Hyun Kim http://orcid.org/0000-0003-1336-3620  Jung Ryeol Lee http://orcid.org/0000-0003-3743-2934  Hye Jin Chang http://orcid.org/0000-0002-1122-1269  Byung Chul Jee http://orcid.org/0000-0003-2289-6090  Chang Suk Suh http://orcid.org/0000-0003-1835-7350  Seok Hyun Kim http://orcid.org/0000-0003-0649-3224 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
• Follicular Fluid Anti-Müllerian Hormone and Embryo Quality 1270  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1266SY.,Non-OADS,/arxiv_data1/oa_pdf/22/85/jkms-29-1266.PMC4168181.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Prospective Korean Multicenter Study for Infectious  Complications in Patients Undergoing Prostate Surgery:   Risk Factors and Efficacy of Antibiotic Prophylaxis This multicenter study was undertaken to determine the efficacy of antibiotic prophylaxis  and identify the risk factors for infectious complications after prostate surgery in Korean  patients.",Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
"Keywords:  Urinary Tract Infections; Transurethral Resection of Prostate; Risk Factors Eu Chang Hwang,1 Seung Il Jung,1   Dong Deuk Kwon,1 Gilho Lee,2   Jae Hyun Bae,3 Yong Gil Na,4   Seung Ki Min,5 Hwancheol Son,6   Sun Ju Lee,7 Jae Min Chung,8   Hong Chung,9 In Rae Cho,10   Young Ho Kim,11 Tae-Hyoung Kim,12   and In Ho Chang12 1Department of Urology, Chonnam National  University, Hwasun; 2Department of Urology,  Dankook University, College of Medicine, Cheonan;  3Department of Urology, Korea University, College of  Medicine, Seoul; 4Department of Urology,  Chungnam National University, College of Medicine,  Daejeon; 5Department of Urology, National Police  Hospital, Seoul; 6Department of Urology, Seoul  National University, College of Medicine, Seoul;  7Department of Urology, Kyung Hee University,  School of Medicine, Seoul; 8Department of Urology,  Kosin University, College of Medicine, Busan;  9Department of Urology, Konkuk University, School  of Medicine, Chungju; 10Department of Urology, Inje  University, College of Medicine, Busan; 11Department  of Urology, Soon Chun Hyang University, College of  Medicine, Bucheon; 12Department of Urology,  Chung-Ang University, College of Medicine, Seoul;  The Korean Association of Urogenital Tract Infection  and Inflammation (KAUTII), Seoul, Korea Received: 6 February 2014 Accepted: 27 May 2014 Address for Correspondence: Seung Il Jung, MD Department of Urology, Chonnam National University Hwasun  Hospital, 322 Seoyang-ro, Hwasun 519-763, Korea Tel: +82.61-379-7749, Fax: +82.61-379-7750 E-mail: drjsi@yahoo.co.kr Funding:  This study was supported by the Research Foundation  Grant funded by the Korean Urological Association (KUA-2012- 002).http://dx.doi.org/10.3346/jkms.2014.29.9.1271  • J Korean Med Sci 2014; 29: 1271-1277 INTRODUCTION The purpose of prophylactic antibiotic use is to prevent local or systemic postproce - dural infection.",Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
• Infectious Complications in Patients Undergoing Prostate Surgery 1272  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1271tiveness in total or radical prostatectomy (10-12).,Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
"• Infectious Complications in Patients Undergoing Prostate Surgery http://jkms.org   1273 http://dx.doi.org/10.3346/jkms.2014.29.9.1271Clinical parameters associated with postoperative  infectious complications  Univariate analysis indicated that long-term ( > 5 days) Foley  catheterization (OR, 2.44; 95% CI, 1.59-3.73, P= 0.001), opera - tion time (OR, 1.02; 95% CI, 1.01-1.05, P= 0.006), transurethral  prostate surgery (OR, 0.42; 95% CI, 0.28-0.64, P= 0.001), DM  (OR, 1.66; 95% CI, 1.03-2.75, P= 0.049), and third-generation cephalosporins (OR, 0.46; 95% CI, 0.23-0.93, P= 0.032) were  risk factors for postoperative infectious complications.",Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
"• Infectious Complications in Patients Undergoing Prostate Surgery 1274  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1271addition, the results of extended spectrum β-lactamase (ESBL)  positivity were similar to those of quinolone resistance rate (21.1%,  Table 4).",Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
"• Infectious Complications in Patients Undergoing Prostate Surgery http://jkms.org   1275 http://dx.doi.org/10.3346/jkms.2014.29.9.1271tions rate was 34.9%, and included postoperative bacteriuria  (29.0%), fever (9.2%), and bacteremia (0.2%).",Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
• Infectious Complications in Patients Undergoing Prostate Surgery 1276  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1271ACKNOWLEDGMENTS We thank the Korean Association of Urogenital Tract Infection  and Inflammation for clinical data collection.,Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
ORCID Eu Chang Hwang http://orcid.org/0000-0002-2031-124X Seung Il Jung http://orcid.org/0000-0003-4864-8175 Dong Deuk Kwon http://orcid.org/0000-0002-4544-5420 Gilho Lee http://orcid.org/0000-0002-9253-6245 Jae Hyun Bae http://orcid.org/0000-0001-9862-3545 Yong Gil Na http://orcid.org/0000-0002-0794-5459 Seung Ki Min http://orcid.org/0000-0002-9638-9668 Hwancheol Son http://orcid.org/0000-0001-5033-0153 Sun Ju Lee http://orcid.org/0000-0002-7195-2872 Jae Min Chung http://orcid.org/0000-0003-3593-9643 Hong Chung http://orcid.org/0000-0002-0151-4965 In Rae Cho http://orcid.org/0000-0002-6331-5806 Young Ho Kim http://orcid.org/0000-0003-3959-0928 Tae-Hyoung Kim http://orcid.org/0000-0002-0257-3449 In Ho Chang http://orcid.org/0000-0003-0240-1310 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
• Infectious Complications in Patients Undergoing Prostate Surgery http://jkms.org   1277 http://dx.doi.org/10.3346/jkms.2014.29.9.127122.,Non-OADS,/arxiv_data1/oa_pdf/58/12/jkms-29-1271.PMC4168182.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Influence of Propofol and Fentanyl on Deep Brain Stimulation of  the Subthalamic Nucleus We investigated the effect of propofol and fentanyl on microelectrode recording (MER)  and its clinical applicability during subthalamic nucleus (STN) deep brain stimulation (DBS)  surgery.",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
"HI09C13540100, HI10C14110400 and  HI12C02050101).http://dx.doi.org/10.3346/jkms.2014.29.9.1278  • J Korean Med Sci 2014; 29: 1278-1286 INTRODUCTION Deep brain stimulation (DBS) of the subthalamic nucleus (STN) reduces motor disabil - ity, motor fluctuations and levodopa-induced dyskinesias (1).",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
"• Effect of Propofol and Fentanyl on Microelectrode Recording http://jkms.org   1279 http://dx.doi.org/10.3346/jkms.2014.29.9.1278of Daily Living (SEADL), the Short Form-36 Health Survey (SF- 36), and neuropsychological tests.",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
"• Effect of Propofol and Fentanyl on Microelectrode Recording 1280  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1278thesia and the pattern on the mean firing rate and the effect of  different combinations of anesthesia and the pattern on the  mean firing rate, analysis of variance (ANOVA) was performed.",OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
• Effect of Propofol and Fentanyl on Microelectrode Recording http://jkms.org   1281 http://dx.doi.org/10.3346/jkms.2014.29.9.1278Fig.,Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
• Effect of Propofol and Fentanyl on Microelectrode Recording 1282  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1278 The recorded neuronal discharge exhibited two types of dis - charge pattern.,OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
• Effect of Propofol and Fentanyl on Microelectrode Recording http://jkms.org   1283 http://dx.doi.org/10.3346/jkms.2014.29.9.1278Fig.,Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
• Effect of Propofol and Fentanyl on Microelectrode Recording 1284  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1278Table 3.,Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
"• Effect of Propofol and Fentanyl on Microelectrode Recording http://jkms.org   1285 http://dx.doi.org/10.3346/jkms.2014.29.9.1278and MAC conditions, our relative proportions are closely coin - cident with previous studies, supporting that our result is valid  (3, 19-25).",Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
ORCID Wonki Kim http://orcid.org/0000-0001-7197-2366  In Ho Song http://orcid.org/0000-0001-6330-3453  Yong Hoon Lim http://orcid.org/0000-0002-0346-2345  Mi-Ryoung Kim http://orcid.org/0000-0003-0671-2263  Young Eun Kim http://orcid.org/0000-0002-7182-6569  Jae Ha Hwang http://orcid.org/0000-0002-6455-3590  In Keyoung Kim http://orcid.org/0000-0002-7761-9456  Sang Woo Song http://orcid.org/0000-0002-5523-3798  Jin Wook Kim http://orcid.org/0000-0002-3773-3940  Woong-Woo Lee http://orcid.org/0000-0002-8767-7967  Han-Joon Kim http://orcid.org/0000-0001-8219-9663  Cheolyoung Kim http://orcid.org/0000-0001-5586-9342  Hee Chan Kim http://orcid.org/0000-0002-2112-426X  In Young Kim http://orcid.org/0000-0001-9580-7074  Hee Pyoung Park http://orcid.org/0000-0002-4772-0780  Dong Gyu Kim http://orcid.org/0000-0002-5740-6189   Beom Seok Jeon http://orcid.org/0000-0003-2491-3544   Sun Ha Paek http://orcid.org/0000-0003-3007-8653   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
• Effect of Propofol and Fentanyl on Microelectrode Recording 1286  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.127824.,Non-OADS,/arxiv_data1/oa_pdf/f5/c3/jkms-29-1278.PMC4168183.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Relationship between Socioeconomic Position and Suicide  Attempts among the Korean Adolescents This study explored the relationship of the subjective socioeconomic position (SEP) as well  as the objective SEP with the rate of suicide attempts in 74,186 adolescents from the 2012  Korea Youth Risk Behavior Web-based Survey (KYRBS).",Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
"115694).http://dx.doi.org/10.3346/jkms.2014.29.9.1287  • J Korean Med Sci 2014; 29: 1287-1292 INTRODUCTION Korea has the highest suicide rate among the Organization of  Economic Co-operation and Development (OECD) countries,  which is at a rate higher than 2.5 times the OECD average (1).",Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
• Socioeconomic Position and Suicide Attempts 1288  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1287MATERIALS AND METHODS Study subjects The subjects were participants in the 2012 Korea Youth Risk Be - havior Web-based Survey (KYRBS).,Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
"• Socioeconomic Position and Suicide Attempts http://jkms.org   1289 http://dx.doi.org/10.3346/jkms.2014.29.9.1287pose of the research, provided written informed consent, and  were assured of the right to refuse to participate or to withdraw  from the study at any stage (19).",Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
• Socioeconomic Position and Suicide Attempts 1290  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1287Table 2.,Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
"• Socioeconomic Position and Suicide Attempts http://jkms.org   1291 http://dx.doi.org/10.3346/jkms.2014.29.9.1287low level of perceived SEP and FAS score (OR, 1.81; 95% CI, 1.18- 2.78 for boys, OR, 1.46; 95% CI, 1.13-1.90 for girls).",Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
• Socioeconomic Position and Suicide Attempts 1292  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1287tive youth sample with a high response rate.,Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
DISCLOSURE Authors declare that they have no conflict of interest ORCID Min Jung Ko http://orcid.org/0000-0003-3599-7173 Eun Young Lee http://orcid.org/0000-0002-0040-7826 Kirang Kim http://orcid.org/0000-0003-3054-8758 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/14/7a/jkms-29-1287.PMC4168184.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Neural Changes Associated with Emotion Processing in Children  Experiencing Peer Rejection: A Functional MRI Study This study was performed to investigate differences between children who did and did not  experience peer rejection in psychological state through surveys and in emotion processing  during an interpersonal stress challenge task to reflect naturalistic interpersonal face-to- face relationships.",Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
"Received: 30 January 2014 Accepted: 12 June 2014 Address for Correspondence: Young-Hoon Kim, MD  Department of Pediatrics, Uijeongbu St. Mary’s Hospital, College  of Medicine, The Catholic University of Korea, 271 Cheonbo-ro,  Uijeongbu 480-717, Korea Tel: +82.31-820-3582, Fax: +82.31-821-3108 E-mail: pedkyh@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.9.1293  • J Korean Med Sci 2014; 29: 1293-1300 INTRODUCTION Interpersonal relationships with peers are important for the men - tal and physical development of school-aged children.",Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
"• Emotion Processing in Children Suffering Peer Rejection 1294  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1293ence peer rejection, especially in activities of brain regions in - volved in face perception, emotion processing and emotion  regulation, including amygdala, and also in response to inter - personal feedback stimuli of negative emotion.",Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
"FMRI data were preprocessed and analyzed using the statis - tical parametric mapping platform (SPM8; Wellcome Depart - ment of Cognitive Neurology, London, UK; http://www.fil.ion.",OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
• Emotion Processing in Children Suffering Peer Rejection http://jkms.org   1295 http://dx.doi.org/10.3346/jkms.2014.29.9.1293ucl.ac.uk/spm/).,Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
"• Emotion Processing in Children Suffering Peer Rejection 1296  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1293tive emotional response was not correlated with the measures  of the degree of attention, the impact for the feedback, task dif - ficulty or the self-relatedness to the task.",Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
• Emotion Processing in Children Suffering Peer Rejection http://jkms.org   1297 http://dx.doi.org/10.3346/jkms.2014.29.9.1293Table 4.,Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
• Emotion Processing in Children Suffering Peer Rejection 1298  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1293Fig.,Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
• Emotion Processing in Children Suffering Peer Rejection http://jkms.org   1299 http://dx.doi.org/10.3346/jkms.2014.29.9.1293ity positively correlated with social anxiety such as peer rejec - tion during fear perception in adolescents (24) and was height - ened in response to fearful face in children with anxiety disor - ders (25).,Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
ORCID Hyun-Seung Lee http://orcid.org/0000-0002-5219-8384 Ji-Eun Lee http://orcid.org/0000-0001-6074-5168 Young-Hoon Kim http://orcid.org/0000-0002-6151-6911 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
• Emotion Processing in Children Suffering Peer Rejection 1300  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1293for Children and Adolescents.,Non-OADS,/arxiv_data1/oa_pdf/96/ff/jkms-29-1293.PMC4168185.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Survival and Neurologic Outcomes of Out-of-Hospital Cardiac  Arrest Patients Who Were Transferred after Return of Spontaneous  Circulation for Integrated Post-Cardiac Arrest Syndrome Care:  The Another Feasibility of the Cardiac Arrest Center It has been proven that safety and efficiency of out-of-hospital cardiac arrest (OHCA)  patients is transported to specialized hospitals that have the capability of performing  therapeutic hypothermia (TH).",Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
"Keywords:  Hypothermia Therapy; Heart Arrest; Cardiopulmonary ResuscitationMun Ju Kang,¹ Tae Rim Lee,²   Tae Gun Shin,² Min Seob Sim,²   Ik Joon Jo,² Keun Jeong Song,²   and Yeon Kwon Jeong²  ¹Department of Emergency Medicine, Samsung  Changwon Hospital, Sungkyunkwan University  School of Medicine, Changwon; ²Department of  Emergency Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea  Received: 19 December 2013 Accepted: 26 June 2014 Address for Correspondence: Min Seob Sim, MD  Department of Emergency Medicine, Samsung Medical Center,  Sungkyunkwan, University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-2053, Fax: +82.2-3410-0012 E-mail: coldco2@naver.com Funding:  This study was supported by grant from the Samsung  Medical Center (CRS 110-17-1).http://dx.doi.org/10.3346/jkms.2014.29.9.1301  • J Korean Med Sci 2014; 29: 1301-1307 INTRODUCTION Out-of-hospital cardiac arrest (OHCA) remains as a common  public health problem and a leading cause of morbidity and  mortality (1).",Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
• Outcomes of the Transferred Patients in OHCA 1302  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1301directly visited patients.,Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
• Outcomes of the Transferred Patients in OHCA http://jkms.org   1303 http://dx.doi.org/10.3346/jkms.2014.29.9.1301as statistically significant difference.,OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
• Outcomes of the Transferred Patients in OHCA 1304  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1301Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
"• Outcomes of the Transferred Patients in OHCA http://jkms.org   1305 http://dx.doi.org/10.3346/jkms.2014.29.9.1301 In the univariate model, the ROSC to induction time and the  induction time had no association with the good neurologic  outcome.",OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
• Outcomes of the Transferred Patients in OHCA 1306  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1301outcomes.,Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
ORCID Mun Ju Kang http://orcid.org/0000-0001-7211-6107 Min Seob Sim http://orcid.org/0000-0001-6645-3684 Tae Rim Lee http://orcid.org/0000-0003-2831-7715 Ik Joon Jo http://orcid.org/0000-0001-8098-1862 Tae Gun Shin http://orcid.org/0000-0001-9657-1040 Keun Jeong Song http://orcid.org/0000-0002-3118-2973 Yeon Kwon Jeong http://orcid.org/0000-0001-9657-1040 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
• Outcomes of the Transferred Patients in OHCA http://jkms.org   1307 http://dx.doi.org/10.3346/jkms.2014.29.9.130130-4.,Non-OADS,/arxiv_data1/oa_pdf/a3/95/jkms-29-1301.PMC4168186.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Diagnostic Imaging Utilization in Cases of Acute Appendicitis:  Multi-Center Experience  The purpose of this cross-sectional study was to measure imaging utilization rates and the  negative appendectomy rate (NAR) in metropolitan Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
06-2013-107) and the Seoul National University  Bundang Hospital Research Fund (02-2014-053).http://dx.doi.org/10.3346/jkms.2014.29.9.1308  • J Korean Med Sci 2014; 29: 1308-1316 INTRODUCTION Previous studies (1-7) consistently showed that increases in  preoperative imaging utilization coincide with reductions in  the negative appendectomy rate (NAR).,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
• Diagnostic Imaging Utilization in Cases of Acute Appendicitis http://jkms.org   1309 http://dx.doi.org/10.3346/jkms.2014.29.9.1308Investigating sites The LOCAT Office invited all members of the Korean Society of  Abdominal Radiology (a nationwide society of abdominal radi - ologists) from 119 hospitals (including 67 in metropolitan Seoul  [Seoul and Gyeonggi]) to participate in this study.,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
"• Diagnostic Imaging Utilization in Cases of Acute Appendicitis 1310  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.13085, 20).",Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
• Diagnostic Imaging Utilization in Cases of Acute Appendicitis http://jkms.org   1311 http://dx.doi.org/10.3346/jkms.2014.29.9.1308dedicated to appendicitis imaging.,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
"• Diagnostic Imaging Utilization in Cases of Acute Appendicitis 1312  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1308was associated with younger age, female gender, presentation  during working hours, and open surgery in the univariable anal - ysis; and with younger age (adjusted odds ratio [AOR], 1.54; 95%  CI, 1.04-2.27; P= 0.029), female gender (AOR, 1.60; 95% CI, 1.12- 2.27; P= 0.009), and presentation during working hours (AOR,  2.54; 95% CI, 1.79-3.61; P< 0.001) in the multivariable analysis  (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
"• Diagnostic Imaging Utilization in Cases of Acute Appendicitis http://jkms.org   1313 http://dx.doi.org/10.3346/jkms.2014.29.9.1308instead of CT was used as the initial imaging modality in every  1,000 patients, there would be 44 additional negative appendec - tomies (risk difference, 4.4 [95% CI, 0-8.8] percentage points).",Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
"• Diagnostic Imaging Utilization in Cases of Acute Appendicitis 1314  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1308able analysis; and with older age (AOR, 2.40; 95% CI, 1.96-2.94;  P< 0.001), male gender (AOR, 1.31; 95% CI, 1.08-1.59; P= 0.006),  and presentation during working hours (AOR, 1.25; 95% CI, 1.02- 1.54; P= 0.030) in the multivariable analysis (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
• Diagnostic Imaging Utilization in Cases of Acute Appendicitis http://jkms.org   1315 http://dx.doi.org/10.3346/jkms.2014.29.9.1308or presented in working hours.,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
ORCID Ji Hoon Park https://orcid.org/0000-0002-6794-4909 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
Available at http://www.hira.or.kr/main.do [accessed on 21 May  2013].,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
Available at http://www.bokjiro.go.kr/data/statusView.do?board_ sid=297&data_sid=5999111 [accessed on 20 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
"• Diagnostic Imaging Utilization in Cases of Acute Appendicitis 1316  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1308CM, Noffsinger AE, Stemmermann GN, Lantz PE, Isaacson PG, editors.",Non-OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
Available at http://en.wikipedia.org/ wiki/Population_density [accessed on 20 January 2014].,OADS,/arxiv_data1/oa_pdf/07/bb/jkms-29-1308.PMC4168187.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Extremely Elevated International Normalized Ratio of Warfarin  in a Patient with CYP2C9*1/*3  and Thyrotoxicosis  A 73-yr-old Korean man with permanent atrial fibrillation visited outpatient clinic with  severely increased International Normalized Ratio (INR) values after taking a usual starting  dosage of warfarin to prevent thromboembolism.",Non-OADS,/arxiv_data1/oa_pdf/56/26/jkms-29-1317.PMC4168188.pdf
"Keywords:  Warfarin; International Normalized Ratio; Thyrotoxicosis; GenotypeJi Eun Lee,1 Duck Hyun Ryu,1   Ho Jung Jeong,1 Jung Hoon Kim,1   Ji Eun Jun,1 June Soo Kim,1   and Soo Youn Lee2  Departments of 1Medicine, and 2Laboratory  Medicine and Genetics, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 7 December 2013 Accepted: 26 May 2014 Address for Correspondence: June Soo Kim, MD Division of Cardiology, Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-3414, Fax: +82.2-3410-3849 E-mail: juneskim@skku.eduhttp://dx.doi.org/10.3346/jkms.2014.29.9.1317  • J Korean Med Sci 2014; 29: 1317-1319 INTRODUCTION Warfarin is the most widely used anticoagulant agent for the  prevention of stroke or systemic thromboembolism in patients  with atrial fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/56/26/jkms-29-1317.PMC4168188.pdf
"• Elevated INR of Warfarin in Thyrotoxicosis 1318  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1317all lysis reagents (Applied Biosystems, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/56/26/jkms-29-1317.PMC4168188.pdf
"• Elevated INR of Warfarin in Thyrotoxicosis http://jkms.org   1319 http://dx.doi.org/10.3346/jkms.2014.29.9.13171/*1  genotypes are 12% and 86.9%, respectively (5).",Non-OADS,/arxiv_data1/oa_pdf/56/26/jkms-29-1317.PMC4168188.pdf
ORCID Ji Eun Lee http://orcid.org/0000-0002-8660-0861  Duck Hyun Ryu http://orcid.org/0000-0003-1426-8318  Ho Jung Jeong http://orcid.org/0000-0003-2944-2294  Jung Hoon Kim http://orcid.org/0000-0003-3140-1328  Ji Eun Jun http://orcid.org/0000-0002-7204-4913  June Soo Kim http://orcid.org/0000-0001-7569-6450  Soo Youn Lee http://orcid.org/0000-0002-0662-7408 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/56/26/jkms-29-1317.PMC4168188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Case of Mental Retardation with Paraphilia Treated with Depot  Leuprorelin Paraphilia is a psychiatric disease that has been difficult to cure.",Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
"Keywords:  Paraphilias; Mental Retardation; Leuprorelin Woo Sung Park,1 Kyung Min Kim,2   Yong Woo Jung,3 and Myung Ho Lim4   Departments of 1Pediatrics, 2Psychiatry, College of  Medicine, Dankook University, Cheonan;  3Department of Pharmacy, College of Pharmacy,  Korea University, Sejong; 4Department of Psychology,  College of Social Science, Dankook University,  Cheonan, Korea Received: 31 August 2013 Accepted: 10 February 2014 Address for Correspondence: Myung Ho Lim, MD Department of Psychology, Environmental Health Center,  College of Social Science, Dankook University,   359 Manghyang-ro, Seobuk-gu, Cheonan 300-714, Korea Tel: +82.41-550-3945, Fax: +82.41-561-3007 E-mail: paperose@dku.edu Funding:  The present research was conducted by the research  fund of Dankook University in 2014.http://dx.doi.org/10.3346/jkms.2014.29.9.1320  • J Korean Med Sci 2014; 29: 1320-1324 INTRODUCTION In the late 19th century, Freud suggested that the cause of sexu - al perversion involves biological and developmental factors, as  well as psychoanalytic factors (1).",Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
"• Mental Retardation with Paraphilia and Leuprorelin http://jkms.org   1321 http://dx.doi.org/10.3346/jkms.2014.29.9.1320goserelin (3.75 mg and 11.25 mg), triptorelin (3.75 mg and 11.25  mg), which was recently approved in Europe for the treatment  of male patients with severe sexual abnormality, and leuprore - lin.",Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
"• Mental Retardation with Paraphilia and Leuprorelin 1322  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1320ation, blood test, and electrocardiogram.",Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
• Mental Retardation with Paraphilia and Leuprorelin http://jkms.org   1323 http://dx.doi.org/10.3346/jkms.2014.29.9.1320Most side effects from hypogonadism are reversibly recovered  when drug administration is stopped.,Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
ORCID Myung Ho Lim http://orcid.org/0000-0001-5370-4376  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
• Mental Retardation with Paraphilia and Leuprorelin 1324  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1320rious behavior in mental retardation.,Non-OADS,/arxiv_data1/oa_pdf/7a/28/jkms-29-1320.PMC4168189.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Seroprevalence of Respiratory Syncytial Virus IgG among Healthy  Young Adults in Basic Training for the Republic of Korea Air  Force This investigation enrolled 570 healthy young males gathered from all over the country for  military service at the Republic of Korea Air Force boot camp.",Non-OADS,/arxiv_data1/oa_pdf/8e/70/jkms-29-1325.PMC4168190.pdf
"Keywords:  Antibodies; Military Facilities; Military Personnel; Respiratory Syncytial Virus  InfectionsWon-Ju Park1,2 1Department of Occupational and Environmental  Medicine, Chonnam National University Hwasun  Hospital, Hwasun; 2Department of Occupational  and Environmental Medicine, Aerospace Medical  Research Center, Republic of Korea Air Force,  Cheongwon, Korea Received: 14 January 2014 Accepted: 13 June 2014 Address for Correspondence: Won-Ju Park, MD Department of Occupational and Environmental Medicine,  Chonnam National University Hwasun Hospital, 322 Seoyang- ro, Hwasun-gun, Jeollanam-do 519-763, Korea Tel: +82.61-379-7788, Fax: +82.61-379-7791 E-mail: luvoem@gmail.com Funding:  This research was supported by the Korean Military  Medical Research Project funded by the ROK Ministry of  National Defense (ROK-MND-2012-KMMRP-010).http://dx.doi.org/10.3346/jkms.2014.29.9.1325  • J Korean Med Sci 2014; 29: 1325-1327 Respiratory infections in the military service are the most com - mon inflictions in the military healthcare area, yet they are prob - lems not easy to unravel.",Non-OADS,/arxiv_data1/oa_pdf/8e/70/jkms-29-1325.PMC4168190.pdf
Park W-J • Seroprevalence of RSV IgG 1326  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.9.1325Institutional Review Boards of the Ministry of National Defense  (IRB No.,Non-OADS,/arxiv_data1/oa_pdf/8e/70/jkms-29-1325.PMC4168190.pdf
Park W-J • Seroprevalence of RSV IgG http://jkms.org   1327 http://dx.doi.org/10.3346/jkms.2014.29.9.1325ORCID Won-Ju Park http://orcid.org/0000-0002-1081-9840 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/70/jkms-29-1325.PMC4168190.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2014.29.9.1328  • J Korean Med Sci 2014; 29: 1328-1329 The Relationship between Homocys - teine and Uric Acid Levels in Gouty  Patients Mehmet Agilli,1 Fevzi Nuri Aydin,2 Tuncer Cayci,3 and  Yasemin Gulcan Kurt3 1Department of Biochemistry, Agri Military Hospital, Agri; 2Department of Biochemistry, Sirnak  Military Hospital, Sirnak; 3Department of Medical Biochemistry, Gulhane Military Medical Academy,  Ankara, Turkey To the Editor: We read with great interest the article by Choi et al.",Non-OADS,/arxiv_data1/oa_pdf/be/70/jkms-29-1328.PMC4168191.pdf
"• The Relationship between Homocysteine and Uric Acid Levels in Gouty Patients http://jkms.org   1329 http://dx.doi.org/10.3346/jkms.2014.29.9.1328dal A, Tell GS, Nygård O, Vollset SE.",OADS,/arxiv_data1/oa_pdf/be/70/jkms-29-1328.PMC4168191.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bb/43/srep06008.PMC4168267.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6008 | DOI: 10.1038/srep06008 5",Non-OADS,/arxiv_data1/oa_pdf/bb/43/srep06008.PMC4168267.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/54/b9/srep06422.PMC4168268.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6422 | DOI: 10.1038/srep06422 7",Non-OADS,/arxiv_data1/oa_pdf/54/b9/srep06422.PMC4168268.pdf
"Reference Solar Spectral Irradiance: Air Mass 1.5 ,,http://rredc.nrel.gov/solar/spectra/am1.5/ .",OADS,/arxiv_data1/oa_pdf/b7/12/srep06427.PMC4168269.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Long, L. & Ye, H. How to be smart and energy efficient: A general discussion on thermochromic windows.",Non-OADS,/arxiv_data1/oa_pdf/b7/12/srep06427.PMC4168269.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6427 | DOI: 10.1038/srep06427 10",Non-OADS,/arxiv_data1/oa_pdf/b7/12/srep06427.PMC4168269.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6424 | DOI: 10.1038/srep06424 8",Non-OADS,/arxiv_data1/oa_pdf/7d/70/srep06424.PMC4168270.pdf
"Each measure was calculated from the Brain Connectivity Matlab toolbox (http://www.brain-connectivity-toolbox.net) or custom written Matlab code (Mathworks, Natick, MA).",OADS,/arxiv_data1/oa_pdf/84/20/srep06431.PMC4168271.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/20/srep06431.PMC4168271.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f9/a8/srep06419.PMC4168275.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6419 | DOI: 10.1038/srep06419 5",Non-OADS,/arxiv_data1/oa_pdf/f9/a8/srep06419.PMC4168275.pdf
The array employed 810 polyclonal andmonoclonal antibodies (array list available at: http://www.kinexus.ca).,OADS,/arxiv_data1/oa_pdf/ff/50/srep06425.PMC4168277.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6425 | DOI: 10.1038/srep06425 10,Non-OADS,/arxiv_data1/oa_pdf/ff/50/srep06425.PMC4168277.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6425 | DOI: 10.1038/srep06425 11",Non-OADS,/arxiv_data1/oa_pdf/ff/50/srep06425.PMC4168277.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/47/srep06401.PMC4168280.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6426 | DOI: 10.1038/srep06426 9",Non-OADS,/arxiv_data1/oa_pdf/66/3d/srep06426.PMC4168283.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/4b/srep06325.PMC4168285.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6325 | DOI: 10.1038/srep06325 11",Non-OADS,/arxiv_data1/oa_pdf/97/4b/srep06325.PMC4168285.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"Descriptive characteristics of the study population Women ( n/C30168) Men ( n/C3067) Median P5,P95 Median P5,P95 pa Age (years) 75.5 68.0 /C187.0 76.0 68.8 /C185.6 0.359 Body mass index (kg/m2) 26.9 21.1 /C135.2 26.5 22.9 /C132.9 0.844 T otal body fat (%) 42.8 32.4 /C150.8 28.9 21.2 /C142.4 B0.0001 25-Hydroxyvitamin D 3(nmol/L) 62.6 38.8 /C191.9 65.6 38.9 /C191.4 0.234 Vitamin D intake ( mg/day) 3.0 0.4 /C110.6 3.2 0.8 /C115.8 0.243 Energy intake (kcal/day) 1,829 1,072 /C12,907 2,124 1,417 /C13,320 B0.0001 Fat intake (g/day) 65.5 33.8 /C1115.6 71.0 47.2 /C1140.4 0.010 Alcohol intake (g/day) 0.4 0.0 /C119.4 5.1 0.0 /C128.9 B0.0001 Physical activity level 1.6 1.4 /C12.0 1.6 1.4 /C11.9 0.095 Vitamin D supplement user ( n, %) 30 (17.9) 4 (6.0) 0.023 Current or ex-smokers ( n, %) 39 (23.5) 47 (70.1) B0.0001 Household income ]1,500 t/month ( n, %) 71 (51.4) 44 (78.6) B0.001 aMann/C1Whitney Utest, Chi-square test, and Fisher’s exact test for analysing sex differences; missing data were present on total body fat ( n/C305), physical activity level ( n/C3026), smoking behaviour ( n/C302), and monthly household net income ( n/C3041).Vitamin D intake and its determinants in elderly subjects Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"bFrequencies were dichotomised in never to several times per month (coded as 0) versus several times per week to daily (coded as 1).Vitamin D intake and its determinants in elderly subjects Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
Available from: http://www.dge.,Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"Am J Clin Nutr 2000; 71: 1161 /C15.Vitamin D intake and its determinants in elderly subjects Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
Available from: http://www.bfr.bund.de/cm/350/verwendung_von_ vitaminen_in_lebensmitteln.,Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
"8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 23632 - http://dx.doi.org/10.3402/fnr.v58.23632",Non-OADS,/arxiv_data1/oa_pdf/34/56/FNR-58-23632.PMC4168313.pdf
Competing Interests Both authors have completed the Uniﬁed CompetingInterest form at http://www.icmje.org/coi_disclosure.pdf(available on request from the corresponding author) anddeclare: the studies presented in this manuscript weresponsored by AbbVie.,Non-OADS,/arxiv_data1/oa_pdf/13/88/bcp0078-0094.PMC4168384.pdf
"Competing Interests All authors have completed the uniﬁed Competing Inter-est Form at http://www.icmje.org/coi_disclosure.pdf(available on request from the corresponding author) anddeclare: YF, EM, SMP, DB, and AR are currently employedby the study sponsor (Bristol-Myers Squibb).",Non-OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
Available at http://clinicaltrials.gov/show/NCT01515189 (last accessed 19 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction =Search.Label_ApprovalHistory#labelinfo (last accessed 13 June 2013).,OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
Available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002213/human _med_001465.jsp&mid =WC0b01ac058001d124 (last accessed 13 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
Available at http://www.winpopt .com/index.htm (last accessed 13 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
"PAGE Conference, June 2011, Athens, Greece.Available at http://www.page-meeting.org/?abstract =2229 (last accessed 13 June 2013).",Non-OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
Available at http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/WomensHealthResearch/UCM133184.pdf (last accessed 20 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/6d/1b/bcp0078-0106.PMC4168385.pdf
Competing Interests All authors have completed the Uniﬁed Competing Inter-est form at http://www.icmje.org/coi_disclosure.pdf anddeclare: A-K.H.,Non-OADS,/arxiv_data1/oa_pdf/51/f5/bcp0078-0158.PMC4168390.pdf
Available at http://uu.diva-portal.org/smash/record.jsf?pid =diva2:615277 (last accessed 20 August 2013).,Non-OADS,/arxiv_data1/oa_pdf/51/f5/bcp0078-0158.PMC4168390.pdf
"Competing Interests All authors have completed the Uniﬁed Competing Inter-est form at http://www.icmje.org/coi_disclosure.pdf (avail-able on request from the corresponding author) anddeclare no support from any organization for the submit-ted work, no ﬁnancial relationships with any organizationsthat might have an interest in the submitted work in theprevious 3 years and no other relationships or activitiesthat could appear to have inﬂuenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/5f/e6/bcp0078-0170.PMC4168391.pdf
"addition, missense mutations were hand-curated using LOVD (www.LOVD.nl), IARC (www.iarc.fr), HGMD (www.hgmd.cf.ac.uk), and Alamut (http://www.interactive-biosoftware.com/software/alamut/features) databases.",OADS,/arxiv_data1/oa_pdf/e4/ac/srep04026.PMC4168524.pdf
